
<html lang="en"     class="pb-page"  data-request-id="ea3dd193-6ac2-4a55-81fd-d1bfafde2796"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00440;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2015.58.issue-18;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer’s Disease Brains" /></meta><meta name="dc.Creator" content="Kenji  Matsumura" /></meta><meta name="dc.Creator" content="Masahiro  Ono" /></meta><meta name="dc.Creator" content="Ayane  Kitada" /></meta><meta name="dc.Creator" content="Hiroyuki  Watanabe" /></meta><meta name="dc.Creator" content="Masashi  Yoshimura" /></meta><meta name="dc.Creator" content="Shimpei  Iikuni" /></meta><meta name="dc.Creator" content="Hiroyuki  Kimura" /></meta><meta name="dc.Creator" content="Yoko  Okamoto" /></meta><meta name="dc.Creator" content="Masafumi  Ihara" /></meta><meta name="dc.Creator" content="Hideo  Saji" /></meta><meta name="dc.Description" content="In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer’s disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethen..." /></meta><meta name="Description" content="In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer’s disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethen..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 1, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00440" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00440" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00440" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00440" /></link>
        
    
    

<title>Structure–Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer’s Disease Brains | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00440" /></meta><meta property="og:title" content="Structure–Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer’s Disease Brains" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0014.jpeg" /></meta><meta property="og:description" content="In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer’s disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with or without a dimethyl amino group. In in vitro autoradiography using AD brain sections, all radioiodinated ligands with a dimethyl amino group bound to Aβ deposits in the sections. In contrast, the ligands without a dimethyl amino group showed different patterns of radioactivity accumulation in the sections depending on the kind of heterocycle contained in their molecules. Particularly, a phenylethenyl benzimidazole derivative ([125I]64) showed marked radioactivity accumulation in the temporal lobe which corresponded with the distribution of tau deposits. [125I]64 also showed the most favorable pharmacokinetics in normal mouse brains (3.69 and 0.06% ID/g at 2 and 60 min postinjection, respectively) among all ligands in this study. Taken together, these results suggest that [123I]64 may be a new candidate tau-imaging agent." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00440"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00440">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00440&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00440&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00440&amp;href=/doi/10.1021/acs.jmedchem.5b00440" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 7241-7257</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00367" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00482" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer’s Disease Brains</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Matsumura">Kenji Matsumura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masahiro++Ono">Masahiro Ono</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ayane++Kitada">Ayane Kitada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroyuki++Watanabe">Hiroyuki Watanabe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masashi++Yoshimura">Masashi Yoshimura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shimpei++Iikuni">Shimpei Iikuni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroyuki++Kimura">Hiroyuki Kimura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yoko++Okamoto">Yoko Okamoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masafumi++Ihara">Masafumi Ihara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hideo++Saji">Hideo Saji</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Pathology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan</span></div><div class="corresp-info"><strong>*</strong>Phone +81-75-753-4608. Fax: +81-75-753-4568. E-mail: <a href="/cdn-cgi/l/email-protection#91fefffed1e1f9f0e3fcbffae8fee5febce4bff0f2bffbe1"><span class="__cf_email__" data-cfemail="4f2021200f3f272e3d22612436203b20623a612e2c61253f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00440&amp;href=/doi/10.1021%2Facs.jmedchem.5b00440" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 7241–7257</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 1, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 March 2015</li><li><span class="item_label"><b>Published</b> online</span>1 September 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 September 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00440" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00440</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7241%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKenji%2BMatsumura%252C%2BMasahiro%2BOno%252C%2BAyane%2BKitada%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D18%26contentID%3Dacs.jmedchem.5b00440%26title%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BHeterocyclic%2BPhenylethenyl%2Band%2BPyridinylethenyl%2BDerivatives%2Bas%2BTau-Imaging%2BAgents%2BThat%2BSelectively%2BDetect%2BNeurofibrillary%2BTangles%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2BBrains%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7257%26publicationDate%3DSeptember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00440"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3127</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00440" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationship Study of Heterocyclic Phenylethenyl and Pyridinylethenyl Derivatives as Tau-Imaging Agents That Selectively Detect Neurofibrillary Tangles in Alzheimer’s Disease Brains&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Matsumura&quot;},{&quot;first_name&quot;:&quot;Masahiro&quot;,&quot;last_name&quot;:&quot;Ono&quot;},{&quot;first_name&quot;:&quot;Ayane&quot;,&quot;last_name&quot;:&quot;Kitada&quot;},{&quot;first_name&quot;:&quot;Hiroyuki&quot;,&quot;last_name&quot;:&quot;Watanabe&quot;},{&quot;first_name&quot;:&quot;Masashi&quot;,&quot;last_name&quot;:&quot;Yoshimura&quot;},{&quot;first_name&quot;:&quot;Shimpei&quot;,&quot;last_name&quot;:&quot;Iikuni&quot;},{&quot;first_name&quot;:&quot;Hiroyuki&quot;,&quot;last_name&quot;:&quot;Kimura&quot;},{&quot;first_name&quot;:&quot;Yoko&quot;,&quot;last_name&quot;:&quot;Okamoto&quot;},{&quot;first_name&quot;:&quot;Masafumi&quot;,&quot;last_name&quot;:&quot;Ihara&quot;},{&quot;first_name&quot;:&quot;Hideo&quot;,&quot;last_name&quot;:&quot;Saji&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;7241-7257&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00440&quot;},&quot;abstract&quot;:&quot;In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer’s disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with or without a dimethyl amino group. In in vitro autoradiography using AD brain sections, all radioiodinated ligands with a dimethyl amino group bound to Aβ deposits in the sections. In contrast, the ligands without a dimethyl amino group showed different patterns of radioactivity accumulation in the sections depending on the kind of heterocycle contained in their molecules. Particularly, a phenylethenyl benzimidazole derivative ([125I]64) showed marked radioactivity accumulation in the temporal lobe which corresponded with the distribution of tau deposits. [125I]64 also showed the most favorable pharmacokinetics in normal mouse brains (3.69 and 0.06% ID/g at 2 and 60 min postinjection, respectively) among all ligands in this study. Taken together, these results suggest tha&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00440&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00440" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00440&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00440" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00440&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00440" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00440&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00440&amp;href=/doi/10.1021/acs.jmedchem.5b00440" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00440" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00440" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00440%26sid%3Dliteratum%253Aachs%26pmid%3D26327138%26genre%3Darticle%26aulast%3DMatsumura%26date%3D2015%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationship%2BStudy%2Bof%2BHeterocyclic%2BPhenylethenyl%2Band%2BPyridinylethenyl%2BDerivatives%2Bas%2BTau-Imaging%2BAgents%2BThat%2BSelectively%2BDetect%2BNeurofibrillary%2BTangles%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2BBrains%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D18%26spage%3D7241%26epage%3D7257%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/jmcmar.2015.58.issue-18/20150924/jmcmar.2015.58.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In order to explore novel tau-imaging agents that can selectively detect neurofibrillary tangles in Alzheimer’s disease (AD) brains, we designed and synthesized a series of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with or without a dimethyl amino group. In <i>in vitro</i> autoradiography using AD brain sections, all radioiodinated ligands with a dimethyl amino group bound to Aβ deposits in the sections. In contrast, the ligands without a dimethyl amino group showed different patterns of radioactivity accumulation in the sections depending on the kind of heterocycle contained in their molecules. Particularly, a phenylethenyl benzimidazole derivative ([<sup>125</sup>I]<b>64</b>) showed marked radioactivity accumulation in the temporal lobe which corresponded with the distribution of tau deposits. [<sup>125</sup>I]<b>64</b> also showed the most favorable pharmacokinetics in normal mouse brains (3.69 and 0.06% ID/g at 2 and 60 min postinjection, respectively) among all ligands in this study. Taken together, these results suggest that [<sup>123</sup>I]<b>64</b> may be a new candidate tau-imaging agent.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a representative neurodegenerative disease which currently affects millions of elderly people worldwide. The latest estimates suggest that more than 26.6 million people worldwide suffer from AD today, with predictions that there could be more than 106 million patients with AD by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> After the age of 65, the risk of developing AD doubles every 5 years so that by the age of 85, some recent studies suggest that ∼50% of individuals will have the disease.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This means that early therapeutic interventions may lead to the prevention of irreversible neuronal damage caused by the disease. However, a definitive diagnosis still relies on the post-mortem examination of human brains. Although the mechanism leading to clinical AD symptoms is not completely understood, the progressive accumulation of senile plaques (SP) made up of amyloid β peptides (Aβ) and neurofibrillary tangles (NFT) composed of hyperphosphorylated tau protein are regarded as two neuropathological hallmarks of the disease. Since these markers probably appear many years prior to the cognitive symptoms of AD, detecting Aβ and/or tau <i>in vivo</i> may lead to an early diagnosis. In recent years, much effort has been focused on the development of diagnostic methods for the disease.</div><div class="NLM_p">Positron emission tomography (PET) and single photon emission computed tomography (SPECT) are useful for imaging Aβ and/or tau noninvasively in living brain tissue. Since deposits of Aβ have been demonstrated in the early stages of the disease process,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> PET- and SPECT-imaging agents targeting Aβ, such as [<sup>11</sup>C]PIB,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> [<sup>11</sup>C]SB-13,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> [<sup>11</sup>C]BF-227,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> [<sup>18</sup>F]GE067 (flutemetamol),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> [<sup>18</sup>F]BAY94-9172 (florbetaben),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> [<sup>18</sup>F]AV-45 (florbetapir),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> [<sup>123</sup>I]IMPY,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> [<sup>18</sup>F]AZD4694 ([<sup>18</sup>F]NAV4694),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and [<sup>18</sup>F]FIBT<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> have been developed. Some of them have been applied for clinical studies and facilitated the imaging of Aβ in living brains. Since these agents have enabled us to visualize the deposits of Aβ in AD brains, which have been confirmed only by the post-mortem examination so far, they have been used as one of the tools for the diagnosis of AD.</div><div class="NLM_p">Among these agents, [<sup>11</sup>C]PIB is considered as one of the gold standards of Aβ imaging and has been used in many clinical studies, demonstrating its utility. Moreover, [<sup>18</sup>F]AV-45, [<sup>18</sup>F]GE067, and [<sup>18</sup>F]BAY94-9172 have been approved by the U.S. FDA over the past few years and applied to clinical studies in order to elucidate the relationship between Aβ deposits and the severity of clinical symptoms of AD. However, some clinical studies on Aβ imaging using [<sup>11</sup>C]PIB have shown a poor association between the density of Aβ deposits and the severity of dementia or neuronal loss.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> These studies suggest that it is not possible to diagnose AD with a high level of accuracy only by Aβ imaging. Meanwhile, many candidates for anti-Aβ drugs have been developed to reduce the amount of Aβ.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> However, some clinical trials of these drugs have ended in failure, indicating that other markers expressed downstream of Aβ deposits may be better suited to evaluate the disease progression.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a></div><div class="NLM_p">The combination of the increased cerebrospinal fluid (CSF) concentrations of total tau and phosphorylated tau and decreased concentration of Aβ may act as pathological CSF biomarker signatures that are diagnostic criteria for AD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, lumbar puncture is still considered to be an invasive procedure for the widespread screening of the population. Additionally, CSF measurements do not provide information on regional brain deposits of tau, which may have clear correlations with cognition or regional brain atrophy, and might not be able to provide important information regarding the therapeutic outcomes or response to current drugs aimed at modulating the amount of tau, such as immunotherapy.</div><div class="NLM_p">The accumulation of tau occurs in the transentorhinal area, followed by the involvement of the entorhinal cortex and hippocampus, progressing to all isocortical association areas.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> The distribution of tau deposits corresponds with the severity of clinical symptoms of AD.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23-26)</a> There are several PET-imaging agents targeting tau, such as [<sup>18</sup>F]THK-5105,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> [<sup>18</sup>F]THK-5117,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> [<sup>18</sup>F]T807,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> [<sup>18</sup>F]T808,<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> [<sup>11</sup>C]PBB3,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> [<sup>11</sup>C]NML,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> [<sup>18</sup>F]NML,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and <sup>18</sup>F-labeled or <sup>11</sup>C-labeled astemizole derivatives.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Some of these agents have been investigated clinically, and their radioactivity accumulation in living brains corresponded to the distribution of tau deposits reported previously. In contrast, the approach in developing SPECT-imaging agents targeting tau in living brains has markedly lagged behind. Since SPECT imaging has advantages in terms of the operating cost and already-installed rate in medical hospitals, it may be more suitable as primary screening for AD patients than PET imaging. Therefore, further investigations are needed to develop useful tau-imaging agents for SPECT. Recently, we reported radioiodinated ligands such as [<sup>125</sup>I]TH2,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> [<sup>125</sup>I]3-OI,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> [<sup>125</sup>I]PDB-3,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and [<sup>125</sup>I]SBIM-3<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> as tau-imaging agents for SPECT. Some <i>in vitro</i> autoradiographic and fluorescent-staining experiments showed the binding affinity of these agents for tau deposits in AD brain sections. Among these agents, [<sup>125</sup>I]SBIM-3 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A) based on a benzimidazole scaffold showed a higher initial uptake into (3.28% ID/g at 2 min postinjection) and more rapid clearance from (0.33% ID/g at 60 min postinjection) normal mouse brains than any other agent. However, [<sup>125</sup>I]SBIM-3 (or SBIM-3) also showed marked binding affinity for Aβ in <i>in vitro</i> autoradiographic and fluorescent-staining experiments using AD brain sections, indicating that further improvement of the ligands is necessary to develop more useful tau-imaging agents which have a higher affinity for tau and lower affinity for Aβ than SBIM-3. On comparing <i>in vitro</i> autoradiography of [<sup>125</sup>I]PDB-3 based on a benzothiazole scaffold with that of [<sup>125</sup>I]SBIM-3, we observed some differences in the distribution of their radioactivity accumulation in AD brain sections. These results suggest that the heterocyclic moiety may be involved in the binding affinity for tau and/or Aβ deposits in AD brains.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy for this work (A). Chemical structure of phenylethenyl and (3-pyridinyl)ethenyl benzothiazole (B), benzoxazole (C), benzofuran (D), benzothiophene (E), and benzimidazole (F) derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the present study, we planned to replace the benzimidazole scaffold in SBIM-3 with other aromatic heterocycles such as benzothiazole, benzoxazole, benzofuran, and benzothiophene, and investigated the binding affinity for tau and Aβ. Additionally, since most Aβ-imaging agents, such as [<sup>11</sup>C]PIB, [<sup>18</sup>F]GE067, [<sup>18</sup>F]BAY94-9172, and [<sup>18</sup>F]AV-45, contain an amino group in their molecules,<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11">(4-11)</a> the moiety may be important for the interaction with Aβ. Therefore, we also designed and synthesized ligands with or without a dimethyl amino group in molecules to investigate the effect of the dimethyl amino group on the binding affinity for tau and Aβ. Moreover, in our previous studies, we succeeded in improving the pharmacokinetics in normal mouse brains by exchanging a phenyl group with a pyridyl group in molecules.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> On the basis of this knowledge, we also planned to substitute a phenyl group with a pyridyl group in molecules to develop agents which display more favorable pharmacokinetics in brains.</div><div class="NLM_p last">Consequently, based on the design strategy described above, we synthesized novel phenylethenyl and (3-pyridinyl)ethenyl derivatives which contained a different type of heterocycle in their molecules (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B–F) and investigated the binding affinity for tau and Aβ deposits in AD brains and pharmacokinetics in normal mouse brains. To our knowledge, this is the first report on the structure–activity relationship study focused on the effect of a heterocyclic moiety and dimethyl amino group on the selective binding affinity for tau deposits in AD brains and pharmacokinetics in normal mouse brains.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthetic routes of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives are outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>, <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Nineteen novel iodinated ligands (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B–F) and tributyltin precursors were successfully prepared according to conventional methods and verified with <sup>1</sup>H NMR, MS (ESI or APCI), and HRMS (EI).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzothiazole Derivatives (A) and Their Precursors (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Phenylethenyl (A) and (3-Pyridinyl)ethenyl (B) Benzoxazole Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzofuran Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzothiophene Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes for Phenylethenyl Benzimidazole Derivatives (A), Their Precursors (B), (3-Pyridinyl)ethenyl Benzimidazole Derivatives (C), and Their Precursors (D)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Phenylethenyl and (3-pyridinyl)ethenyl benzothiazole derivatives (<b>3</b>, <b>4</b>, <b>5</b>, <b>6</b>, <b>9</b>, <b>10</b>, <b>11</b>, and <b>12</b>) were obtained by a condensation reaction between each carbaldehyde with 6-bromo-2-methylbenzothiazole or 6-iodo-2-methylbenzothiazole, as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The bromo ligands (<b>9</b>, <b>10</b>, <b>11</b>, and <b>12</b>) were then reacted with bis(tributyltin) using Pd(0) as the catalyst, and the corresponding tributyltin precursors (<b>13</b>, <b>14</b>, <b>15</b>, and <b>16</b>) were obtained. Other heterocyclic (benzoxazole, benzofuran, and benzothiophene) phenylethenyl and (3-pyridinyl)ethenyl derivatives were also obtained by a condensation reaction between two reagents, as shown in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>, <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, and <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, respectively. Then, the corresponding tributyltin precursors were obtained by the same reaction described above. These tributyltin precursors were readily reacted with iodine in chloroform at room temperature to yield iodo ligands. Phenylethenyl and (3-pyridinyl)ethenyl benzimidazole derivatives (<b>64</b>, <b>65</b>, <b>70</b>, <b>71</b>, <b>72</b>, and <b>73</b>) were obtained by an intermolecular cyclization reaction between 4-iodobenzene-1,2-diamine or 4-bromobenzene-1,2-diamine with cinnamaldehyde, <b>68</b>, or <b>69</b> using Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> as an oxidant agent. Derivatives <b>66</b>, <b>74</b>, and <b>75</b> were obtained by protecting the amino groups of <b>65</b>, <b>72</b>, and <b>73</b> with a <i>tert</i>-butoxycarbonyl (Boc) group. Derivatives <b>67</b>, <b>76</b>, and <b>77</b> were obtained using the same reaction as described above. Purities of key ligands were shown to be higher than 95% by high-performance liquid chromatography (HPLC).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Immunohistochemical Staining Using AD Brain Sections</h3><div class="NLM_p">After confirmation of the distribution of tau and Aβ deposits in brain sections from an AD patient by immunohistochemical staining, we used them for the following experiments. In our previous studies, we had difficulty evaluating the binding affinity of ligands for tau and Aβ deposits in AD brains by <i>in vitro</i> autoradiography since we used only brain sections from the temporal lobe, where both tau and Aβ accumulated abundantly. To further verify the binding affinity of the ligands for tau deposits clearly, we needed to carry out fluorescent-staining experiments by which we could observe images with a higher resolution than by <i>in vitro</i> autoradiography. In the present study, to evaluate the binding affinity of ligands for tau and Aβ by <i>in vitro</i> autoradiography more clearly than before, we used AD brain sections from two different regions, the basal frontal and temporal lobes. It is well known that tau and Aβ accumulate at different proportions in these regions. First, we carried out immunohistochemical staining of tau and Aβ using the sections from the frontal lobe. We confirmed that Aβ accumulated abundantly in the cortex of the frontal lobe (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A), whereas there were no tau deposits in the same region (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). Next, we also carried out the same staining using the sections from the temporal lobe. Similarly to the sections from the frontal lobe, we observed Aβ deposits in the cortex of the temporal lobe (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). Although we also observed abundant deposits of tau in the same region (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D), the pattern of tau deposits was completely different from that of Aβ deposits. Therefore, we used these brain sections to determine the selective binding affinity for tau according to the criteria that favorable tau-imaging agents should accumulate in the sections from the temporal lobe, not the frontal lobe. On the basis of the points described above, we carried out the following <i>in vitro</i> autoradiographic experiments.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Immunohistochemical staining with antibodies against Aβ<sub>1–42</sub> (BC05: A and C) and phosphorylated tau (AT8: B and D) in sections of the frontal lobe (A and B) and temporal lobe (C and D) from an AD patient (76-year-old male).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Radiolabeling</h3><div class="NLM_p">In accordance with the solvent and HPLC conditions as shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Table S1</a>, we carried out radiolabeling of each ligand. The radioiodinated ligands with a benzothiazole, benzoxazole, benzofuran, and benzothiophene moiety were prepared from the corresponding tributyltin precursors through an iododestannylation reaction using hydrogen peroxide as an oxidant with a radiochemical yield of 12–85% (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>A). The radioiodinated ligands with a benzimidazole moiety were prepared from the corresponding tributyltin precursors through the iododestannylation reaction followed by stirring with TFA to remove the Boc-protecting groups, with a radiochemical yield of 25–40% (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>B). After purification by HPLC, the specific activity of the no-carrier-added preparation was comparable to that of [<sup>125</sup>I]NaI (81.4 TBq/mmol). Finally, the identity of each ligand was verified with HPLC by coinjection with a nonradioactive ligand from HPLC data. All radioiodinated ligands were obtained with a radiochemical purity of >95% after purification by HPLC. It is well known that phenylethenyl and pyridinylethenyl derivatives show photoisomerization.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> We observed two signal peaks of almost all heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives on HPLC analysis, which indicated that these derivatives showed photoisomerization (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Table S1</a>).</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Two Radiolabeling Methods of Heterocyclic Phenylethenyl and (3-Pyridinyl)ethenyl Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vitro</i> Autoradiography</h3><div class="NLM_p">In our previous studies, we carried out binding experiments using recombinant tau aggregates to quantify the binding affinity of ligands for tau.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> However, a previous study indicated that these aggregates do not completely imitate the conformation of native tau deposits in AD brains.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Since an assay using human brain samples from AD patients may provide more reliable information on the tau–ligand interaction than that using recombinant tau aggregates, such an experiment is commonly used in other research.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Therefore, in the present study, we planned to evaluate the binding affinity of ligands for tau based on <i>in vitro</i> autoradiography using AD brain sections.</div><div class="NLM_p">First, radioiodinated heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with a dimethyl amino group (including [<sup>125</sup>I]SBIM-3, which we previously reported as a tau-imaging agent<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>) were investigated for the binding affinity for tau and Aβ by <i>in vitro</i> autoradiography using the AD brain sections, as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and B shows the autoradiographic images of a phenylethenyl benzothiazole derivative ([<sup>125</sup>I]<b>3</b>). <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C and D shows the autoradiographic images of a (3-pyridinyl)ethenyl benzothiazole derivative ([<sup>125</sup>I]<b>4</b>). We observed marked radioactivity accumulation of [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>4</b> in the cortexes of both the frontal and temporal lobes (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A–D). Since we observed only Aβ deposits in the frontal lobe (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A and B), the radioactivity accumulation of [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>4</b> in the cortex of the frontal lobe indicated that these ligands bound to Aβ strongly (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B and D). The level of radioactivity accumulation of both ligands, especially [<sup>125</sup>I]<b>4</b>, in the white matter of the brain was relatively low, indicating the nonspecific binding of these ligands in the AD brain to be low. Ligands such as [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>4</b>, which have a high binding affinity for Aβ, strongly bind to Aβ deposits in the temporal lobe. As a result, the signal from the ligands binding to Aβ was so overwhelming that the signal from the ligands binding to tau was obscured (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and C). In addition to [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>4</b>, other heterocyclic derivatives with a dimethyl amino group also accumulated in the cortex of the frontal lobe, which indicated these ligands had marked affinity for Aβ (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>F, H, J, L, N, P, R, and T). Although we could not clearly evaluate the binding affinity for tau in the brain sections by <i>in vitro</i> autoradiography (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, C, E, G, I, K, M, O, Q, and S), we confirmed that these ligands bound to tau by fluorescent-staining experiments (the fluorescent-staining image using compound <b>3</b> was shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S1</a>). These results suggest that heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with a dimethyl amino group bind to Aβ, and the difference in the heterocyclic moiety in their molecules did not markedly affect their radioactivity accumulation in the cortex of the AD brain. In our previous study, we confirmed that [<sup>125</sup>I]SBIM-3, a phenylethenyl benzimidazole derivative with a dimethyl amino group, bound to both tau and Aβ deposits in AD brain sections.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In the present study, we observed the reproducibility of the binding of SBIM-3 to these deposits in another AD patient’s brain.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>3</b> (A and B), [<sup>125</sup>I]<b>4</b> (C and D), [<sup>125</sup>I]<b>28</b> (E and F), [<sup>125</sup>I]<b>22</b> (G and H), [<sup>125</sup>I]<b>43</b> (I and J), [<sup>125</sup>I]<b>44</b> (K and L), [<sup>125</sup>I]<b>59</b> (M and N), [<sup>125</sup>I]<b>60</b> (O and P), [<sup>125</sup>I]SBIM-3 (Q and R), and [<sup>125</sup>I]<b>70</b> (S and T) in brain sections from the AD patient. A, C, E, G, I, K, M, O, Q, and S are the sections from the temporal lobe. B, D, F, H, J, L, N, P, R, and T are the sections from the frontal lobe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Radioiodinated heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives without a dimethyl amino group were also analyzed with <i>in vitro</i> autoradiography (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A–T). <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and B shows the autoradiographic images of a phenylethenyl benzothiazole derivative ([<sup>125</sup>I]<b>5</b>). <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C and D shows the autoradiographic images of a (3-pyridinyl)ethenyl benzothiazole derivative ([<sup>125</sup>I]<b>6</b>). As well as [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>4</b>, these images showed marked radioactivity accumulation of [<sup>125</sup>I]<b>5</b> and [<sup>125</sup>I]<b>6</b> in the cortexes of both the frontal and temporal lobes, respectively (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A–D). Despite the elimination of a dimethyl amino group, we could not identify any improvement in the selective binding affinity of these ligands for tau deposits in the AD brain. These results indicated that the benzothiazole moiety still had such high binding affinity for Aβ that the signal from the ligand bound to Aβ still overwhelmed the signal from the ligand bound to tau. On the basis of many previous studies regarding Aβ-imaging agents, it is well known that the substituted amino group plays an important role in binding to Aβ deposits in AD brains. However, the results of this experiment also indicated that a heterocyclic moiety in molecules may be as important to the binding affinity for Aβ as the substituted amino group. Similarly to [<sup>125</sup>I]<b>5</b> and [<sup>125</sup>I]<b>6</b>, other heterocyclic (benzoxazole, benzofuran, and benzothiophene) derivatives bound to Aβ (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>F, H, J, L, N, and P). Although we could not identify any effect of the elimination of a dimethyl amino group from these ligands, only phenylethenyl and (3-pyridinyl)ethenyl benzimidazole derivatives showed interesting results. While benzimidazole derivatives with a dimethyl amino group ([<sup>125</sup>I]SBIM-3 and [<sup>125</sup>I]<b>70</b>) bound to Aβ deposits in the cortex of the frontal lobe (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>R and T), benzimidazole derivatives without the dimethyl amino group ([<sup>125</sup>I]<b>64</b> and [<sup>125</sup>I]<b>71</b>) did not show marked radioactivity accumulation in the cortex of the frontal lobe, where only Aβ accumulated abundantly (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>R and T). The results indicated that the binding affinity of [<sup>125</sup>I]<b>64</b> and [<sup>125</sup>I]<b>71</b> for Aβ was markedly decreased because of the elimination of the dimethyl amino group from [<sup>125</sup>I]SBIM-3 and [<sup>125</sup>I]<b>70</b>. Conversely, radioactivity accumulation of these ligands in the cortex of the temporal lobe was maintained, which indicated that these ligands still had the binding affinity for tau even after the removal of the dimethyl amino group (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>Q and S). Since the level of the nonspecific binding of [<sup>125</sup>I]<b>64</b> in the white matter of the brain was lower than that of [<sup>125</sup>I]<b>71</b>, we could obtain a clear autoradiographic image using [<sup>125</sup>I]<b>64</b>. Compared to the pattern of radioactivity accumulation of [<sup>125</sup>I]<b>64</b> in the cortex of the temporal lobe with that of tau and Aβ deposits, the radioactivity accumulation of [<sup>125</sup>I]<b>64</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>V) corresponded with tau deposits (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>U) more closely than Aβ deposits (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>W). Moreover, [<sup>125</sup>I]<b>64</b> showed almost no accumulation in a control brain section (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S2</a>).</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>5</b> (A and B), [<sup>125</sup>I]<b>6</b> (C and D), [<sup>125</sup>I]<b>23</b> (E and F), [<sup>125</sup>I]<b>29</b> (G and H), [<sup>125</sup>I]<b>45</b> (I and J), [<sup>125</sup>I]<b>46</b> (K and L), [<sup>125</sup>I]<b>61</b> (M and N), [<sup>125</sup>I]<b>62</b> (O and P), [<sup>125</sup>I]<b>64</b> (Q and R), and [<sup>125</sup>I]<b>71</b> (S and T) in brain sections from the AD patient. A, C, E, G, I, K, M, O, Q, and S are the sections from the temporal lobe. B, D, F, H, J, L, N, P, R, and T are the sections from the frontal lobe. U, V, and W are high magnification images of <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D, panel Q from this figure, and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we quantitatively evaluated the relationship between the radioactivity accumulation of [<sup>125</sup>I]<b>64</b> in the sections and the density of tau and Aβ deposits based on the results of <i>in vitro</i> autoradiography and immunohistochemical staining. The cortexes of the frontal and temporal lobes are divided into four (gyrus cinguli, gyrus rectus, gyrus orbitalis, and gyrus frontalis inferior) and six (gyrus temporalis transversalis, gyrus temporalis superior, gyrus temporalis medius, gyrus temporalis inferior, gyrus parahippocampalis, and hippocampus) regions, respectively. Then, the proportion of tau and Aβ deposits in each region was calculated, respectively. The radioactivity accumulation of [<sup>125</sup>I]<b>64</b> in the cortex of each region was also quantified. Finally, we compared the quantified radioactivity accumulation of [<sup>125</sup>I]<b>64</b> with the proportion of tau and Aβ deposits in each region. As described above, we observed only Aβ deposits in the frontal lobe (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a–d, red columns). In the temporal lobe, the proportion of tau deposits was much higher than that of Aβ deposits (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>e–j, blue and red columns, respectively). Compared to the calculated radioactivity accumulation of [<sup>125</sup>I]<b>64</b> in each region with the proportion of tau and Aβ deposits in the corresponding region, the distribution of [<sup>125</sup>I]<b>64</b> corresponded with that of tau deposits more closely than that of Aβ deposits (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a–j, green columns). Although the radioactivity accumulation of the other heterocyclic derivatives without a dimethyl amino group ([<sup>125</sup>I]<b>5</b>, [<sup>125</sup>I]<b>6</b>, [<sup>125</sup>I]<b>23</b>, [<sup>125</sup>I]<b>29</b>, [<sup>125</sup>I]<b>45</b>, [<sup>125</sup>I]<b>46</b>, [<sup>125</sup>I]<b>61</b>, [<sup>125</sup>I]<b>62</b>, and [<sup>125</sup>I]<b>71</b>) showed poorer correspondence with the distribution of tau deposits (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S3</a>), [<sup>125</sup>I]<b>64</b> could selectively detect tau deposits in the AD brain. In a previous study, a ligand based on a benzimidazole scaffold with a diethyl amino group, BF-126, clearly stained tau deposits in <i>in vitro</i> fluorescent-staining experiments using AD brain sections.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, another study also suggested that the ligand has a sufficient affinity to stain Aβ deposits in AD brains depending on its concentration.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Similarly, we confirmed that SBIM-3, a phenylethenyl benzimidazole derivative with a dimethyl amino group, had the binding affinity for both tau and Aβ deposits in the AD brain sections, as shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>Q and R. Therefore, the results of <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>64</b>, as presented in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>Q and R, strongly suggested that the higher selective binding affinity of [<sup>125</sup>I]<b>64</b> for tau deposits than [<sup>125</sup>I]SBIM-3 should be due to the elimination of the dimethyl amino group. However, the radioactivity accumulation of [<sup>125</sup>I]<b>64</b> in the white matter of the brain was relatively high, indicating that further molecular modifications of <b>64</b> were needed to develop ligands which show lower nonspecific binding.</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Radioactivity of [<sup>125</sup>I]<b>64</b> that accumulated in the cortexes of the frontal and temporal lobes (green columns) and the percent areas of immunostaining for tau (blue columns) and Aβ (red columns) in the same region. The cortexes of the frontal and temporal lobes were divided into four (a, b, c, and d) and six (e, f, g, h, i, and j) regions, respectively. The regions a, b, c, and d are gyrus cinguli, gyrus rectus, gyrus orbitalis, and gyrus frontalis inferior, respectively. The regions e, f, g, h, i, and j are gyrus temporalis transversalis, gyrus temporalis superior, gyrus temporalis medius, gyrus temporalis inferior, gyrus parahippocampalis, and hippocampus, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further investigate the selectivity of these ligands for tau, we calculated the ratios of the radioactivity accumulation of each ligand in the cortex of the temporal lobe to that in the cortex of the frontal lobe (T/F values). Since the level of Aβ deposits in the frontal lobe is equivalent to that in the temporal lobe, it should be possible to evaluate the selective binding of the ligands for tau deposits in the AD brain by calculating of the T/F values of each ligand. The T/F values of each ligand were calculated as shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. [<sup>125</sup>I]<b>64</b> displayed the highest T/F value (T/F value of [<sup>125</sup>I]<b>64</b> = 5.85) among all ligands without a dimethyl amino group (T/F values of the other ligands = 0.87–2.62), suggesting that [<sup>125</sup>I]<b>64</b> is a promising lead ligand for the development of useful tau-imaging agents.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chemical Structure of Heterocyclic Phenylethenyl and (3-Pyridinyl)ethenyl Derivatives without a Dimethyl Amino Group and the T/F Values of These Ligands</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ligands</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">T/F value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>5</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>6</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>23</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">0.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>29</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>45</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">2.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>46</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>61</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">1.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>62</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>64</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">5.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>71</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">1.09</td></tr></tbody></table></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>In Vivo</i> Biodistribution in Normal Mice</h3><div class="NLM_p">To evaluate the uptake of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives into brains, a biodistribution study in normal mice was performed with each ligand, as shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S4</a>. Since there are no tau deposits in normal mice, a high initial uptake and rapid clearance from the brain are thought to be highly desirable properties of useful tau-imaging agents. In general, radiotracers with moderate lipophilicity, indicated by log D<sub>7.4</sub> values in the approximate range 2.0–3.5, show optimal passive brain uptake <i>in vivo</i>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Since the log D<sub>7.4</sub>-values of these ligands indicated that these ligands displayed uptake into normal mouse brains (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). We confirmed that all ligands displayed uptake into the brains and different pharmacokinetics depending on the kind of heterocycle contained in the molecule (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Compared with the ratios of the uptake of ligands into brains at 2 and 60 min after injection (brain<sub>2 min</sub> and brain<sub>60 min</sub>, respectively), phenylethenyl and (3-pyridinyl)ethenyl benzimidazole derivatives (brain<sub>2 min</sub>/brain<sub>60 min</sub> = 9.94–61.5) showed the highest ratios, followed in order by phenylethenyl and (3-pyridinyl)ethenyl benzoxazole (brain<sub>2 min</sub>/brain<sub>60 min</sub> = 1.16–16.5), benzothiazole (brain<sub>2 min</sub>/brain<sub>60 min</sub> = 1.27–12.5), benzofuran (brain<sub>2 min</sub>/brain<sub>60 min</sub> = 0.90–4.72), and benzothiophene (brain<sub>2 min</sub>/brain<sub>60 min</sub> = 0.70–2.13) derivatives. In particular, the uptake of [<sup>125</sup>I]<b>64</b>, which showed the selective binding affinity for tau in <i>in vitro</i> autoradiography, into brains at 2 min after the injection was 3.69% ID/g. Moreover, [<sup>125</sup>I]<b>64</b> also showed a rapid clearance from the brain (brain<sub>60 min</sub> of [<sup>125</sup>I]<b>64</b> was 0.06% ID/g). As a result, the brain<sub>2 min</sub>/brain<sub>60 min</sub> ratio of [<sup>125</sup>I]<b>64</b> was 61.5, equivalent to or higher than those of [<sup>18</sup>F]THK-5105,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> [<sup>18</sup>F]THK-5117,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> [<sup>18</sup>F]T807,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> [<sup>18</sup>F]T808,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and [<sup>11</sup>C]PBB3<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> reported previously as tau-imaging agents (9.20, 23.3, 7.17 (the ratio of brain<sub>5 min</sub>/brain<sub>30 min</sub>), 2.91 (the ratio of brain<sub>2.5 min</sub>/brain<sub>20 min</sub>), and 64.0, respectively). [<sup>125</sup>I]<b>64</b> displayed a high uptake in the liver (liver<sub>2 min</sub> = 17.1% ID/g) and kidney (kidney<sub>2 min</sub> = 12.3% ID/g) followed by a rapid clearance (liver<sub>60 min</sub> = 2.65% ID/g and kidney<sub>60 min</sub> = 2.30% ID/g), while the intestine exhibited an accumulation of radioactivity over time (intestine<sub>60 min</sub> = 30.6% ID/g). The accumulation in the thyroid (thyroid<sub>60 min</sub> = 0.11% ID) suggested that [<sup>125</sup>I]<b>64</b> may be stable for deiodination <i>in vivo</i> by 60 min after the injection (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Table S2</a>). On the basis of <i>in vitro</i> autoradiography using the AD brain sections and <i>in vivo</i> biodistribution in normal mice for these series of compounds, [<sup>125</sup>I]<b>64</b>, which exhibits the highest selective binding affinity for tau and the most favorable pharmacokinetics in normal mouse brains, was selected for further biological evaluation.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Brain Uptake of Radioactivity after the Injection of Each Derivative in Normal Mice<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>, Ratio of Radioactivity Accumulation at 2 and 60 min Postinjection (brain<sub>2 min</sub>/brain<sub>60 min</sub>), and log D<sub>7.4</sub> Values</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">time after injection (min)</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ligands</th><th class="colsep0 rowsep0" align="center">2</th><th class="colsep0 rowsep0" align="center">10</th><th class="colsep0 rowsep0" align="center">30</th><th class="colsep0 rowsep0" align="center">60</th><th class="colsep0 rowsep0" align="center">brain<sub>2 min</sub>/brain<sub>60 min</sub></th><th class="colsep0 rowsep0" align="center">log D<sub>7.4</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>3</b></td><td class="colsep0 rowsep0" align="left">1.49 (0.18)</td><td class="colsep0 rowsep0" align="left">1.72 (0.28)</td><td class="colsep0 rowsep0" align="left">1.79 (0.22)</td><td class="colsep0 rowsep0" align="left">1.41 (0.35)</td><td class="colsep0 rowsep0" align="left">1.27<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>4</b></td><td class="colsep0 rowsep0" align="left">2.48 (0.36)</td><td class="colsep0 rowsep0" align="left">2.83 (0.20)</td><td class="colsep0 rowsep0" align="left">1.96 (0.18)</td><td class="colsep0 rowsep0" align="left">1.21 (0.27)</td><td class="colsep0 rowsep0" align="left">2.34<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>5</b></td><td class="colsep0 rowsep0" align="left">2.48 (0.24)</td><td class="colsep0 rowsep0" align="left">2.78 (0.12)</td><td class="colsep0 rowsep0" align="left">2.34 (0.27)</td><td class="colsep0 rowsep0" align="left">1.58 (0.19)</td><td class="colsep0 rowsep0" align="left">1.76<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>6</b></td><td class="colsep0 rowsep0" align="left">3.75 (0.40)</td><td class="colsep0 rowsep0" align="left">2.15 (0.11)</td><td class="colsep0 rowsep0" align="left">0.68 (0.07)</td><td class="colsep0 rowsep0" align="left">0.30 (0.07)</td><td class="colsep0 rowsep0" align="left">12.5</td><td class="colsep0 rowsep0" align="left">3.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>28</b></td><td class="colsep0 rowsep0" align="left">2.09 (0.22)</td><td class="colsep0 rowsep0" align="left">2.01 (0.09)</td><td class="colsep0 rowsep0" align="left">2.08 (0.16)</td><td class="colsep0 rowsep0" align="left">1.80 (0.14)</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">3.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>22</b></td><td class="colsep0 rowsep0" align="left">2.88 (0.10)</td><td class="colsep0 rowsep0" align="left">3.20 (0.21)</td><td class="colsep0 rowsep0" align="left">1.93 (0.28)</td><td class="colsep0 rowsep0" align="left">1.10 (0.08)</td><td class="colsep0 rowsep0" align="left">2.91<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>23</b></td><td class="colsep0 rowsep0" align="left">3.90 (0.17)</td><td class="colsep0 rowsep0" align="left">3.32 (0.19)</td><td class="colsep0 rowsep0" align="left">2.67 (0.27)</td><td class="colsep0 rowsep0" align="left">1.75 (0.18)</td><td class="colsep0 rowsep0" align="left">2.23</td><td class="colsep0 rowsep0" align="left">3.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>29</b></td><td class="colsep0 rowsep0" align="left">5.61 (0.61)</td><td class="colsep0 rowsep0" align="left">2.87 (0.31)</td><td class="colsep0 rowsep0" align="left">0.78 (0.10)</td><td class="colsep0 rowsep0" align="left">0.34 (0.05)</td><td class="colsep0 rowsep0" align="left">16.5</td><td class="colsep0 rowsep0" align="left">3.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>43</b></td><td class="colsep0 rowsep0" align="left">1.05 (0.07)</td><td class="colsep0 rowsep0" align="left">1.15 (0.05)</td><td class="colsep0 rowsep0" align="left">1.10 (0.12)</td><td class="colsep0 rowsep0" align="left">1.17 (0.11)</td><td class="colsep0 rowsep0" align="left">0.90</td><td class="colsep0 rowsep0" align="left">2.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>44</b></td><td class="colsep0 rowsep0" align="left">1.30 (0.15)</td><td class="colsep0 rowsep0" align="left">1.58 (0.16)</td><td class="colsep0 rowsep0" align="left">1.42 (0.09)</td><td class="colsep0 rowsep0" align="left">1.07 (0.21)</td><td class="colsep0 rowsep0" align="left">1.48<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>45</b></td><td class="colsep0 rowsep0" align="left">1.09 (0.09)</td><td class="colsep0 rowsep0" align="left">1.47 (0.12)</td><td class="colsep0 rowsep0" align="left">1.44 (0.13)</td><td class="colsep0 rowsep0" align="left">1.40 (0.14)</td><td class="colsep0 rowsep0" align="left">1.05<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>46</b></td><td class="colsep0 rowsep0" align="left">2.88 (0.22)</td><td class="colsep0 rowsep0" align="left">2.53 (0.17)</td><td class="colsep0 rowsep0" align="left">1.38 (0.25)</td><td class="colsep0 rowsep0" align="left">0.61 (0.11)</td><td class="colsep0 rowsep0" align="left">4.72</td><td class="colsep0 rowsep0" align="left">3.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>59</b></td><td class="colsep0 rowsep0" align="left">0.87 (0.07)</td><td class="colsep0 rowsep0" align="left">0.84 (0.09)</td><td class="colsep0 rowsep0" align="left">0.93 (0.08)</td><td class="colsep0 rowsep0" align="left">0.88 (0.09)</td><td class="colsep0 rowsep0" align="left">1.06<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>60</b></td><td class="colsep0 rowsep0" align="left">1.41 (0.14)</td><td class="colsep0 rowsep0" align="left">1.86 (0.11)</td><td class="colsep0 rowsep0" align="left">1.47 (0.07)</td><td class="colsep0 rowsep0" align="left">1.13 (0.09)</td><td class="colsep0 rowsep0" align="left">1.65<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>61</b></td><td class="colsep0 rowsep0" align="left">0.98 (0.05)</td><td class="colsep0 rowsep0" align="left">1.16 (0.09)</td><td class="colsep0 rowsep0" align="left">1.31 (0.04)</td><td class="colsep0 rowsep0" align="left">1.40 (0.05)</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">2.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>62</b></td><td class="colsep0 rowsep0" align="left">2.41 (0.10)</td><td class="colsep0 rowsep0" align="left">2.56 (0.23)</td><td class="colsep0 rowsep0" align="left">1.81 (0.13)</td><td class="colsep0 rowsep0" align="left">1.20 (0.13)</td><td class="colsep0 rowsep0" align="left">2.13<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]SBIM-3<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">3.28 (0.25)</td><td class="colsep0 rowsep0" align="left">1.61 (0.18)</td><td class="colsep0 rowsep0" align="left">0.68 (0.11)</td><td class="colsep0 rowsep0" align="left">0.33 (0.06)</td><td class="colsep0 rowsep0" align="left">9.94</td><td class="colsep0 rowsep0" align="left">2.23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>70</b></td><td class="colsep0 rowsep0" align="left">2.85 (0.53)</td><td class="colsep0 rowsep0" align="left">1.22 (0.06)</td><td class="colsep0 rowsep0" align="left">0.26 (0.04)</td><td class="colsep0 rowsep0" align="left">0.08 (0.01)</td><td class="colsep0 rowsep0" align="left">35.6</td><td class="colsep0 rowsep0" align="left">3.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>64</b></td><td class="colsep0 rowsep0" align="left">3.69 (0.23)</td><td class="colsep0 rowsep0" align="left">1.20 (0.08)</td><td class="colsep0 rowsep0" align="left">0.18 (0.02)</td><td class="colsep0 rowsep0" align="left">0.06 (0.01)</td><td class="colsep0 rowsep0" align="left">61.5</td><td class="colsep0 rowsep0" align="left">3.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>71</b></td><td class="colsep0 rowsep0" align="left">3.21 (0.26)</td><td class="colsep0 rowsep0" align="left">0.61 (0.08)</td><td class="colsep0 rowsep0" align="left">0.12 (0.01)</td><td class="colsep0 rowsep0" align="left">0.06 (0.01)</td><td class="colsep0 rowsep0" align="left">53.5</td><td class="colsep0 rowsep0" align="left">3.15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Each value is expressed as % ID/g and represents the mean (SD) of 5 animals.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Expressed as the brain<sub>30 min</sub>/brain<sub>60 min</sub> ratio.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Expressed as the brain<sub>10 min</sub>/brain<sub>60 min</sub> ratio.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Data are from ref <a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">42</a>.</p></div></div></div><div class="NLM_p last">We determined the <i>in vitro</i> stability of [<sup>125</sup>I]<b>64</b> in mouse plasma. After the incubation of [<sup>125</sup>I]<b>64</b> in mouse plasma for 60 min, the sample was analyzed by HPLC. Since only radioactivity derived from [<sup>125</sup>I]<b>64</b> was detected, [<sup>125</sup>I]<b>64</b> would be stable in mouse plasma until 60 min (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S5</a>). Conversely, when radioactivity was analyzed in mouse plasma by HPLC after the injection of [<sup>125</sup>I]<b>64</b> into normal mice, we identified the conversion of [<sup>125</sup>I]<b>64</b> to several different chemical forms (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S6</a>). The percent of the intact form decreased with time and reached 46.5 and 13.1% at 2 and 10 min after injection, respectively. This profile was comparable to that of [<sup>18</sup>F]flutemetamol in rats reported previously,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> suggesting that [<sup>123/125</sup>I]<b>64</b> has sufficient <i>in vivo</i> stability for clinical trials. The difference in the stability of [<sup>125</sup>I]<b>64</b> between <i>in vitro</i> and <i>in vivo</i> may be attributable to radiometabolites produced by the <i>in vivo</i> metabolism of [<sup>125</sup>I]<b>64</b> in organs such as the liver and kidney. When we carried out HPLC, the analysis of the radioactivity in the brain at 2 min postinjection of [<sup>125</sup>I]<b>64</b>, approximately 92% of [<sup>125</sup>I]<b>64</b> existed as an intact form in the brain (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Figure S7</a>). This means that the intact [<sup>125</sup>I]<b>64</b> can enter the brain, and its radiometabolites hardly enter the brain despite its relatively rapid metabolism of [<sup>125</sup>I]<b>64</b> in plasma.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We designed and synthesized a series of heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with or without a dimethyl amino group to evaluate which moiety plays an important role in the binding affinity for Aβ and tau deposits in AD brains. Radioiodinated ligands were synthesized with a radiochemical yield of 12–85%, and HPLC analysis indicated that almost all ligands showed photoisomerization. In <i>in vitro</i> autoradiography using AD brain sections, all heterocyclic phenylethenyl and (3-pyridinyl)ethenyl derivatives with a dimethyl amino group showed a high binding affinity for Aβ in the AD brain sections. In contrast, the derivatives without a dimethyl amino group showed different patterns of radioactivity accumulation in the cortex of the AD brain depending on the kind of heterocycle contained in their molecules. In particular, the radioiodinated phenylethenyl benzimidazole derivative ([<sup>125</sup>I]<b>64</b>) showed marked radioactivity accumulation in the cortex of the temporal lobe from the AD patient, and the distribution of radioactivity corresponded with tau deposits, although there was a relatively high nonspecific binding of [<sup>125</sup>I]<b>64</b> in the white matter of the brain. On comparing the ratios of the radioactivity accumulation of these ligands in the temporal lobe to the frontal lobe (T/F values), we found that [<sup>125</sup>I]<b>64</b> may detect tau deposits in the AD brain more selectively than any other ligand (the T/F value of [<sup>125</sup>I]<b>64</b> = 5.85). In biodistribution experiments using normal mice, [<sup>125</sup>I]<b>64</b> showed a high initial uptake into (3.69% ID/g at 2 min postinjection) and rapid clearance from (0.06% ID/g at 60 min postinjection) the brains. In conclusion, these results suggest that [<sup>123</sup>I]<b>64</b> may become a useful tau-imaging agent. Also, these new findings of the present study may provide valuable information for the development of more useful agents that can selectively detect NFT in AD brains.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04452" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04452" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Remarks</h3><div class="NLM_p last">All reagents were commercial products and used without further purification unless indicated otherwise. All ligands were purified by Smart Flash EPCLC W-Prep 2XY (Yamazen corporation) unless indicated otherwise. <sup>1</sup>H NMR spectra were recorded on a JNM-ECS400 (JEOL) with TMS as an internal standard. Coupling constants are reported in Hertz. Multiplicity was defined as singlet (s), doublet (d), triplet (t), quartet (q), or multiplet (m). ESI or APCI mass spectrometry was conducted with a SHIMADZU LCMS-2020. High-resolution mass spectrometry (HRMS) was carried out with a GCMate II (JEOL). HPLC was performed with a Shimadzu system (an LC-20AD pump with an SPD-20AUV detector, λ = 254 nm) using a Cosmosil C<sub>18</sub> column (Nacalai Tesque, COSMOSIL 5C<sub>18</sub>-AR-II 4.6 mm I.D. × 150 mm or COSMOSIL 5C<sub>18</sub>-MS-II 4.6 mm I.D. × 150 mm) and acetonitrile/H<sub>2</sub>O as the mobile phase at a flow rate of 1.0 mL/min. All key ligands were proven by this method to show >95% purity.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-(2,4-Diiodophenyl)acetamide (<b>1</b>)</h4><div class="NLM_p last">A mixture of 2,4-diiodoaniline (1.00 g, 2.90 mmol) and acetic anhydride (274 μL, 2.90 mmol) in dichloromethane (10.0 mL) was stirred at room temperature for 12 h. After pouring it into water, the mixture was extracted with chloroform (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 786 mg of <b>1</b> (70.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (s, 1H), 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.7 Hz, 1H), 7.38 (s, 1H), 2.23 (s, 3H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-Iodo-2-methylbenzo[<i>d</i>]thiazole (<b>2</b>)</h4><div class="NLM_p last">A mixture of CuI (42.0 mg, 0.220 mmol), <b>1</b> (876 mg, 2.20 mmol), and Na<sub>2</sub>S·9H<sub>2</sub>O (1.59 g, 6.60 mmol) in DMF (4.00 mL) was stirred at 80 °C for 12 h. The reaction mixture was cooled to room temperature, and then 2.00 mL of concentrated HCl was added, and the mixture was stirred at 80 °C for 12 h. After adding 20.0 mL of saturated NaHCO<sub>3</sub> aq, it was extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 302 mg of <b>2</b> (50.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16 (d, <i>J</i> = 1.5 Hz, 1H), 7.73 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.68 (d, <i>J</i> = 8.7 Hz, 1H), 2.82 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 276.0 [MH<sup>+</sup>].</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>E</i>)-4-(2-(6-Iodobenzo[<i>d</i>]thiazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>3</b>)</h4><div class="NLM_p last">To a solution of <b>2</b> (275 mg, 1.00 mmol) in MeOH (5.00 mL) were added <i>p</i>-dimethylaminobenzaldehyde (149 mg, 1.00 mmol) and solid NaOH (120 mg, 3.00 mmol) as a base catalyst. The reaction mixture was stirred and heated to reflux. After refluxing for 24 h, the resulting yellow solid was collected by filtration and washed with MeOH and water. The solid was dried under vacuum to yield 203 mg of <b>3</b> (50.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (d, <i>J</i> = 1.8 Hz, 1H), 7.71 (dd, <i>J</i> = 8.7, 1.6 Hz, 1H), 7.65 (d, <i>J</i> = 8.5 Hz, 1H), 7.47 (d, <i>J</i> = 8.9 Hz, 2H), 7.46 (d, <i>J</i> = 16.3 Hz, 1H), 7.16 (d, <i>J</i> = 16.3 Hz, 1H), 6.72 (d, <i>J</i> = 8.9 Hz, 2H), 3.04 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>17</sub>H<sub>15</sub>IN<sub>2</sub>S (M<sup>+</sup>) 406.0001, found 405.9998.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>E</i>)-5-(2-(6-Iodobenzo[<i>d</i>]thiazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>4</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 60.0 mg of <b>4</b> (29.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (d, <i>J</i> = 1.7 Hz, 1H), 7.70–7.73 (m, 2H), 7.66 (d, <i>J</i> = 8.7 Hz, 1H), 7.42 (d, <i>J</i> = 16.2 Hz, 1H), 7.13 (d, <i>J</i> = 16.2 Hz, 1H), 6.56 (d, <i>J</i> = 9.0 Hz, 1H), 3.16 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>16</sub>H<sub>14</sub>IN<sub>3</sub>S (M<sup>+</sup>) 406.9953, found 406.9955.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>E</i>)-6-Iodo-2-styrylbenzo[<i>d</i>]thiazole (<b>5</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 10.0 mg of <b>5</b> (15.2%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.55 (s, 1H), 7.75–7.82 (m, 4H), 7.70 (d, <i>J</i> = 16.3 Hz, 1H), 7.62 (d, <i>J</i> = 16.3 Hz, 1H), 7.39–7.47 (m, 3H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>15</sub>H<sub>10</sub>INS (M<sup>+</sup>) 362.9579, found 362.9586.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>E</i>)-6-Iodo-2-(2-(pyridin-3-yl)vinyl)benzo[<i>d</i>]thiazole (<b>6</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 30.0 mg of <b>6</b> (45.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (d, <i>J</i> = 2.0 Hz, 1H), 8.57 (d, <i>J</i> = 1.7 Hz, 2H), 8.24 (d, <i>J</i> = 7.8 Hz, 1H), 7.71–7.84 (m, 4H), 7.47 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>14</sub>H<sub>9</sub>IN<sub>2</sub>S (M<sup>+</sup>) 363.9531, found 363.9536.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(4-Bromo-2-iodophenyl)acetamide (<b>7</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>1</b> was employed to afford 1.50 g of <b>7</b> (88.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.45 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.38 (s, 1H), 2.24 (s, 3H).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Bromo-2-methylbenzo[<i>d</i>]thiazole (<b>8</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>2</b> was employed to afford 134 mg of <b>8</b> (29.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.95 (d, <i>J</i> = 1.7 Hz, 1H), 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.54 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 2.82 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 228.0 [MH<sup>+</sup>].</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>E</i>)-4-(2-(6-Bromobenzo[<i>d</i>]thiazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>9</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 179 mg of <b>9</b> (50.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 1.7 Hz, 1H), 7.77 (d, <i>J</i> = 8.7 Hz, 1H), 7.52 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 2H), 7.44 (d, <i>J</i> = 16.0 Hz, 1H), 7.15 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 8.7 Hz, 2H), 3.03 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 359.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>E</i>)-5-(2-(6-Bromobenzo[<i>d</i>]thiazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>10</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 150 mg of <b>10</b> (41.8%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (s, 1H), 7.95 (s, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.70 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.53 (dd, <i>J</i> = 8.7, 2.0 Hz, 1H), 7.40 (d, <i>J</i> = 16.0 Hz, 1H), 7.13 (d, <i>J</i> = 16.0 Hz, 1H), 6.55 (d, <i>J</i> = 9.0 Hz, 1H), 3.15 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 360.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>E</i>)-6-Bromo-2-styrylbenzo[<i>d</i>]thiazole (<b>11</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 50.0 mg of <b>11</b> (31.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 1.4 Hz, 1H), 7.91 (d, <i>J</i> = 8.7 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 2H), 7.71 (d, <i>J</i> = 16.3 Hz, 1H), 7.65–7.68 (m, 1H), 7.63 (d, <i>J</i> = 16.3 Hz, 1H), 7.39–7.47 (m, 3H). MS (ESI) <i>m</i>/<i>z</i> 316.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>E</i>)-6-Bromo-2-(2-(pyridin-3-yl)vinyl)benzo[<i>d</i>]thiazole (<b>12</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>3</b> was employed to afford 49.0 mg of <b>12</b> (31.0%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (d, <i>J</i> = 2.0 Hz, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1H), 8.44 (d, <i>J</i> = 2.0 Hz, 1H), 8.25 (d, <i>J</i> = 7.8 Hz, 1H), 7.93 (d, <i>J</i> = 8.7 Hz, 1H), 7.79 (d, <i>J</i> = 16.5 Hz, 1H), 7.74 (d, <i>J</i> = 16.2 Hz, 1H), 7.67–7.70 (m, 1H), 7.48 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 317.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-4-(2-(6-(tributylstannyl)benzo[<i>d</i>]thiazol-2-yl)vinyl)aniline (<b>13</b>)</h4><div class="NLM_p last">A mixture of <b>9</b> (130 mg, 0.360 mmol), (SnBu<sub>3</sub>)<sub>2</sub> (364 μL, 0.730 mmol), and (Ph<sub>3</sub>P)<sub>4</sub>Pd (180 mg, 0.116 mmol) in a mixed solvent (15.0 mL, dioxane/Et<sub>3</sub>N = 2/1) was stirred and heated to reflux. After refluxing for 8 h, the mixture was concentrated under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 104 mg of <b>13</b> (50.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89–7.91 (m, 2H), 7.50 (dd, <i>J</i> = 8.1, 0.9 Hz, 1H), 7.47 (d, <i>J</i> = 8.7 Hz, 2H), 7.45 (d, <i>J</i> = 15.9 Hz, 1H), 7.20 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 9.0 Hz, 2H), 3.02 (s, 6H), 0.87–1.59 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 571.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-5-(2-(6-(tributylstannyl)benzo[<i>d</i>]thiazol-2-yl)vinyl)pyridin-2-amine (<b>14</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>13</b> was employed to afford 170 mg of <b>14</b> (48.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 2.3 Hz, 1H), 7.90–7.92 (m, 2H), 7.70 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 8.1 Hz, 1H), 7.40 (d, <i>J</i> = 16.0 Hz, 1H), 7.17 (d, <i>J</i> = 16.0 Hz, 1H), 6.53 (d, <i>J</i> = 9.0 Hz, 1H), 3.12 (s, 6H), 0.88–1.65 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 572.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>E</i>)-2-Styryl-6-(tributylstannyl)benzo[<i>d</i>]thiazole (<b>15</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>13</b> was employed to afford 89.0 mg of <b>15</b> (30.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94–7.97 (m, 2H), 7.33–7.59 (m, 8H), 0.88–1.61 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 528.3 [MH<sup>+</sup>].</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>E</i>)-2-(2-(Pyridin-3-yl)vinyl)-6-(tributylstannyl)benzo[<i>d</i>]thiazole (<b>16</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>13</b> was employed to afford 76.0 mg of <b>16</b> (45.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.80 (s, 1H), 8.58 (d, <i>J</i> = 4.6 Hz, 1H), 7.89–7.99 (m, 3H), 7.45–7.58 (m, 3H), 7.34 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 0.88–1.66 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 529.3 [MH<sup>+</sup>].</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Bromo-2-methylbenzo[<i>d</i>]oxazole (<b>17</b>)</h4><div class="NLM_p last">To a mixture of triethyl orthoacetate (656 μL, 3.60 mmol) and 2-amino-5-bromophenol (561 mg, 3.00 mmol) was added a catalytic amount of 1,3-dibromo-5,5-dimethylhydantoin (17.2 mg, 6.00 × 10<sup>–2</sup> mmol). The mixture was stirred at room temperature for 10 min. The mixture was then extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 560 mg of <b>17</b> (88.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61 (d, <i>J</i> = 1.7 Hz, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (dd, <i>J</i> = 7.8, 1.2 Hz, 1H), 2.61 (s, 3H). MS (ESI) <i>m</i>/<i>z</i> 212.0 [MH<sup>+</sup>].</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>E</i>)-5-(2-(6-Bromobenzo[<i>d</i>]oxazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>18</b>)</h4><div class="NLM_p last">To a solution of <b>17</b> (560 mg, 2.65 mmol) in MeOH (5.00 mL) were added 6-(dimethylamino)nicotinaldehyde (398 mg, 2.65 mmol) and solid NaOH (319 mg, 7.96 mmol) as a base catalyst. The reaction mixture was stirred and heated to reflux. After refluxing for 2.5 h, the resulting yellow solid was collected by filtration and washed with MeOH and water. The solid was dried under vacuum to yield 220 mg of <b>18</b> (24.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 2.3 Hz, 1H), 7.74 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.69 (d, <i>J</i> = 16.2 Hz, 1H), 7.66 (d, <i>J</i> = 1.7 Hz, 1H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 7.43 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 6.79 (d, <i>J</i> = 16.2 Hz, 1H), 6.57 (d, <i>J</i> = 9.0 Hz, 1H), 3.17 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 344.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>E</i>)-6-Bromo-2-styrylbenzo[<i>d</i>]oxazole (<b>19</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>18</b> was employed to afford 235 mg of <b>19</b> (18.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.05 (d, <i>J</i> = 2.0 Hz, 1H), 7.82–7.86 (m, 3H), 7.71 (d, <i>J</i> = 8.4 Hz, 1H), 7.56 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.45–7.47 (m, 3H), 7.34 (d, <i>J</i> = 16.2 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 300.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-5-(2-(6-(tributylstannyl)benzo[<i>d</i>]oxazol-2-yl)vinyl)pyridin-2-amine (<b>20</b>)</h4><div class="NLM_p last">A mixture of <b>18</b> (100 mg, 0.290 mmol), (SnBu<sub>3</sub>)<sub>2</sub> (292 μL, 0.580 mmol), and (Ph<sub>3</sub>P)<sub>4</sub>Pd (145 mg, 0.130 mmol) in a mixed solvent (15.0 mL, dioxane/Et<sub>3</sub>N = 2/1) was stirred and heated to reflux. After refluxing for 4 h, the mixture was concentrated under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 74.0 mg of <b>20</b> (45.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, <i>J</i> = 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.64–7.70 (m, 2H), 7.61 (s, 1H), 7.37 (d, <i>J</i> = 7.5 Hz, 1H), 6.83 (d, <i>J</i> = 16.2 Hz, 1H), 6.56 (d, <i>J</i> = 9.0 Hz, 1H), 3.15 (s, 6H), 0.88–1.77 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 556.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>E</i>)-2-Styryl-6-(tributylstannyl)benzo[<i>d</i>]oxazole (<b>21</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>20</b> was employed to afford 155 mg of <b>21</b> (38.6%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (d, <i>J</i> = 16.2 Hz, 1H), 7.70 (d, <i>J</i> = 7.5 Hz, 1H), 7.64 (s, 1H), 7.59 (d, <i>J</i> = 7.3 Hz, 2H), 7.36–7.42 (m, 4H), 7.09 (d, <i>J</i> = 16.5 Hz, 1H), 0.8–1.61 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 512.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>E</i>)-5-(2-(6-Iodobenzo[<i>d</i>]oxazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>22</b>)</h4><div class="NLM_p last">To a solution of <b>20</b> (70.0 mg, 0.130 mmol) in chloroform (30.0 mL) was added a solution of iodine in chloroform (3.00 mL, 50.0 mg/mL). The mixture was stirred at room temperature for 1 h and saturated NaHSO<sub>3</sub> aq was added to quench the reaction. The mixture was extracted with chloroform (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 15.0 mg of <b>22</b> (30.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, <i>J</i> = 2.3 Hz, 1H), 7.84 (d, <i>J</i> = 1.5 Hz, 1H), 7.73 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.69 (d, <i>J</i> = 16.2 Hz, 1H), 7.61 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 6.79 (d, <i>J</i> = 16.0 Hz, 1H), 6.56 (d, <i>J</i> = 9.0 Hz, 1H), 3.16 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>16</sub>H<sub>14</sub>IN<sub>3</sub>O (M<sup>+</sup>) 391.01819, found 391.01764.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>E</i>)-6-Iodo-2-styrylbenzo[<i>d</i>]oxazole (<b>23</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>22</b> was employed to afford 100 mg of <b>23</b> (95.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (s, 1H), 7.81–7.85 (m, 3H), 7.71 (d, <i>J</i> = 8.1 Hz, 1H), 7.56 (d, <i>J</i> = 8.1 Hz, 1H), 7.45–7.46 (m, 3H), 7.34 (d, <i>J</i> = 16.5 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>15</sub>H<sub>10</sub>INO (M<sup>+</sup>) 346.9807, found 346.9813.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>E</i>)-4-(2-(6-Bromobenzo[<i>d</i>]oxazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>24</b>)</h4><div class="NLM_p last">To a mixture of 2-amino-5-bromophenol (935 mg, 5.00 mmol) and 4-(dimethylamino) cinnamic acid (955 mg, 5.00 mmol) was added polyphosphoric acid (12.0 g). The mixture was stirred at 180 <b>°</b>C for 1 h. After cooling to room temperature, water (100 mL) was added to the mixture, and it was neutralized by K<sub>2</sub>CO<sub>3</sub>. The mixture was extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 130 mg of <b>24</b> (7.60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 16.2 Hz, 1H), 7.63 (s, 1H), 7.47–7.52 (m, 3H), 7.40 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 6.79 (d, <i>J</i> = 16.2 Hz, 1H), 6.70 (d, <i>J</i> = 9.0 Hz, 2H), 3.03 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 343.2 [MH<sup>+</sup>].</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>E</i>)-6-Bromo-2-(2-(pyridin-3-yl)vinyl)benzo[<i>d</i>]oxazole (<b>25</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>24</b> was employed to afford 1.40 g of <b>25</b> (93.3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (s, 1H), 8.60 (d, <i>J</i> = 4.6 Hz, 1H), 8.30 (d, <i>J</i> = 7.8 Hz, 1H), 8.08 (d, <i>J</i> = 1.5 Hz, 1H), 7.87 (d, <i>J</i> = 16.5 Hz, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.58 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.47–7.57 (m, 2H). MS (ESI) <i>m</i>/<i>z</i> 301.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-4-(2-(6-(tributylstannyl)benzo[<i>d</i>]oxazol-2-yl)vinyl)aniline (<b>26</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>20</b> was employed to afford 30.0 mg of <b>26</b> (14.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.71 (d, <i>J</i> = 16.2 Hz, 1H), 7.65 (d, <i>J</i> = 7.5 Hz, 1H), 7.59 (s, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 2H), 7.36 (d, <i>J</i> = 7.5 Hz, 1H), 6.85 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 8.7 Hz, 2H), 3.03 (s, 6H), 0.88–1.58 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 555.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>E</i>)-2-(2-(Pyridin-3-yl)vinyl)-6-(tributylstannyl)benzo[<i>d</i>]oxazole (<b>27</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>20</b> was employed to afford 826 mg of <b>27</b> (40.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.80 (s, 1H), 8.58 (d, <i>J</i> = 4.9 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.66–7.76 (m, 3H), 7.43 (d, <i>J</i> = 7.5, 1H), 7.29–7.32 (m, 1H), 7.15 (dd, <i>J</i> = 16.2, 1.4 Hz, 1H), 0.99–1.62 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 513.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>E</i>)-4-(2-(6-Iodobenzo[<i>d</i>]oxazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>28</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>22</b> was employed to afford 10.0 mg of <b>28</b> (50.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (s, 1H), 7.72 (d, <i>J</i> = 16.0 Hz, 1H), 7.59 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.49 (d, <i>J</i> = 9.0 Hz, 2H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 9.0 Hz, 2H), 3.04 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>17</sub>H<sub>15</sub>IN<sub>2</sub>O (M<sup>+</sup>) 390.0229, found 390.0227.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>E</i>)-6-Iodo-2-(2-(pyridin-3-yl)vinyl)benzo[<i>d</i>]oxazole (<b>29</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>22</b> was employed to afford 80.6 mg of <b>29</b> (46.3%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.82 (d, <i>J</i> = 2.0 Hz, 1H), 8.62 (dd, <i>J</i> = 4.9, 1.4 Hz, 1H), 7.91–7.94 (m, 2H), 7.78 (d, <i>J</i> = 16.5 Hz, 1H), 7.67 (dd, <i>J</i> = 8.4, 1.5 Hz, 1H), 7.48 (d, <i>J</i> = 8.4 Hz, 1H), 7.38 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H), 7.12 (d, <i>J</i> = 16.5 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>14</sub>H<sub>9</sub>IN<sub>2</sub>O (M<sup>+</sup>) 347.9760, found 347.9754.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-Bromo-2-hydroxybenzaldehyde (<b>30</b>)</h4><div class="NLM_p last">4-Bromophenol (6.50 mL, 61.2 mmol), MgCl<sub>2</sub> (8.74 g, 91.8 mmol), and triethylamine (32.0 mL) were dissolved in dry acetonitrile (100 mL) and stirred at room temperature for 20 min. To the solution was added paraformaldehyde (12.3 g, 411 mmol). The reaction mixture was stirred and heated to reflux for 4 h. After cooling to room temperature, water was added, and the mixture was acidified (pH 2.0) with diluted HCl. The mixture was extracted with diethyl ether (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 10.9 g of <b>30</b> (89.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.1 (s, 1H), 9.86 (s, 1H), 7.41 (d, <i>J</i> = 8.2 Hz, 1H), 7.15–7.20 (m, 2H).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Ethyl 6-bromobenzofuran-2-carboxylate (<b>31</b>)</h4><div class="NLM_p last">A mixture of <b>30</b> (5.00 g, 25.0 mmol), K<sub>2</sub>CO<sub>3</sub> (10.4 g, 75.0 mmol), and bromoacetate (2.77 mL, 25.0 mmol) in DMF (10.0 mL) was stirred at 105 <b>°</b>C for 1 h. After cooling to room temperature, the mixture was extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 4.40 g of <b>31</b> (65.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (s, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 1H), 7.49 (s, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 4.45 (q, <i>J</i> = 7.0 Hz, 2H), 1.43 (t, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (6-Bromobenzofuran-2-yl)methanol (<b>32</b>)</h4><div class="NLM_p last">LAH (1.87 g, 49.3 mmol) was dissolved in THF at 0 °C and <b>31</b> (4.40 g, 16.4 mmol) of a THF solution was added, followed by stirring at 0 °C for 1 h. After the completion of the reaction, saturated Na<sub>2</sub>SO<sub>4</sub> aq was added to the resulting mixture at 0 °C and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 2.10 g of <b>32</b> (56.6%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.63 (s, 1H), 7.43 (d, <i>J</i> = 8.2 Hz, 1H), 7.32 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 6.68 (s, 1H), 4.65 (s, 2H).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 6-Bromo-2-(bromomethyl)benzofuran (<b>33</b>)</h4><div class="NLM_p last">To a stirred solution of <b>32</b> (2.10 g, 9.29 mmol) in diethyl ether (10.0 mL) was added phosphorus tribromide (441 μL, 4.65 mmol) at 0 °C, followed by stirring at room temperature for 1 h. The reaction mixture was neutralized with saturated NaHCO<sub>3</sub> aq and extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to yield 1.80 g of <b>33</b> (67.3%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.66 (s, 1H), 7.40 (d, <i>J</i> = 8.2 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 6.72 (s, 1H), 4.56 (s, 2H).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Diethyl ((6-bromobenzofuran-2-yl)methyl)phosphonate (<b>34</b>)</h4><div class="NLM_p last">A mixture of <b>33</b> (1.80 g, 6.25 mmol) and triethyl phosphite (1.16 mL, 6.88 mmol) in toluene (20.0 mL) was stirred and heated to reflux for 24 h. After cooling to room temperature, the solvent was removed under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 2.30 g of <b>34</b> (100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61 (s, 1H), 7.37 (d, <i>J</i> = 8.4 Hz, 1H), 7.33 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 6.62 (d, <i>J</i> = 3.8 Hz, 1H), 4.09–4.16 (m, 4H), 3.35 (d, <i>J</i> = 21.2 Hz, 2H), 1.29–1.36 (m, 6H).</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>E</i>)-4-(2-(6-Bromobenzofuran-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>35</b>)</h4><div class="NLM_p last">To a solution of <b>34</b> (1.74 g, 5.03 mmol) in MeOH (30.0 mL) was added <i>p</i>-dimethylaminobenzaldehyde (750 mg, 5.03 mmol) and 5 M sodium methoxide (5.00 mL, 25.0 mmol) as a base catalyst. The reaction mixture was stirred and heated to reflux. After refluxing for 15 h, the resulting yellow solid was collected by filtration and washed with MeOH and water. The solid was dried under vacuum to yield 475 mg of <b>35</b> (27.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60 (s, 1H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.34 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.25 (d, <i>J</i> = 16.0 Hz, 1H), 6.76 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 9.0 Hz, 2H), 6.51 (s, 1H), 3.01 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 342.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>E</i>)-5-(2-(6-Bromobenzofuran-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>36</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>35</b> was employed to afford 200 mg of <b>36</b> (58.5%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (d, <i>J</i> = 2.0 Hz, 1H), 7.88 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 7.81 (s, 1H), 7.54 (d, <i>J</i> = 8.1 Hz, 1H), 7.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.19 (d, <i>J</i> = 16.2 Hz, 1H), 7.05 (d, <i>J</i> = 16.2 Hz, 1H), 6.84 (s, 1H), 6.70 (d, <i>J</i> = 9.0 Hz, 1H), 3.07 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 343.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>E</i>)-6-Bromo-2-styrylbenzofuran (<b>37</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>35</b> was employed to afford 198 mg of <b>37</b> (66.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.86 (s, 1H), 7.67 (d, <i>J</i> = 8.1 Hz, 2H), 7.59 (d, <i>J</i> = 8.1 Hz, 1H), 7.39–7.43 (m, 3H), 7.31–7.34 (m, 3H), 7.00 (s, 1H). MS (ESI) <i>m</i>/<i>z</i> 299.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>E</i>)-3-(2-(6-Bromobenzofuran-2-yl)vinyl)pyridine (<b>38</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>35</b> was employed to afford 117 mg of <b>38</b> (39.3%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (s, 1H), 8.50 (d, <i>J</i> = 4.6 Hz, 1H), 8.12 (d, <i>J</i> = 8.1 Hz, 1H), 7.88 (s, 1H), 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.42–7.49 (m, 3H), 7.31 (d, <i>J</i> = 16.2 Hz, 1H), 7.04 (s, 1H). MS (ESI) <i>m</i>/<i>z</i> 300.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-4-(2-(6-(tributylstannyl)benzofuran-2-yl)vinyl)aniline (<b>39</b>)</h4><div class="NLM_p last">A mixture of <b>35</b> (171 mg, 0.500 mmol), (SnBu<sub>3</sub>)<sub>2</sub> (501 μL, 1.00 mmol), and (Ph<sub>3</sub>P)<sub>4</sub>Pd (248 mg, 0.215 mmol) in a mixed solvent (15.0 mL, dioxane/Et<sub>3</sub>N = 2/1) was stirred and heated to reflux. After refluxing for 3 h, the mixture was concentrated under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to yield 100 mg of <b>39</b> (36.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (s, 1H), 7.47 (d, <i>J</i> = 7.3 Hz, 1H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.23–7.27 (m, 2H), 6.81 (d, <i>J</i> = 16.0 Hz, 1H), 6.72 (d, <i>J</i> = 8.9 Hz, 2H), 6.54 (s, 1H), 3.00 (s, 6H), 0.87–1.60 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 554.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-5-(2-(6-(tributylstannyl)benzofuran-2-yl)vinyl)pyridin-2-amine (<b>40</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>39</b> was employed to afford 100 mg of <b>40</b> (30.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, <i>J</i> = 2.3 Hz, 1H), 7.67 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.57 (s, 1H), 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.18–7.25 (m, 2H), 6.78 (d, <i>J</i> = 16.0 Hz, 1H), 6.51–6.55 (m, 2H), 3.12 (s, 6H), 0.89–1.73 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 555.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>E</i>)-Tributyl(2-styrylbenzofuran-6-yl)stannane (<b>41</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>39</b> was employed to afford 65.0 mg of <b>41</b> (25.3%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24−7.59 (m, 9H), 7.01 (d, <i>J</i> = 16.0 Hz, 1H), 6.65 (s, 1H), 0.86–1.56 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 511.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>E</i>)-3-(2-(6-(Tributylstannyl)benzofuran-2-yl)vinyl)pyridine (<b>42</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>39</b> was employed to afford 41.5 mg of <b>42</b> (21.2%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.70 (d, <i>J</i> = 1.7 Hz, 1H), 8.41 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H), 8.06–8.09 (m, 1H), 7.53–7.56 (m, 2H), 7.44 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.26–7.31 (m, 3H), 6.84 (d, <i>J</i> = 0.9 Hz, 1H), 0.86–1.63 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 512.3 [MH<sup>+</sup>].</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>E</i>)-4-(2-(6-Iodobenzofuran-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>43</b>)</h4><div class="NLM_p last">To a solution of <b>39</b> (100 mg, 0.180 mmol) in chloroform (40.0 mL) was added a solution of iodine in chloroform (3.00 mL, 50.0 mg/mL). The mixture was stirred at room temperature for 1 h and saturated NaHSO<sub>3</sub> aq was added to quench the reaction. The mixture was extracted with chloroform (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 18.0 mg of <b>43</b> (25.6%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (s, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 7.22–7.24 (m, 2H), 6.75 (d, <i>J</i> = 16.0 Hz, 1H), 6.70 (d, <i>J</i> = 8.7 Hz, 2H), 6.49 (s, 1H), 2.99 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>18</sub>H<sub>16</sub>INO (M<sup>+</sup>) 389.02769, found 389.02814.</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>E</i>)-5-(2-(6-Iodobenzofuran-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>44</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>43</b> was employed to afford 20.0 mg of <b>44</b> (28.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (d, <i>J</i> = 2.3 Hz, 1H), 7.79 (s, 1H), 7.66 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 7.48 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 7.23 (d, <i>J</i> = 8.1 Hz, 1H), 7.19 (d, <i>J</i> = 16.2 Hz, 1H), 6.73 (d, <i>J</i> = 16.0 Hz, 1H), 6.52–6.54 (m, 2H), 3.13 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>17</sub>H<sub>15</sub>IN<sub>2</sub>O (M<sup>+</sup>) 390.02295, found 390.02270.</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>E</i>)-6-Iodo-2-styrylbenzofuran (<b>45</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>43</b> was employed to afford 20.0 mg of <b>45</b> (29.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (s, 1H), 7.28–7.54 (m, 8H), 6.97 (d, <i>J</i> = 16.2 Hz, 1H), 6.63 (s, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>16</sub>H<sub>11</sub>IO (M<sup>+</sup>) 345.9855, found 345.9858.</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>E</i>)-3-(2-(6-Iodobenzofuran-2-yl)vinyl)pyridine (<b>46</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>43</b> was employed to afford 20.0 mg of <b>46</b> (74.9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (s, 1H), 8.50 (d, <i>J</i> = 4.9 Hz, 1H), 8.12 (d, <i>J</i> = 7.8 Hz, 1H), 8.01 (s, 1H), 7.58 (d, <i>J</i> = 8.1 Hz, 1H), 7.42–7.49 (m, 3H), 7.30 (d, <i>J</i> = 16.2 Hz, 1H), 7.02 (s, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>15</sub>H<sub>10</sub>INO (M<sup>+</sup>) 346.9807, found 346.9810.</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl 6-bromobenzo[<i>b</i>]thiophene-2-carboxylate (<b>47</b>)</h4><div class="NLM_p last">To a solution of 4-bromo-2-fluorobenzaldehyde (808 mg, 4.00 mmol) in DMSO (5.00 mL) were added methyl mercaptoacetate (375 μL, 4.13 mmol) and triethylamine (1.50 mL). The reaction mixture was stirred under nitrogen atmosphere at 80 °C for 3 h. After cooling to room temperature, the mixture was poured into water (20.0 mL) with vigorous stirring. After 1 h of digestion, the formed solid was collected by filtration and washed with water. The solid was dried under vacuum to yield 700 mg of <b>47</b> (64.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (s, 1H), 8.22 (s, 1H), 7.98 (d, <i>J</i> = 8.7 Hz, 1H), 7.64 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 3.90 (s, 3H).</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (6-Bromobenzo[<i>b</i>]thiophen-2-yl)methanol (<b>48</b>)</h4><div class="NLM_p last">LAH (756 mg, 19.9 mmol) was dissolved in THF at 0 °C, and <b>47</b> (1.79 g, 6.64 mmol) of a THF solution was added, followed by stirring at 0 °C for 3 h. After the completion of the reaction, saturated Na<sub>2</sub>SO<sub>4</sub> aq was added to the resulting mixture at 0 °C and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 1.20 g of <b>48</b> (74.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.95 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.18 (s, 1H), 4.92 (d, <i>J</i> = 6.0 Hz, 2H), 1.89 (t, <i>J</i> = 6.2 Hz, 1H).</div></div><div id="sec4_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 6-Bromo-2-(bromomethyl)benzo[<i>b</i>]thiophene (<b>49</b>)</h4><div class="NLM_p last">To a stirred solution of <b>48</b> (1.20 g, 4.96 mmol) in diethyl ether (10.0 mL) was added phosphorus tribromide (235 μL, 2.48 mmol) at 0 °C, followed by stirring at room temperature for 1 h. The reaction mixture was neutralized with saturated NaHCO<sub>3</sub> aq and extracted with ethyl acetate (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to yield 1.51 g of <b>49</b> (100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (s, 1H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.45 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.28 (s, 1H), 4.75 (s, 2H).</div></div><div id="sec4_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Diethyl ((6-bromobenzo[<i>b</i>]thiophen-2-yl)methyl)phosphonate (<b>50</b>)</h4><div class="NLM_p last">A mixture of <b>49</b> (1.51 g, 4.96 mmol) and triethyl phosphite (4.17 mL, 24.8 mmol) in toluene (40.0 mL) was stirred and heated to reflux for 44 h. After cooling to room temperature, the solvent was removed under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 2.47 g of <b>50</b> (100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90 (s, 1H), 7.55 (d, <i>J</i> = 8.5 Hz, 1H), 7.42 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 7.18 (d, <i>J</i> = 3.2 Hz, 1H), 4.07–4.19 (m, 4H), 3.40 (d, <i>J</i> = 21.3 Hz, 2H), 1.28–1.39 (m, 6H).</div></div><div id="sec4_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>E</i>)-4-(2-(6-Bromobenzo[<i>b</i>]thiophen-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>51</b>)</h4><div class="NLM_p last">To a solution of <b>50</b> (2.81 g, 7.76 mmol) in MeOH (30.0 mL) were added <i>p</i>-dimethylaminobenzaldehyde (1.16 g, 7.76 mmol) and 5 M sodium methoxide (7.76 mL, 38.8 mmol) as a base catalyst. The reaction mixture was stirred and heated to reflux. After refluxing for 24 h, the resulting yellow solid was collected by filtration and washed with MeOH and water. The solid was dried under vacuum to yield 500 mg of <b>51</b> (18.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.87 (s, 1H), 7.50 (d, <i>J</i> = 8.7 Hz, 1H), 7.37–7.41 (m, 3H), 7.06–7.10 (m, 2H), 6.92 (d, <i>J</i> = 16.0 Hz, 1H), 6.71 (d, <i>J</i> = 9.0 Hz, 2H), 3.00 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 358.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>E</i>)-5-(2-(6-Bromobenzo[<i>b</i>]thiophen-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>52</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>51</b> was employed to afford 100 mg of <b>52</b> (27.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25 (d, <i>J</i> = 2.3 Hz, 1H), 7.88 (s, 1H), 7.66 (dd, <i>J</i> = 8.7, 2.3 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 1H), 7.40 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.11 (s, 1H), 7.06 (d, <i>J</i> = 16.0 Hz, 1H), 6.87 (d, <i>J</i> = 16.0 Hz, 1H), 6.54 (d, <i>J</i> = 9.0 Hz, 1H), 3.14 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 359.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>E</i>)-6-Bromo-2-styrylbenzo[<i>b</i>]thiophene (<b>53</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>51</b> was employed to afford 182 mg of <b>53</b> (58.0%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (s, 1H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H), 7.65 (d, <i>J</i> = 7.8 Hz, 2H), 7.60 (d, <i>J</i> = 16.2 Hz, 1H), 7.49–7.52 (m, 2H), 7.38–7.42 (m, 2H), 7.29–7.33 (m, 1H), 7.06 (d, <i>J</i> = 16.0 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 315.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>E</i>)-3-(2-(6-Bromobenzo[<i>b</i>]thiophen-2-yl)vinyl)pyridine (<b>54</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>51</b> was employed to afford 77.0 mg of <b>54</b> (24.4%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (s, 1H), 8.49 (d, <i>J</i> = 4.6 Hz, 1H), 8.26 (s, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 7.78 (d, <i>J</i> = 8.7 Hz, 1H), 7.74 (d, <i>J</i> = 16.2 Hz, 1H), 7.51–7.53 (m, 2H), 7.42 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.10 (d, <i>J</i> = 16.2 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 316.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-4-(2-(6-(tributylstannyl)benzo[<i>b</i>]thiophen-2-yl)vinyl)aniline (<b>55</b>)</h4><div class="NLM_p last">A mixture of <b>51</b> (179 mg, 0.500 mmol), (SnBu<sub>3</sub>)<sub>2</sub> (501 μL, 1.00 mmol), and (Ph<sub>3</sub>P)<sub>4</sub>Pd (248 mg, 0.215 mmol) in a mixed solvent (15.0 mL, dioxane/Et<sub>3</sub>N = 2/1) was stirred and heated to reflux. After refluxing for 3 h, the mixture was concentrated under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to give 100 mg of <b>55</b> (35.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.83 (s, 1H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.39 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (d, <i>J</i> = 7.5 Hz, 1H), 7.09–7.13 (m, 2H), 6.93 (d, <i>J</i> = 16.0 Hz, 1H), 6.69 (d, <i>J</i> = 9.0 Hz, 2H), 2.97 (s, 6H), 0.88–1.60 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 570.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>E</i>)-<i>N</i>,<i>N</i>-Dimethyl-5-(2-(6-(tributylstannyl)benzo[<i>b</i>]thiophen-2-yl)vinyl)pyridin-2-amine (<b>56</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>55</b> was employed to afford 100 mg of <b>56</b> (35.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25 (d, <i>J</i> = 2.3 Hz, 1H), 7.83 (s, 1H), 7.66 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 7.8 Hz, 1H), 7.14 (s, 1H), 7.10 (d, <i>J</i> = 16.0 Hz, 1H), 6.87 (d, <i>J</i> = 16.0 Hz, 1H), 6.53 (d, <i>J</i> = 8.7 Hz, 1H), 3.13 (s, 6H), 0.88–1.66 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 571.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>E</i>)-Tributyl(2-styrylbenzo[<i>b</i>]thiophen-6-yl)stannane (<b>57</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>55</b> was employed to afford 59.0 mg of <b>57</b> (19.3%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86 (s, 1H), 7.65 (d, <i>J</i> = 7.8 Hz, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 2H), 7.34–7.40 (m, 4H), 7.29 (d, <i>J</i> = 6.1 Hz, 1H), 7.23 (d, <i>J</i> = 7.8 Hz, 1H), 6.99 (d, <i>J</i> = 16.0 Hz, 1H), 0.88–1.60 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 527.3 [MH<sup>+</sup>].</div></div><div id="sec4_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-3-(2-(6-(Tributylstannyl)benzo[<i>b</i>]thiophen-2-yl)vinyl)pyridine (<b>58</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>55</b> was employed to afford 35.2 mg of <b>58</b> (27.0%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.49 (d, <i>J</i> = 4.9 Hz, 1H), 7.87 (s, 1H), 7.81 (d, <i>J</i> = 7.8 Hz, 1H), 7.67 (d, <i>J</i> = 7.8 Hz, 1H), 7.36–7.42 (m, 2H), 7.26–7.30 (m, 2H), 6.94 (d, <i>J</i> = 16.0 Hz, 1H), 0.88–1.60 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 528.3 [MH<sup>+</sup>].</div></div><div id="sec4_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>E</i>)-4-(2-(6-Iodobenzo[<i>b</i>]thiophen-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylaniline (<b>59</b>)</h4><div class="NLM_p last">To a solution of <b>55</b> (100 mg, 0.180 mmol) in chloroform (40.0 mL) was added a solution of iodine in chloroform (5.00 mL, 50.0 mg/mL). The mixture was stirred at room temperature for 20 min, and saturated NaHSO<sub>3</sub> aq was added to quench the reaction. The mixture was extracted with chloroform (50.0 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to yield 20.0 mg of <b>59</b> (28.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (s, 1H), 7.62 (d, <i>J</i> = 8.1 Hz, 1H), 7.54 (d, <i>J</i> = 8.1 Hz, 1H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.26–7.31 (m, 2H), 6.93 (d, <i>J</i> = 15.9 Hz, 1H), 6.72 (d, <i>J</i> = 8.1 Hz, 2H), 2.95 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>18</sub>H<sub>16</sub>INS (M<sup>+</sup>) 405.00484, found 405.00538.</div></div><div id="sec4_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>E</i>)-5-(2-(6-Iodobenzo[<i>b</i>]thiophen-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>60</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>59</b> was employed to afford 20.0 mg of <b>60</b> (28.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 8.07 (s, 1H), 7.65 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.57 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.38 (d, <i>J</i> = 8.4 Hz, 1H), 7.09 (s, 1H), 7.05 (d, <i>J</i> = 16.0 Hz, 1H), 6.87 (d, <i>J</i> = 16.0 Hz, 1H), 6.53 (d, <i>J</i> = 8.7 Hz, 1H), 3.13 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>17</sub>H<sub>15</sub>IN<sub>2</sub>S (M<sup>+</sup>) 406.00010, found 405.99981.</div></div><div id="sec4_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> (<i>E</i>)-6-Iodo-2-styrylbenzo[<i>b</i>]thiophene (<b>61</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>59</b> was employed to afford 35.0 mg of <b>61</b> (86.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 7.59 (d, <i>J</i> = 8.1 Hz, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 2H), 7.42 (d, <i>J</i> = 8.1 Hz, 1H), 7.35–7.39 (m, 2H), 7.26–7.30 (m, 2H), 7.18 (s, 1H), 7.00 (d, <i>J</i> = 16.2 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>16</sub>H<sub>11</sub>IS (M<sup>+</sup>) 361.9626, found 361.9631.</div></div><div id="sec4_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (<i>E</i>)-3-(2-(6-Iodobenzo[<i>b</i>]thiophen-2-yl)vinyl)pyridine (<b>62</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>59</b> was employed to afford 22.6 mg of <b>62</b> (100%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 8.51 (d, <i>J</i> = 4.6 Hz, 1H), 8.12 (s, 1H), 7.81 (d, <i>J</i> = 8.1 Hz, 1H), 7.62 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.34 (d, <i>J</i> = 16.2 Hz, 1H), 7.30 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H), 7.24 (s, 1H), 6.96 (d, <i>J</i> = 16.0 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>15</sub>H<sub>10</sub>INS (M<sup>+</sup>) 362.9579, found 362.9586.</div></div><div id="sec4_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-Iodobenzene-1,2-diamine (<b>63</b>)</h4><div class="NLM_p last">To a mixture of 4-iodo-2-nitroaniline (2.64 g, 10.0 mmol) and concentrated HCl (2.50 mL) in 80% EtOH (60.0 mL) was added powdered iron (2.23 g, 40.0 mmol). The reaction mixture was stirred and heated to reflux for 6 h. After cooling to room temperature, the precipitate of iron oxides and hydroxy salts was removed by filtration. The solvent was removed under vacuum, and the residue was neutralized with saturated NaHCO<sub>3</sub> aq and extracted with ethyl acetate (100 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 1.98 g of <b>63</b> (89.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.78 (d, <i>J</i> = 2.0 Hz, 1H), 6.62 (d, <i>J</i> = 8.0 Hz, 1H), 6.30 (d, <i>J</i> = 8.0 Hz, 1H), 4.63 (s, 2H), 4.57 (s, 2H). MS (APCI) <i>m</i>/<i>z</i> 235 [MH<sup>+</sup>].</div></div><div id="sec4_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> (<i>E</i>)-6-Iodo-2-styryl-<i>1H</i>-benzo[<i>d</i>]imidazole (<b>64</b>)</h4><div class="NLM_p last">A mixture of <b>63</b> (234 mg, 1.00 mmol), cinnamaldehyde (126 μL, 1.00 mmol), and Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub> (190 mg, 1.00 mmol) dissolved in 5.00 mL of DMF was stirred at 105 °C for 2 h. The mixture was extracted with ethyl acetate (100 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to yield 200 mg of <b>64</b> (57.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (s, 1H), 7.67–7.71 (m, 3H), 7.43–7.48 (m, 3H), 7.36–7.39 (m, 2H), 7.22 (d, <i>J</i> = 16.5 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>15</sub>H<sub>11</sub>IN<sub>2</sub> (M<sup>+</sup>) 345.9967, found 345.9973.</div></div><div id="sec4_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> (<i>E</i>)-6-Bromo-2-styryl-<i>1H</i>-benzo[<i>d</i>]imidazole (<b>65</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>64</b> was employed to afford 200 mg of <b>65</b> (67.1%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.78 (s, 1H), 7.67–7.71 (m, 3H), 7.43–7.54 (m, 3H), 7.31–7.40 (m, 2H), 7.31 (s, 1H), 7.22 (d, <i>J</i> = 16.5 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 299.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>tert</i>-Butyl (<i>E</i>)-6-bromo-2-styryl-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>66</b>)</h4><div class="NLM_p last">A mixture of <b>65</b> (200 mg, 0.670 mmol), di-<i>tert</i>-butyl dicarbonate (293 mg, 1.34 mmol), DMAP (catalytic), triethylamine (5.00 mL), and dichloromethane (10.0 mL) was stirred at room temperature for 24 h. The reaction mixture was extracted with chloroform (100 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/4) to yield 200 mg of <b>66</b> (74.9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65–8.08 (m, 6H), 7.41–7.55 (m, 4H), 1.70 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 399.2 [MH<sup>+</sup>].</div></div><div id="sec4_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>tert</i>-Butyl (<i>E</i>)-2-styryl-6-(tributylstannyl)-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>67</b>)</h4><div class="NLM_p last">A mixture of <b>66</b> (200 mg, 0.500 mmol), (SnBu<sub>3</sub>)<sub>2</sub> (583 μL, 1.00 mmol), and (Ph<sub>3</sub>P)<sub>4</sub>Pd (250 mg, 0.220 mmol) in a mixed solvent (10.0 mL, dioxane/Et<sub>3</sub>N = 1/1) was stirred and heated to reflux. After refluxing for 2 h, the mixture was concentrated under vacuum, and the residue was purified by silica gel chromatography (ethyl acetate/hexane = 1/10) to yield 41.0 mg of <b>67</b> (13.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–8.03 (m, 3H), 7.63–7.76 (m, 3H), 7.32–7.43 (m, 4H), 1.76 (s, 9H), 0.88–1.63 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 611.4 [MH<sup>+</sup>].</div></div><div id="sec4_2_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> (<i>E</i>)-3-(6-(Dimethylamino)pyridin-3-yl)acrylaldehyde (<b>68)</b></h4><div class="NLM_p last">To a solution of 6-(dimethylamino)nicotinaldehyde (600 mg, 4.00 mmol), (1,3-dioxolan-2-ylmethyl)triphenylphosphonium bromide (3.43 g, 8.00 mmol), and 18-crown-6 (catalytic) in THF (25.0 mL) was added NaH (384 mg, 16.0 mmol) in one portion. After stirring at room temperature for 2 h, the same amount of NaH was added, and the stirring was continued overnight. The reaction mixture was quenched with water and extracted with diethyl ether (50.0 mL × 3). Combined organic layers were removed under vacuum. The residue was dissolved in a mixture of THF (50.0 mL) and 10% HCl (20.0 mL) and stirred at room temperature for 6 h. The reaction mixture was alkalized with 10% NaOH aq and extracted with dichloromethane (100 mL × 2). Combined organic layers were dried over MgSO<sub>4</sub> and concentrated under vacuum. The residue was purified by silica gel chromatography (ethyl acetate/hexane = 2/1) to yield 1.22 g of <b>68</b> (86.6%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.61 (d, <i>J</i> = 7.8 Hz, 1H), 8.30 (d, <i>J</i> = 2.3 Hz, 1H), 7.68 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.37 (d, <i>J</i> = 15.6 Hz, 1H), 6.50–6.57 (m, 2H), 3.18 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 177.2 [MH<sup>+</sup>].</div></div><div id="sec4_2_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> (<i>E</i>)-3-(Pyridin-3-yl)acrylaldehyde <b>(69)</b></h4><div class="NLM_p last">The same reaction described above for the preparation of <b>68</b> was employed to afford 565 mg of <b>69</b> (85.0%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.71 (d, <i>J</i> = 7.5 Hz, 1H), 8.91 (s, 1H), 8.64 (d, <i>J</i> = 4.6 Hz, 1H), 8.22 (d, <i>J</i> = 8.1 Hz, 1H), 7.80 (d, <i>J</i> = 15.9 Hz, 1H), 7.51 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 7.02 (dd, <i>J</i> = 16.0, 7.5 Hz, 1H).</div></div><div id="sec4_2_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> (<i>E</i>)-5-(2-(6-Iodo-<i>1H</i>-benzo[<i>d</i>]imidazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>70</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>64</b> was employed to afford 100 mg of <b>70</b> (25.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (s, 1H), 8.02–8.05 (m, 2H), 7.80 (d, <i>J</i> = 16.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.03 (d, <i>J</i> = 16.2 Hz, 1H), 6.88 (d, <i>J</i> = 9.3 Hz, 1H), 3.15 (s, 6H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>16</sub>H<sub>15</sub>IN<sub>4</sub> (M<sup>+</sup>) 390.0342, found 390.0335.</div></div><div id="sec4_2_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> (<i>E</i>)-6-Iodo-2-(2-(pyridin-3-yl)vinyl)-<i>1H</i>-benzo[<i>d</i>]imidazole (<b>71</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>64</b> was employed to afford 73.6 mg of <b>71</b> (21.2%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.74 (d, <i>J</i> = 2.0 Hz, 1H), 8.50 (dd, <i>J</i> = 4.6, 1.5 Hz, 1H), 8.13 (d, <i>J</i> = 8.1 Hz, 1H), 7.90 (s, 1H), 7.60 (d, <i>J</i> = 16.8 Hz, 1H), 7.53 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.49 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 7.35 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 16.5 Hz, 1H). HRMS (EI) <i>m</i>/<i>z</i> calcd. for C<sub>14</sub>H<sub>10</sub>IN<sub>3</sub> (M<sup>+</sup>) 346.9920, found 346.9915.</div></div><div id="sec4_2_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> (<i>E</i>)-5-(2-(6-Bromo-<i>1H</i>-benzo[<i>d</i>]imidazol-2-yl)vinyl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine (<b>72</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>64</b> was employed to afford 648 mg of <b>72</b> (77.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (d, <i>J</i> = 2.3 Hz, 1H), 7.96 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 7.73 (d, <i>J</i> = 1.8 Hz, 1H), 7.63 (d, <i>J</i> = 16.5 Hz, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 1H), 7.34 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 6.99 (d, <i>J</i> = 16.5 Hz, 1H), 6.78 (d, <i>J</i> = 9.2 Hz, 1H), 3.11 (s, 6H). MS (ESI) <i>m</i>/<i>z</i> 343.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (<i>E</i>)-6-Bromo-2-(2-(pyridin-3-yl)vinyl)-<i>1H</i>-benzo[<i>d</i>]imidazole (<b>73</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>64</b> was employed to afford 176 mg of <b>73</b> (58.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 8.50 (dd, <i>J</i> = 4.9, 1.7 Hz, 1H), 8.12 (d, <i>J</i> = 7.8 Hz, 1H), 7.69 (s, 1H), 7.59 (d, <i>J</i> = 16.5 Hz, 1H), 7.45–7.50 (m, 2H), 7.35 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.24 (d, <i>J</i> = 16.5 Hz, 1H). MS (ESI) <i>m</i>/<i>z</i> 300.1 [MH<sup>+</sup>].</div></div><div id="sec4_2_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>tert</i>-Butyl (<i>E</i>)-6-bromo-2-(2-(6-(dimethylamino)pyridin-3-yl)vinyl)-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>74</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>66</b> was employed to afford 710 mg of <b>74</b> (84.8%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 2.3 Hz, 1H), 8.09 (d, <i>J</i> = 2.1 Hz, 1H), 7.90 (d, <i>J</i> = 15.8 Hz, 1H), 7.79 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.67 (d, <i>J</i> = 15.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.7 Hz, 1H), 7.44 (dd, <i>J</i> = 8.5, 2.1 Hz, 1H), 6.55 (d, <i>J</i> = 8.9 Hz, 1H), 3.16 (s, 6H), 1.75 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 443.2 [MH<sup>+</sup>].</div></div><div id="sec4_2_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>tert</i>-Butyl (<i>E</i>)-6-bromo-2-(2-(pyridin-3-yl)vinyl)-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>75</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>66</b> was employed to afford 137 mg of <b>75</b> (58.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (s, 1H), 8.57 (d, <i>J</i> = 4.6 Hz, 1H), 7.87–8.01 (m, 4H), 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.43 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.34 (dd, <i>J</i> = 7.8, 4.6 Hz, 1H), 1.75 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 400.2 [MH<sup>+</sup>].</div></div><div id="sec4_2_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>tert</i>-Butyl (<i>E</i>)-2-(2-(6-(dimethylamino)pyridin-3-yl)vinyl)-6-(tributylstannyl)-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>76</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>67</b> was employed to afford 30.0 mg of <b>76</b> (18.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.16–8.36 (m, 1H), 7.68–8.00 (m, 3H), 7.31–7.41 (m, 2H), 6.15–6.56 (m, 1H), 4.91–5.32 (m, 1H), 2.90–3.15 (m, 6H), 1.68–1.75 (m, 9H), 0.84–1.65 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 655.5 [MH<sup>+</sup>].</div></div><div id="sec4_2_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>tert</i>-Butyl (<i>E</i>)-2-(2-(pyridin-3-yl)vinyl)-6-(tributylstannyl)-<i>1H</i>-benzo[<i>d</i>]imidazole-1-carboxylate (<b>77</b>)</h4><div class="NLM_p last">The same reaction described above for the preparation of <b>67</b> was employed to afford 31.1 mg of <b>77</b> (25.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (d, <i>J</i> = 1.7 Hz, 1H), 8.56 (d, <i>J</i> = 3.8 Hz, 1H), 8.05 (d, <i>J</i> = 16.0 Hz, 1H), 7.88–7.97 (m, 4H), 7.42 (d, <i>J</i> = 7.8 Hz, 1H), 7.33 (dd, <i>J</i> = 8.1, 4.9 Hz, 1H), 1.75 (s, 9H), 0.87–1.60 (m, 27H). MS (ESI) <i>m</i>/<i>z</i> 612.4 [MH<sup>+</sup>].</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Immunohistochemical Staining Using AD Brain Sections</h3><div class="NLM_p last">Post-mortem brain tissues from an autopsy-confirmed case of AD (a 76-year-old male) were obtained from Graduate School of Medicine, Kyoto University. Six-micrometer-thick serial sections of paraffin-embedded blocks were used for staining. The sections were subjected to two 15 min incubations in xylene, two 1 min incubations in 100% EtOH, one 1 min incubation in 90% EtOH, one 1 min incubation in 80% EtOH, and one 1 min incubation in 70% EtOH to completely deparaffinize them, followed by two 2.5 min washes in H<sub>2</sub>O. They were then autoclaved for 15 min in 0.01 M citric acid buffer (pH 6.8) and incubated with 90% formic acid for 5 min to activate the antigen. After two 5 min incubations in PBS-Tween 20, the sections were incubated at room temperature with an antiphosphorylated tau (AT8, Thermo Scientific) or Aβ<sub>1–42</sub> (BC05, Wako) primary antibody for 1 h. After three 5 min incubations in PBS-Tween 20, they were incubated with biotinylated goat antimouse IgG (Histofine Simple Stain Mouse MAX-PO (MULTI), Nichirei Biosciences Inc.) at room temperature for 30 min. After three 3 min incubations in PBS-Tween 20 and one 5 min incubation in TBS, the sections were incubated with DAB as a chromogen for 1 min. After being washed with H<sub>2</sub>O, the sections were observed under a microscope (BIOREVO BZ-9000, Keyence Corp.).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Radiolabeling</h3><div class="NLM_p last">The radioiodinated forms of ligands were prepared from the corresponding tributyltin precursors by iododestannylation according to the conventional method<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> (see the detailed method in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Supporting Information</a>). See the solvent used in radiolabeling, HPLC conditions used for the purification of each ligand, and the retention time of each ligand in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> <i>In Vitro</i> Autoradiography</h3><div class="NLM_p last">Post-mortem brain tissues from an autopsy-confirmed case of AD (a 76-year-old male) and a healthy control (a 73-year-old male) were obtained from Graduate School of Medicine, Kyoto University and BioChain Institute Inc., respectively. The presence and location of tau and Aβ deposits in the sections were confirmed with immunohistochemical staining using an antiphosphoylated tau antibody (AT8) and Aβ<sub>1–42</sub> antibody (BC05), respectively. Deparaffinization was carried out according to the procedure described above. The sections were incubated with radioiodinated ligands (370 kBq/mL in 50% EtOH) for 2 h at room temperature. They were then dipped in 50% EtOH for 2 h and washed with H<sub>2</sub>O for 30 s. After drying, the <sup>125</sup>I-labeled sections were exposed to a BAS imaging plate (Fuji Film) overnight. Autoradiographic images were obtained using a BAS5000 scanner system (Fuji Film).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Measurement of log D<sub>7.4</sub> Values</h3><div class="NLM_p last">The experimental determination of partition coefficients of each radioiodinated ligand was performed in 1-octanol and 0.01 M PBS (−) at a pH of 7.4 according to the conventional method<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (see the detailed method in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> <i>In Vivo</i> Biodistribution in Normal Mice</h3><div class="NLM_p last">The experiments with animals were conducted in accordance with our institutional guidelines and approved by Kyoto University. A saline solution (100 μL) of each radioiodinated ligand (19.6–29.4 kBq) containing EtOH (10.0 μL) and Tween 80 (0.100 μL) was injected intravenously directly into the tails of ddY mice (5-week-old male). The mice were sacrificed at various time points postinjection. The organs of interest were removed and weighed, and the radioactivity was measured with an automatic γ counter (Wizard 1470, PerkinElmer).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00440">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00440" class="ext-link">10.1021/acs.jmedchem.5b00440</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Summary of the method and solvent used in radiolabeling, HPLC condition used for the purification of each ligand, the retention time of each ligand in the HPLC analysis, biodistribution of radioactivity after injection of [<sup>125</sup>I]<b>64</b> in normal mice, <i>in vitro</i> fluorescent-staining image of compound <b>3</b> in the AD brain section, <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>64</b> in the healthy control brain section, quantitative analysis of autoradiography of each ligand, evaluation of <i>in vitro</i> and <i>in vivo</i> stability of [<sup>125</sup>I]<b>64</b>, <sup>1</sup>H NMR spectra files, and detailed methods for radiolabeling and measurements of log D<sub>7.4</sub> values (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf">jm5b00440_si_001.pdf (15.55 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00440" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masahiro Ono</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3e5150517e4e565f4c53105547514a51134b105f5d10544e"><span class="__cf_email__" data-cfemail="3758595877475f56455a195c4e5843581a42195654195d47">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Matsumura</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayane Kitada</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroyuki Watanabe</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masashi Yoshimura</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shimpei Iikuni</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroyuki Kimura</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yoko Okamoto</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology, National Cerebral and Cardiovascular
Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masafumi Ihara</span> - <span class="hlFld-Affiliation affiliation">Department
of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideo Saji</span> - <span class="hlFld-Affiliation affiliation">Department
of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical
Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2424e7209-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71511" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71511" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the “Funding Program for Next Generation World-Leading Researchers (NEXT Program),” initiated by the Council for Science and Technology Policy (CSTP), Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control (15H01555) from MEXT, and JSPS Research Fellowships for Young Scientists.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i104" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i104"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i105" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i105"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β peptides</p></td></tr><tr><td class="NLM_term">SP</td><td class="NLM_def"><p class="first last">senile plaques</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">MS (ESI or APCI)</td><td class="NLM_def"><p class="first last">mass spectrometry (electrospray ionization or atmospheric pressure chemical ionization)</p></td></tr><tr><td class="NLM_term">HRMS (EI)</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry (electron impact)</p></td></tr><tr><td class="NLM_term">Na<sub>2</sub>S<sub>2</sub>O<sub>5</sub></td><td class="NLM_def"><p class="first last">sodium metabisulfite</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">NaI</td><td class="NLM_def"><p class="first last">sodium iodide</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term"><i>J</i></td><td class="NLM_def"><p class="first last">coupling constant (in NMR spectrometry)</p></td></tr><tr><td class="NLM_term">MgSO<sub>4</sub></td><td class="NLM_def"><p class="first last">magnesium sulfate</p></td></tr><tr><td class="NLM_term">CuI</td><td class="NLM_def"><p class="first last">copper(I) iodide</p></td></tr><tr><td class="NLM_term">Na<sub>2</sub>S·9H<sub>2</sub>O</td><td class="NLM_def"><p class="first last">sodium sulfide nonahydrate</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N,N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">NaHCO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium hydrogen carbonate</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">(SnBu<sub>3</sub>)<sub>2</sub></td><td class="NLM_def"><p class="first last">bis(tributyltin)</p></td></tr><tr><td class="NLM_term">(Ph<sub>3</sub>P)<sub>4</sub>Pd</td><td class="NLM_def"><p class="first last">tetrakis(triphenylphosphine)palladium(0)</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">NaHSO<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium hydrogen sulfite</p></td></tr><tr><td class="NLM_term">K<sub>2</sub>CO<sub>3</sub></td><td class="NLM_def"><p class="first last">potassium carbonate</p></td></tr><tr><td class="NLM_term">MgCl<sub>2</sub></td><td class="NLM_def"><p class="first last">magnesium chloride</p></td></tr><tr><td class="NLM_term">LAH</td><td class="NLM_def"><p class="first last">lithium aluminum hydride</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last">tris-buffered saline</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last"><i>N,N</i>-dimethyl-4-aminopyridine</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">DAB</td><td class="NLM_def"><p class="first last">3,3′-diaminobenzidine</p></td></tr><tr><td class="NLM_term">H<sub>2</sub>O<sub>2</sub></td><td class="NLM_def"><p class="first last">hydrogen peroxide</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">DBDMH</td><td class="NLM_def"><p class="first last">1,3-dibromo-5,5-dimethylhydantoin</p></td></tr><tr><td class="NLM_term">PPA</td><td class="NLM_def"><p class="first last">polyphosphoric acid</p></td></tr><tr><td class="NLM_term">(HCHO)<sub>n</sub></td><td class="NLM_def"><p class="first last">paraformaldehyde</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">PBr<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphorus tribromide</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">P(OEt)<sub>3</sub></td><td class="NLM_def"><p class="first last">triethyl phosphite</p></td></tr><tr><td class="NLM_term">NaOMe</td><td class="NLM_def"><p class="first last">sodium methoxide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">(CH<sub>3</sub>CO)<sub>2</sub>O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler-Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, H. M.</span><span> </span><span class="NLM_article-title">Forecasting the global burden of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/j.jalz.2007.04.381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.jalz.2007.04.381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19595937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-191&author=R.+Brookmeyerauthor=E.+Johnsonauthor=K.+Ziegler-Grahamauthor=H.+M.+Arrighi&title=Forecasting+the+global+burden+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2007.04.381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the global burden of Alzheimer's disease</span></div><div class="casAuthors">Brookmeyer Ron; Johnson Elizabeth; Ziegler-Graham Kathryn; Arrighi H Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our goal was to forecast the global burden of Alzheimer's disease and evaluate the potential impact of interventions that delay disease onset or progression.  METHODS:  A stochastic, multistate model was used in conjunction with United Nations worldwide population forecasts and data from epidemiological studies of the risks of Alzheimer's disease.  RESULTS:  In 2006, the worldwide prevalence of Alzheimer's disease was 26.6 million.  By 2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be living with the disease.  We estimate about 43% of prevalent cases need a high level of care, equivalent to that of a nursing home.  If interventions could delay both disease onset and progression by a modest 1 year, there would be nearly 9.2 million fewer cases of the disease in 2050, with nearly the entire decline attributable to decreases in persons needing a high level of care.  CONCLUSIONS:  We face a looming global epidemic of Alzheimer's disease as the world's population ages.  Modest advances in therapeutic and preventive strategies that lead to even small delays in the onset and progression of Alzheimer's disease can significantly reduce the global burden of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScBQJ_4Qj7YMSzjBFCN0BJfW6udTcc2eaO_YAsxYEHdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D&md5=f89fab48e87760875e35c68876a42664</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.04.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.04.381%26sid%3Dliteratum%253Aachs%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DZiegler-Graham%26aufirst%3DK.%26aulast%3DArrighi%26aufirst%3DH.%2BM.%26atitle%3DForecasting%2520the%2520global%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D191%26doi%3D10.1016%2Fj.jalz.2007.04.381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelario, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindler, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span> </span><span class="NLM_article-title">Regenerative medicine in Alzheimer’s disease</span> <span class="citation_source-journal">Transl Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.trsl.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.trsl.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24286919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2c3hslWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2014&pages=432-438&author=K.+M.+Felsensteinauthor=K.+M.+Candelarioauthor=D.+A.+Steindlerauthor=D.+R.+Borchelt&title=Regenerative+medicine+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trsl.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Regenerative medicine in Alzheimer's disease</span></div><div class="casAuthors">Felsenstein Kevin M; Candelario Kate M; Steindler Dennis A; Borchelt David R</div><div class="citationInfo"><span class="NLM_cas:title">Translational research : the journal of laboratory and clinical medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Identifying novel, effective therapeutics for Alzheimer's disease (AD) is one of the major unmet medical needs for the coming decade.  Because the current paradigm for developing and testing disease-modifying AD therapies is protracted and likely to be even longer, with the shift toward earlier intervention in preclinical AD, it is an open issue whether we can develop, test, and widely deploy a novel therapy in time to help the current at-risk generation if we continue to follow the standard paradigms of discovery and drug development.  There is an imperative need to find safe and effective preventive measures that can be distributed rapidly to stem the coming wave of AD that will potentially engulf the next generation.  We can define regenerative medicine broadly as approaches that use stem cell-based therapies or approaches that seek to modulate inherent neurogenesis.  Neurogenesis, although most active during prenatal development, has been shown to continue in several small parts of the brain, including the hippocampus and the subventricular zone, suggesting its potential to reverse cognitive deficits.  If AD pathology affects neurogenesis, then it follows that conditions that stimulate endogenous neurogenesis (eg, environmental stimuli, physical activity, trophic factors, cytokines, and drugs) may help to promote the regenerative and recovery process.  Herein, we review the complex logistics of potentially implementing neurogenesis-based therapeutic strategies for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQupbKU3HIWG_9pSBfyDvp7fW6udTcc2eaO_YAsxYEHdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3hslWgtg%253D%253D&md5=2ff49da967dde5b3db399f6d73e5a9d3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DCandelario%26aufirst%3DK.%2BM.%26aulast%3DSteindler%26aufirst%3DD.%2BA.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26atitle%3DRegenerative%2520medicine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTransl%2520Res.%26date%3D2014%26volume%3D163%26spage%3D432%26epage%3D438%26doi%3D10.1016%2Fj.trsl.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/S1474-4422(09)70299-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS1474-4422%2809%2970299-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20083042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=119-128&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=L.+M.+Shawauthor=P.+S.+Aisenauthor=M.+W.+Weinerauthor=R.+C.+Petersenauthor=J.+Q.+Trojanowski&title=Hypothetical+model+of+dynamic+biomarkers+of+the+Alzheimer%E2%80%99s+pathological+cascade&doi=10.1016%2FS1474-4422%2809%2970299-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade</span></div><div class="casAuthors">Jack, Clifford R., Jr.; Knopman, David S.; Jagust, William J.; Shaw, Leslie M.; Aisen, Paul S.; Weiner, Michael W.; Petersen, Ronald C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently available evidence strongly supports the position that the initiating event in Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately leading to formation of Aβ plaques in the brain.  This process occurs while individuals are still cognitively normal.  Biomarkers of brain β-amyloidosis are redns. in CSF Aβ42 and increased amyloid PET tracer retention.  After a lag period, which varies from patient to patient, neuronal dysfunction and neurodegeneration become the dominant pathol. processes.  Biomarkers of neuronal injury and neurodegeneration are increased CSF tau and structural MRI measures of cerebral atrophy.  Neurodegeneration is accompanied by synaptic dysfunction, which is indicated by decreased fluorodeoxyglucose uptake on PET.  We propose a model that relates disease stage to AD biomarkers in which Aβ biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegenerative biomarkers become abnormal later, and correlate with clin. symptom severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnmdY1Eeez7Vg90H21EOLACvtfcHk0liMM7GIoP-UeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D&md5=5337b3e576ab1e8c58292c2572fb62f6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970299-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DHypothetical%2520model%2520of%2520dynamic%2520biomarkers%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520pathological%2520cascade%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D119%26epage%3D128%26doi%3D10.1016%2FS1474-4422%2809%2970299-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Development of positron emission tomography β-amyloid plaque imaging agents</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1053/j.semnuclmed.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1053%2Fj.semnuclmed.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23026364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=423-432&author=C.+A.+Mathisauthor=N.+S.+Masonauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Development+of+positron+emission+tomography+%CE%B2-amyloid+plaque+imaging+agents&doi=10.1053%2Fj.semnuclmed.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of positron emission tomography β-amyloid plaque imaging agents</span></div><div class="casAuthors">Mathis Chester A; Mason N Scott; Lopresti Brian J; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">For 100 years, β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) have been recognized as the neuropathological hallmarks of Alzheimer's disease (AD), and their presence or absence could only be assessed postmortem using stains and dyes that identified these microscopic structures.  Approximately 10 years ago, the first successful Aβ plaque-specific positron emission tomography (PET) imaging study was conducted in a living human subject clinically diagnosed with probable AD using the (11)C-labeled radiopharmaceutical Pittsburgh Compound B (PiB).  Laboratory studies and preclinical evaluations to design PiB began a decade earlier than the first human PiB PET study and involved chemical modifications of different well-known dyes that bound specifically to the extended β-pleated sheets that comprise the fibrils of amyloid proteins such as Aβ plaques, NFTs, α-synuclein deposits, and prions.  These preclinical studies were conducted in our laboratories at the University of Pittsburgh, starting with Congo red derivatives, followed by Chrysamine G derivatives, followed by X-series compounds, and finally with neutral derivatives of thioflavin-T.  The in vitro and in vivo evaluations of the different derivatives as candidate PET radioligands for imaging Aβ plaques and neurofibrillary tangles in human brain are described in this review, along with the specific evaluation criteria by which the candidate radioligands were judged.  Out of these studies came PiB, a PET radioligand that binds selectively and with high affinity to only fibrillar forms of Aβ.  PiB has been used in many different human research protocols throughout the world and has demonstrated the usefulness of assessing the Aβ plaque status of subjects many years before the clinical diagnosis of probable AD.  Recently, longer-lived (18)F-radiolabeled Aβ-selective radiopharmaceuticals have been developed.  It is likely that the full clinical impact of these imaging agents will be realized by identifying presymptomatic subjects who would benefit from early drug treatments with future disease-modifying AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5GsYnd2H3WtyzdcP07UmufW6udTcc2eZpa85vpqG7qrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D&md5=e9c01e3c4335a6b85dd838c64277e0ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DDevelopment%2520of%2520positron%2520emission%2520tomography%2520%25CE%25B2-amyloid%2520plaque%2520imaging%2520agents%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D42%26spage%3D423%26epage%3D432%26doi%3D10.1053%2Fj.semnuclmed.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobrega, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title"><sup>11</sup>C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer’s disease</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span><span class="refDoi"> DOI: 10.1016/S0969-8051(03)00049-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0969-8051%2803%2900049-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=12900282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=565-571&author=M.+Onoauthor=A.+Wilsonauthor=J.+Nobregaauthor=D.+Westawayauthor=P.+Verhoeffauthor=Z.+P.+Zhuangauthor=M.+P.+Kungauthor=H.+F.+Kung&title=11C-labeled+stilbene+derivatives+as+A%CE%B2-aggregate-specific+PET+imaging+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0969-8051%2803%2900049-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">11C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer's disease</span></div><div class="casAuthors">Ono, Masahiro; Wilson, Alan; Nobrega, Jose; Westaway, David; Verhoeff, Paul; Zhuang, Zhi-Ping; Kung, Mei-Ping; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-571</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A series of stilbene derivs. as potential diagnostic imaging agents targeting amyloid plaques in Alzheimer's disease (AD) were synthesized and evaluated.  The syntheses of the stilbenes were successfully achieved by a simple Wadsworth-Emmons reaction between di-Et (4-nitrobenzyl)phosphonate and 4-methoxybenzaldehyde. 4-N,N-dimethylamino-4'-methyoxy and the corresponding 4-N-monomethylamino-, 4'-hydroxy stilbenes showed good binding affinities towards Aβ aggregates in vitro (Ki < 10 nM).  The 11C labeled 4-N-methylamino-4'-hydroxystilbene, [11C]4, was prepd. by 11C methylation of 4-amino-4'-hydroxystilbene.  The [11C]4 displayed a moderate lipophilicity (log P = 2.36), and showed a very good brain penetration and washout from normal rat brain after an iv injection.  In vitro autoradiog. of transgenic AD mouse brain sections showed a high specific labeling of β-amyloid plaques, whereas the control sections showed no binding.  Taken together the data suggest that a relatively simple stilbene deriv., [11C]4, N-[11C]methylamino-4'-hydroxystilbene, may be useful as a positron emission tomog. (PET) imaging agent for mapping Aβ plaques in the brain of patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_fzcBd7sevLVg90H21EOLACvtfcHk0liMM7GIoP-UeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFynsbw%253D&md5=18d2f044489140a061da96846d1cc46a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900049-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900049-0%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DNobrega%26aufirst%3DJ.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DVerhoeff%26aufirst%3DP.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3D11C-labeled%2520stilbene%2520derivatives%2520as%2520A%25CE%25B2-aggregate-specific%2520PET%2520imaging%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D565%26epage%3D571%26doi%3D10.1016%2FS0969-8051%2803%2900049-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waragai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Amyloid PET in mild cognitive impairment and Alzheimer’s disease with BF-227: comparison to FDG-PET</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1007/s00415-009-5396-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00415-009-5396-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19946781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1CktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2010&pages=721-727&author=K.+Furukawaauthor=N.+Okamuraauthor=M.+Tashiroauthor=M.+Waragaiauthor=S.+Furumotoauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudoauthor=H.+Arai&title=Amyloid+PET+in+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease+with+BF-227%3A+comparison+to+FDG-PET&doi=10.1007%2Fs00415-009-5396-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET</span></div><div class="casAuthors">Furukawa, Katsutoshi; Okamura, Nobuyuki; Tashiro, Manabu; Waragai, Masaaki; Furumoto, Shozo; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721-727</span>CODEN:
                <span class="NLM_cas:coden">JNRYA9</span>;
        ISSN:<span class="NLM_cas:issn">0340-5354</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We recently developed a novel PET tracer, 11C-labeled 2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole ([11C]BF-227), and had success with in vivo detection of amyloid plaques in Alzheimer's disease (AD) brains (Kudo et al. in J Nucl Med 8:553-561, 2007).  We applied this tracer to subjects with mild cognitive impairment (MCI) and AD in order to elucidate the status of amyloid plaque deposition in MCI and compared the diagnostic performance of BF-227-PET with that of FDG-PET in AD cases.  We studied 12 aged normal (AN) subjects, 15 MCIs and 15 ADs with PET using [11C]BF-227.  PET images were obtained after administration of BF-227 and the regional standardized uptake value (SUV) and the ratio of regional to cerebellar SUV were calcd. as an index of BF-227 binding.  AD patients showed increased uptake of [11C]BF-227 in the neocortical areas and striatum as well as decreased glucose metab. in temporoparietal, posterior cingulate and medial temporal areas.  MCI subjects showed a significant increase in BF-227 uptake in the neocortical areas similar to AD, and the most significant difference of BF-227 retention was obsd. in the parietal lobe if its retentions for MCI were compared to those for AD and AN.  On the other hand, glucose hypometabolism in MCI was confined to cingulate and medial temporal cortices.  Neocortical BF-227 uptake neg. correlated with glucose metab.  Receiver operating characteristic (ROC) anal. indicated higher specificity and sensitivity with BF-227-PET than those with FDG-PET for differential diagnosis between AD and normal control.  We conclude that [11C]BF-227-PET has a possibility to be a useful technol. for early detection of AD pathol. and also even in the MCI stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquDEyzTS1_hbVg90H21EOLACvtfcHk0lghmmdNtFXCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1CktL4%253D&md5=edca72231634343ed69f65e0b752d89b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00415-009-5396-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00415-009-5396-8%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DWaragai%26aufirst%3DM.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DAmyloid%2520PET%2520in%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520BF-227%253A%2520comparison%2520to%2520FDG-PET%26jtitle%3DJ.%2520Neurol.%26date%3D2010%26volume%3D257%26spage%3D721%26epage%3D727%26doi%3D10.1007%2Fs00415-009-5396-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Vandenberghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanoiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasselbalch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraux, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelissen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owenius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurfjell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1002/ana.22068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.22068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20687209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3cjpsleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=319-329&author=R.+Vandenbergheauthor=K.+Van+Laereauthor=A.+Ivanoiuauthor=E.+Salmonauthor=C.+Bastinauthor=E.+Triauauthor=S.+Hasselbalchauthor=I.+Lawauthor=A.+Andersenauthor=A.+Kornerauthor=L.+Minthonauthor=G.+Garrauxauthor=N.+Nelissenauthor=G.+Bormansauthor=C.+Buckleyauthor=R.+Oweniusauthor=L.+Thurfjellauthor=G.+Farrarauthor=D.+J.+Brooks&title=18F-flutemetamol+amyloid+imaging+in+Alzheimer+disease+and+mild+cognitive+impairment%3A+a+phase+2+trial&doi=10.1002%2Fana.22068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial</span></div><div class="casAuthors">Vandenberghe Rik; Van Laere Koen; Ivanoiu Adrian; Salmon Eric; Bastin Christine; Triau Eric; Hasselbalch Steen; Law Ian; Andersen Allan; Korner Alex; Minthon Lennart; Garraux Gaetan; Nelissen Natalie; Bormans Guy; Buckley Chris; Owenius Rikard; Thurfjell Lennart; Farrar Gill; Brooks David J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB).  Its availability, however, is limited by the need for an on-site cyclotron.  Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology.  METHODS:  Twenty-seven patients with early-stage clinically probable Alzheimer disease (AD), 20 with amnestic mild cognitive impairment (MCI), and 15 cognitively intact healthy volunteers (HVs) above and 10 HVs below 55 years of age participated.  The primary endpoint was the efficacy of blinded visual assessments of (18)F-flutemetamol scans in assigning subjects to a raised versus normal uptake category, with clinical diagnosis as the standard of truth (SOT).  As secondary objectives, we determined the correlation between the regional standardized uptake value ratios (SUVRs) for (18)F-flutemetamol and its parent molecule (11)C-PIB in 20 of the AD subjects and 20 of the MCI patients.  We also determined test-retest variability of (18)F-flutemetamol SUVRs in 5 of the AD subjects.  RESULTS:  Blinded visual assessments of (18)F-flutemetamol scans assigned 25 of 27 scans from AD subjects and 1 of 15 scans from the elderly HVs to the raised category, corresponding to a sensitivity of 93.1% and a specificity of 93.3% against the SOT.  Correlation coefficients between cortical (18)F-flutemetamol SUVRs and (11)C-PIB SUVRs ranged from 0.89 to 0.92.  Test-retest variabilities of regional SUVRs were 1 to 4%.  INTERPRETATION:  (18)F-Flutemetamol performs similarly to the (11)C-PIB parent molecule within the same subjects and provides high test-retest replicability and potentially much wider accessibility for clinical and research use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8869ZYPKnLP_I8Jvzw4xCfW6udTcc2ebb6N361oqSWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjpsleisg%253D%253D&md5=1cef58b91f2f25d7d48fef9d352c64b0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fana.22068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22068%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DIvanoiu%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%26aulast%3DBastin%26aufirst%3DC.%26aulast%3DTriau%26aufirst%3DE.%26aulast%3DHasselbalch%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DA.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DGarraux%26aufirst%3DG.%26aulast%3DNelissen%26aufirst%3DN.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DBuckley%26aufirst%3DC.%26aulast%3DOwenius%26aufirst%3DR.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DFarrar%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3D18F-flutemetamol%2520amyloid%2520imaging%2520in%2520Alzheimer%2520disease%2520and%2520mild%2520cognitive%2520impairment%253A%2520a%2520phase%25202%2520trial%26jtitle%3DAnn.%2520Neurol.%26date%3D2010%26volume%3D68%26spage%3D319%26epage%3D329%26doi%3D10.1002%2Fana.22068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer’s disease: a miniperspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1021/jm901039z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901039z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12hs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=933-941&author=H.+F.+Kungauthor=S.+R.+Choiauthor=W.+Quauthor=W.+Zhangauthor=D.+Skovronsky&title=18F+stilbenes+and+styrylpyridines+for+PET+imaging+of+A%CE%B2+plaques+in+Alzheimer%E2%80%99s+disease%3A+a+miniperspective&doi=10.1021%2Fjm901039z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">18F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer's Disease: A Miniperspective</span></div><div class="casAuthors">Kung, Hank F.; Choi, Seok Rye; Qu, Wenchao; Zhang, Wei; Skovronsky, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors discuss progress in th use of 18F stilbenes and styrylpyridines as PET imaging agents for β-amyloid and the diagnosis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRBBwwer3WhLVg90H21EOLACvtfcHk0lhdVgFxMWjr7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12hs7%252FM&md5=9f39e880eb3170222b301369020a66e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm901039z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901039z%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSkovronsky%26aufirst%3DD.%26atitle%3D18F%2520stilbenes%2520and%2520styrylpyridines%2520for%2520PET%2520imaging%2520of%2520A%25CE%25B2%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520miniperspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D933%26epage%3D941%26doi%3D10.1021%2Fjm901039z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilker, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautkramer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doraiswamy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowsky, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehntner, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Group, A. A. S.</span><span> </span><span class="NLM_article-title">Use of florbetapir-PET for imaging β-amyloid pathology</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1001/jama.2010.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1001%2Fjama.2010.2008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2011&pages=275-283&author=C.+M.+Clarkauthor=J.+A.+Schneiderauthor=B.+J.+Bedellauthor=T.+G.+Beachauthor=W.+B.+Bilkerauthor=M.+A.+Mintunauthor=M.+J.+Pontecorvoauthor=F.+Heftiauthor=A.+P.+Carpenterauthor=M.+L.+Flitterauthor=M.+J.+Krautkramerauthor=H.+F.+Kungauthor=R.+E.+Colemanauthor=P.+M.+Doraiswamyauthor=A.+S.+Fleisherauthor=M.+N.+Sabbaghauthor=C.+H.+Sadowskyauthor=E.+P.+Reimanauthor=S.+P.+Zehntnerauthor=D.+M.+Skovronskyauthor=A.+A.+S.+Group&title=Use+of+florbetapir-PET+for+imaging+%CE%B2-amyloid+pathology&doi=10.1001%2Fjama.2010.2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Fjama.2010.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2010.2008%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DBedell%26aufirst%3DB.%2BJ.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DBilker%26aufirst%3DW.%2BB.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26aulast%3DHefti%26aufirst%3DF.%26aulast%3DCarpenter%26aufirst%3DA.%2BP.%26aulast%3DFlitter%26aufirst%3DM.%2BL.%26aulast%3DKrautkramer%26aufirst%3DM.%2BJ.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DColeman%26aufirst%3DR.%2BE.%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DFleisher%26aufirst%3DA.%2BS.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DSadowsky%26aufirst%3DC.%2BH.%26aulast%3DReiman%26aufirst%3DE.%2BP.%26aulast%3DZehntner%26aufirst%3DS.%2BP.%26aulast%3DSkovronsky%26aufirst%3DD.%2BM.%26aulast%3DGroup%26aufirst%3DA.%2BA.%2BS.%26atitle%3DUse%2520of%2520florbetapir-PET%2520for%2520imaging%2520%25CE%25B2-amyloid%2520pathology%26jtitle%3DJAMA%26date%3D2011%26volume%3D305%26spage%3D275%26epage%3D283%26doi%3D10.1001%2Fjama.2010.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">IMPY: an improved thioflavin-T derivative for <i>in vivo</i> labeling of β-amyloid plaques</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">956</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1016/S0006-8993(02)03436-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0006-8993%2802%2903436-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=12445687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslamsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=956&publication_year=2002&pages=202-210&author=M.+P.+Kungauthor=C.+Houauthor=Z.+P.+Zhuangauthor=B.+Zhangauthor=D.+Skovronskyauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=H.+F.+Kung&title=IMPY%3A+an+improved+thioflavin-T+derivative+for+in+vivo+labeling+of+%CE%B2-amyloid+plaques&doi=10.1016%2FS0006-8993%2802%2903436-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques</span></div><div class="casAuthors">Kung, Mei-Ping; Hou, Catherine; Zhuang, Zhi-Ping; Zhang, Bin; Skovronsky, Daniel; Trojanowski, John Q.; Lee, Virginia M.-Y.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">956</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-210</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Development of small mol. probes for in vivo labeling and detection of β-amyloid (Aβ) plaques in patients of Alzheimer's disease (AD) is of significant scientific interest, and it may also assist the development of drugs targeting Aβ plaques for treatment of AD.  A novel probe, [123I/125I]IMPY, 6-iodo-2-(4'-dimethylamino-)phenyl-imidazo[1,2-a]pyridine, was successfully prepd. with an iododestannylation reaction catalyzed by hydrogen peroxide.  The modified thioflavin-T deriv. displayed a good binding affinity for preformed synthetic Aβ40 aggregates in soln. (Ki=15±5 nM) and showed selective plaque labeling on postmortem AD brain sections.  Biodistribution study in normal mice after an iv injection of [125I]IMPY exhibited excellent brain uptake (2.9% initial dose/brain at 2 min) and fast washout (0.2% initial dose/brain at 60 min).  These properties are highly desirable for amyloid plaque imaging agents.  In vivo plaque labeling was evaluated in a transgenic mouse model (Tg2576) engineered to produce excess amyloid plaques in the brain.  Ex vivo autoradiograms of brain sections of the Tg 2576 mouse obtained at 4 h after an i.v. injection of [125I]IMPY clearly displayed a distinct plaque labeling with a low background activity.  When the same brain section was stained with a fluorescent dye, thioflavin-S, the same Aβ plaques showed prominent fluorescent labeling consistent with the results of the autoradiogram.  In conclusion, these findings clearly suggest that radioiodinated IMPY demonstrates desirable characteristics for in vivo labeling of Aβ plaques and it may be useful as a mol. imaging agent to study amyloidogenesis in the brain of living AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI2dGp5YDjNbVg90H21EOLACvtfcHk0lhdVgFxMWjr7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslamsLo%253D&md5=80674965784bfb672f0050c624f16140</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903436-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903436-4%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DIMPY%253A%2520an%2520improved%2520thioflavin-T%2520derivative%2520for%2520in%2520vivo%2520labeling%2520of%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D956%26spage%3D202%26epage%3D210%26doi%3D10.1016%2FS0006-8993%2802%2903436-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cselenyi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.2967/jnumed.112.114785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.112.114785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=880-886&author=C.+C.+Roweauthor=S.+Pejoskaauthor=R.+S.+Mulliganauthor=G.+Jonesauthor=J.+G.+Chanauthor=S.+Svenssonauthor=Z.+Cselenyiauthor=C.+L.+Mastersauthor=V.+L.+Villemagne&title=Head-to-head+comparison+of+11C-PiB+and+18F-AZD4694+%28NAV4694%29+for+%CE%B2-amyloid+imaging+in+aging+and+dementia&doi=10.2967%2Fjnumed.112.114785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.114785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.114785%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DJ.%2BG.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DCselenyi%26aufirst%3DZ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DHead-to-head%2520comparison%2520of%252011C-PiB%2520and%252018F-AZD4694%2520%2528NAV4694%2529%2520for%2520%25CE%25B2-amyloid%2520imaging%2520in%2520aging%2520and%2520dementia%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D880%26epage%3D886%26doi%3D10.2967%2Fjnumed.112.114785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yousefi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Reutern, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzezga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1021/cn5001827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn5001827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2MzlvFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=428-437&author=B.+H.+Yousefiauthor=A.+Manookauthor=T.+Grimmerauthor=T.+Arzbergerauthor=B.+von+Reuternauthor=G.+Henriksenauthor=A.+Drzezgaauthor=S.+Forsterauthor=M.+Schwaigerauthor=H.+J.+Wester&title=Characterization+and+first+human+investigation+of+FIBT%2C+a+novel+fluorinated+A%CE%B2+plaque+neuroimaging+PET+radioligand&doi=10.1021%2Fcn5001827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span></div><div class="casAuthors">Yousefi Behrooz Hooshyar; Manook Andre; Grimmer Timo; Arzberger Thomas; von Reutern Boris; Henriksen Gjermund; Drzezga Alexander; Forster Stefan; Schwaiger Markus; Wester Hans-Jurgen; Yousefi Behrooz Hooshyar; Manook Andre; Grimmer Timo; Arzberger Thomas; von Reutern Boris; Henriksen Gjermund; Drzezga Alexander; Forster Stefan; Schwaiger Markus; Wester Hans-Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS chemical neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Imidazo[2,1-b]benzothiazoles (IBTs) are a promising novel class of amyloid positron emission tomography (PET) radiopharmaceuticals for diagnosis of neurodegenerative disorders like Alzheimer's disease (AD).  Their good in vivo imaging properties have previously been shown in preclinical studies.  Among IBTs, fluorinated [(18)F]FIBT was selected for further characterization and advancement toward use in humans. [(18)F]FIBT characteristics were analyzed in relation to Pittsburgh compound B (PiB) as reference ligand. [(18)F]FIBT and [(3)H]PiB were coinjected to an APP/PS1 mouse for ex vivo dual-label autoradiographic correlation.  Acute dose toxicity of FIBT was examined in two groups of healthy mice.  Preexisting in vivo stability and biodistribution studies in mice were complemented with analogous studies in rats. [(18)F]FIBT was titrated against postmortem human AD brain homogenate in a saturation binding assay previously performed with [(3)H]PiB.  Binding of [(18)F]FIBT to human AD brain was further analyzed by in vitro incubation of human AD brain sections in comparison to [(11)C]PiB in relation to standard immunohistochemistry.  Finally, [(18)F]FIBT was administered to two human subjects for a dynamic 90 min PET/MR brain investigation.  Ex vivo autoradiography confirmed good uptake of [(18)F]FIBT to mouse brain and its excellent correlation to [(3)H]PiB binding.  No toxicity of FIBT could be found in mice at a concentration of 33.3 nmol/kg.  As in mice, [(18)F]FIBT was showing high in vivo stability in rats and comparable regional brain biodistribution dynamics to [(3)H]PiB.  Radioligand saturation binding confirmed at least one high-affinity binding component of [(18)F]FIBT around 1 nM.  Good binding of FIBT relative to PiB was further confirmed in binding assays and autoradiographies using post-mortem AD brain.  First use of [(18)F]FIBT in humans successfully yielded clinical [(18)F]FIBT PET/MR images with very good contrast.  In summary, [(18)F]FIBT has been characterized to be a new lead compound with improved binding characteristics and pharmacokinetics on its own as well as in comparison to PiB.  A pilot human PET investigation provided high-quality images with a plausible tracer distribution pattern.  Detailed clinical investigations are needed to confirm these first results and to explore the specific qualities of [(18)F]FIBT PET for dementia imaging in relation to established ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzH6fM48tHLUNHe_gFldTbfW6udTcc2eaDUTDrL9Rnzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzlvFCntw%253D%253D&md5=7b45c9345ace413b3546e906c4c0dc58</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcn5001827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5001827%26sid%3Dliteratum%253Aachs%26aulast%3DYousefi%26aufirst%3DB.%2BH.%26aulast%3DManook%26aufirst%3DA.%26aulast%3DGrimmer%26aufirst%3DT.%26aulast%3DArzberger%26aufirst%3DT.%26aulast%3Dvon%2BReutern%26aufirst%3DB.%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DDrzezga%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DS.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DCharacterization%2520and%2520first%2520human%2520investigation%2520of%2520FIBT%252C%2520a%2520novel%2520fluorinated%2520A%25CE%25B2%2520plaque%2520neuroimaging%2520PET%2520radioligand%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D428%26epage%3D437%26doi%3D10.1021%2Fcn5001827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senjem, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiung, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunter, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Neuroimaging, I. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1093/brain/awp062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1093%2Fbrain%2Fawp062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2009&pages=1355-1365&author=C.+R.+Jackauthor=V.+J.+Loweauthor=S.+D.+Weigandauthor=H.+J.+Wisteauthor=M.+L.+Senjemauthor=D.+S.+Knopmanauthor=M.+M.+Shiungauthor=J.+L.+Gunterauthor=B.+F.+Boeveauthor=B.+J.+Kempauthor=M.+Weinerauthor=R.+C.+Petersen&title=Alzheimer%E2%80%99s+Disease+Neuroimaging%2C+I.+Serial+PIB+and+MRI+in+normal%2C+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease%3A+implications+for+sequence+of+pathological+events+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawp062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawp062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawp062%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DLowe%26aufirst%3DV.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DSenjem%26aufirst%3DM.%2BL.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DShiung%26aufirst%3DM.%2BM.%26aulast%3DGunter%26aufirst%3DJ.%2BL.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DKemp%26aufirst%3DB.%2BJ.%26aulast%3DWeiner%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Neuroimaging%252C%2520I.%2520Serial%2520PIB%2520and%2520MRI%2520in%2520normal%252C%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520sequence%2520of%2520pathological%2520events%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2009%26volume%3D132%26spage%3D1355%26epage%3D1365%26doi%3D10.1093%2Fbrain%2Fawp062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larossa, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheline, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dence, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1212/01.wnl.0000228230.26044.a4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.wnl.0000228230.26044.a4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=446-452&author=M.+A.+Mintunauthor=G.+N.+Larossaauthor=Y.+I.+Shelineauthor=C.+S.+Denceauthor=S.+Y.+Leeauthor=R.+H.+Machauthor=W.+E.+Klunkauthor=C.+A.+Mathisauthor=S.+T.+DeKoskyauthor=J.+C.+Morris&title=%5B11C%5DPIB+in+a+nondemented+population%3A+potential+antecedent+marker+of+Alzheimer+disease&doi=10.1212%2F01.wnl.0000228230.26044.a4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000228230.26044.a4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000228230.26044.a4%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DLarossa%26aufirst%3DG.%2BN.%26aulast%3DSheline%26aufirst%3DY.%2BI.%26aulast%3DDence%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3D%255B11C%255DPIB%2520in%2520a%2520nondemented%2520population%253A%2520potential%2520antecedent%2520marker%2520of%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26spage%3D446%26epage%3D452%26doi%3D10.1212%2F01.wnl.0000228230.26044.a4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Aizenstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebes, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopelas, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziolko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snitz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houck, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Frequent amyloid deposition without significant cognitive impairment among the elderly</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1509</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span><span class="refDoi"> DOI: 10.1001/archneur.65.11.1509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1001%2Farchneur.65.11.1509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19001171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjt1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1509-1517&author=H.+J.+Aizensteinauthor=R.+D.+Nebesauthor=J.+A.+Saxtonauthor=J.+C.+Priceauthor=C.+A.+Mathisauthor=N.+D.+Tsopelasauthor=S.+K.+Ziolkoauthor=J.+A.+Jamesauthor=B.+E.+Snitzauthor=P.+R.+Houckauthor=W.+Biauthor=A.+D.+Cohenauthor=B.+J.+Loprestiauthor=S.+T.+DeKoskyauthor=E.+M.+Halliganauthor=W.+E.+Klunk&title=Frequent+amyloid+deposition+without+significant+cognitive+impairment+among+the+elderly&doi=10.1001%2Farchneur.65.11.1509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent amyloid deposition without significant cognitive impairment among the elderly</span></div><div class="casAuthors">Aizenstein Howard Jay; Nebes Robert D; Saxton Judith A; Price Julie C; Mathis Chester A; Tsopelas Nicholas D; Ziolko Scott K; James Jeffrey A; Snitz Beth E; Houck Patricia R; Bi Wenzhu; Cohen Ann D; Lopresti Brian J; DeKosky Steven T; Halligan Edythe M; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1509-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To characterize the prevalence of amyloid deposition in a clinically unimpaired elderly population, as assessed by Pittsburgh Compound B (PiB) positron emission tomography (PET) imaging, and its relationship to cognitive function, measured with a battery of neuropsychological tests.  DESIGN:  Subjects underwent cognitive testing and PiB PET imaging (15 mCi for 90 minutes with an ECAT HR+ scanner).  Logan graphical analysis was applied to estimate regional PiB retention distribution volume, normalized to a cerebellar reference region volume, to yield distribution volume ratios (DVRs).  SETTING:  University medical center.  PARTICIPANTS:  From a community-based sample of volunteers, 43 participants aged 65 to 88 years who did not meet diagnostic criteria for Alzheimer disease or mild cognitive impairment were included.  MAIN OUTCOME MEASURES:  Regional PiB retention and cognitive test performance.  RESULTS:  Of 43 clinically unimpaired elderly persons imaged, 9 (21%) showed evidence of early amyloid deposition in at least 1 brain area using an objectively determined DVR cutoff.  Demographic characteristics did not differ significantly between amyloid-positive and amyloid-negative participants, and neurocognitive performance was not significantly worse among amyloid-positive compared with amyloid-negative participants.  CONCLUSIONS:  Amyloid deposition can be identified among cognitively normal elderly persons during life, and the prevalence of asymptomatic amyloid deposition may be similar to that of symptomatic amyloid deposition.  In this group of participants without clinically significant impairment, amyloid deposition was not associated with worse cognitive function, suggesting that an elderly person with a significant amyloid burden can remain cognitively normal.  However, this finding is based on relatively small numbers and needs to be replicated in larger cohorts.  Longitudinal follow-up of these subjects will be required to support the potential of PiB imaging to identify preclinical Alzheimer disease, or, alternatively, to show that amyloid deposition is not sufficient to cause Alzheimer disease within some specified period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrc8iIT-fqA-b6AVA-44PTfW6udTcc2eaDUTDrL9Rnzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjt1Crtg%253D%253D&md5=a583c1fce52c4ee0a7851f3fb1a98a7f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1001%2Farchneur.65.11.1509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.65.11.1509%26sid%3Dliteratum%253Aachs%26aulast%3DAizenstein%26aufirst%3DH.%2BJ.%26aulast%3DNebes%26aufirst%3DR.%2BD.%26aulast%3DSaxton%26aufirst%3DJ.%2BA.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DTsopelas%26aufirst%3DN.%2BD.%26aulast%3DZiolko%26aufirst%3DS.%2BK.%26aulast%3DJames%26aufirst%3DJ.%2BA.%26aulast%3DSnitz%26aufirst%3DB.%2BE.%26aulast%3DHouck%26aufirst%3DP.%2BR.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DCohen%26aufirst%3DA.%2BD.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DHalligan%26aufirst%3DE.%2BM.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DFrequent%2520amyloid%2520deposition%2520without%2520significant%2520cognitive%2520impairment%2520among%2520the%2520elderly%26jtitle%3DArch.%2520Neurol.%26date%3D2008%26volume%3D65%26spage%3D1509%26epage%3D1517%26doi%3D10.1001%2Farchneur.65.11.1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1038/nrd2896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1038%2Fnrd2896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20431570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification&doi=10.1038%2Fnrd2896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: strategies for disease modification</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the largest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  However, in recent years, several approaches aimed at inhibiting disease progression have advanced to clin. trials.  Among these, strategies targeting the prodn. and clearance of the amyloid-β peptide - a cardinal feature of Alzheimer's disease that is thought to be important in disease pathogenesis - are the most advanced.  Approaches aimed at modulating the abnormal aggregation of tau filaments (another key feature of the disease), and those targeting metabolic dysfunction, are also being evaluated in the clinic.  This article discusses recent progress with each of these strategies, with a focus on anti-amyloid strategies, highlighting the lessons learned and the challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM0fsdJQ-z7Vg90H21EOLACvtfcHk0lgIlGbFJ5zNNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D&md5=281ba27137d2a1fa173d5dde1dcbe772</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd2896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2896%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398%26doi%3D10.1038%2Fnrd2896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Sting of Alzheimer’s failures offset by upcoming prevention trials</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1038/nrd3842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1038%2Fnrd3842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=657-660&author=A.+Mullard&title=Sting+of+Alzheimer%E2%80%99s+failures+offset+by+upcoming+prevention+trials&doi=10.1038%2Fnrd3842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd3842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3842%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DSting%2520of%2520Alzheimer%25E2%2580%2599s%2520failures%2520offset%2520by%2520upcoming%2520prevention%2520trials%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D657%26epage%3D660%26doi%3D10.1038%2Fnrd3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gilman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovira, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orgogozo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Team, A. N. S.</span><span> </span><span class="NLM_article-title">Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1212/01.WNL.0000159740.16984.3C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.WNL.0000159740.16984.3C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=1553-1562&author=S.+Gilmanauthor=M.+Kollerauthor=R.+S.+Blackauthor=L.+Jenkinsauthor=S.+G.+Griffithauthor=N.+C.+Foxauthor=L.+Eisnerauthor=L.+Kirbyauthor=M.+B.+Roviraauthor=F.+Foretteauthor=J.+M.+Orgogozoauthor=A.+N.+S.+Team&title=Clinical+effects+of+A%CE%B2+immunization+%28AN1792%29+in+patients+with+AD+in+an+interrupted+trial&doi=10.1212%2F01.WNL.0000159740.16984.3C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000159740.16984.3C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000159740.16984.3C%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DS.%26aulast%3DKoller%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DR.%2BS.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DGriffith%26aufirst%3DS.%2BG.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DEisner%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DL.%26aulast%3DRovira%26aufirst%3DM.%2BB.%26aulast%3DForette%26aufirst%3DF.%26aulast%3DOrgogozo%26aufirst%3DJ.%2BM.%26aulast%3DTeam%26aufirst%3DA.%2BN.%2BS.%26atitle%3DClinical%2520effects%2520of%2520A%25CE%25B2%2520immunization%2520%2528AN1792%2529%2520in%2520patients%2520with%2520AD%2520in%2520an%2520interrupted%2520trial%26jtitle%3DNeurology%26date%3D2005%26volume%3D64%26spage%3D1553%26epage%3D1562%26doi%3D10.1212%2F01.WNL.0000159740.16984.3C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadegarfar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A.</span><span> </span><span class="NLM_article-title">Long-term effects of Aβ<sub>42</sub> immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1016/S0140-6736(08)61075-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0140-6736%2808%2961075-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=18640458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=216-223&author=C.+Holmesauthor=D.+Bocheauthor=D.+Wilkinsonauthor=G.+Yadegarfarauthor=V.+Hopkinsauthor=A.+Bayerauthor=R.+W.+Jonesauthor=R.+Bullockauthor=S.+Loveauthor=J.+W.+Nealauthor=E.+Zotovaauthor=J.+A.+Nicoll&title=Long-term+effects+of+A%CE%B242+immunisation+in+Alzheimer%E2%80%99s+disease%3A+follow-up+of+a+randomised%2C+placebo-controlled+phase+I+trial&doi=10.1016%2FS0140-6736%2808%2961075-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effects of Aβ42 immunization in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial</span></div><div class="casAuthors">Holmes, Clive; Boche, Delphine; Wilkinson, David; Yadegarfar, Ghasem; Hopkins, Vivienne; Bayer, Anthony; Jones, Roy W.; Bullock, Roger; Love, Seth; Neal, James W.; Zotova, Elina; Nicoll, James A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9634</span>),
    <span class="NLM_cas:pages">216-223</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Immunization of patients with Alzheimer's disease with full-length amyloid-β peptide (Aβ42) can clear amyloid plaques from the brain.  Our aim was to assess the relation between Aβ42 immune response, degree of plaque removal, and long-term clin. outcomes.  In June, 2003, consent for long-term clin. follow-up, post-mortem neuropathol. examn., or both, was sought from 80 patients (or their carers) who had entered a phase I randomized, placebo-controlled trial of immunization with Aβ42 (AN1792, Elan Pharmaceuticals) in Sept., 2000.  The follow-up study was completed in Sept., 2006.  Plaques were assessed in terms of the percentage area of the cortex with Aβ immunostaining (Aβ load) and in terms of characteristic histol. features reflecting plaque removal.  Survival of all 80 individuals until severe dementia or death was assessed with a Cox proportional hazard model.  Twenty participants-15 in the AN1792 group, five in the placebo group-died before follow-up started.  A further 22 patients-19 in the AN1792 group, three in the placebo group-died during follow-up.  Nine of the deceased patients, all in the AN1792 group, had given consent for post-mortem anal.; one of these who did not die with Alzheimer's disease was excluded.  In the remaining eight participants who received immunization and who were examd. neuropathol., mean Aβ load was lower than in an unimmunized control group that was matched for age at death (2.1% [SE 0.7] in treated participants vs 5.1% [0.9] in controls; mean difference 3.0%, 95% CI 0.6-5.4; p=0.02).  Although there was considerable variation in Aβ load and degree of plaque removal among immunized participants, the degree of plaque removal varied significantly with mean antibody response attained during the treatment study period (Kruskal-Wallis p=0.02).  Seven of the eight immunized patients who underwent post-mortem assessment, including those with virtually complete plaque removal, had severe end stage dementia before death.  In the whole cohort, there was no evidence of improved survival (hazard ratio 0.93, 95% CI 0.43-3.11; p=0.86) or of an improvement in the time to severe dementia (1.18, 0.45-3.11; p=0.73) in the AN1792 group vs. the placebo group.  Although immunization with Aβ42 resulted in clearance of amyloid plaques in patients with Alzheimer's disease, this clearance did not prevent progressive neurodegeneration.  Alzheimer's Research Trust, Medical Research Council.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUUTVhBpFGbVg90H21EOLACvtfcHk0ljv3FuGDs180w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWkt74%253D&md5=df6930a3270378deacfe5ee43f3f155f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961075-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961075-2%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBoche%26aufirst%3DD.%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DYadegarfar%26aufirst%3DG.%26aulast%3DHopkins%26aufirst%3DV.%26aulast%3DBayer%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DR.%2BW.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26aulast%3DZotova%26aufirst%3DE.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%26atitle%3DLong-term%2520effects%2520of%2520A%25CE%25B242%2520immunisation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520follow-up%2520of%2520a%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D216%26epage%3D223%26doi%3D10.1016%2FS0140-6736%2808%2961075-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankratz, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2FS1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0ljv3FuGDs180w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapik-Czajka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewczuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Neuroimaging, I. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1002/ana.21610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.21610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19296504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=403-413&author=L.+M.+Shawauthor=H.+Vandersticheleauthor=M.+Knapik-Czajkaauthor=C.+M.+Clarkauthor=P.+S.+Aisenauthor=R.+C.+Petersenauthor=K.+Blennowauthor=H.+Soaresauthor=A.+Simonauthor=P.+Lewczukauthor=R.+Deanauthor=E.+Siemersauthor=W.+Potterauthor=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Alzheimer%E2%80%99s+Disease+Neuroimaging%2C+I.+Cerebrospinal+fluid+biomarker+signature+in+Alzheimer%E2%80%99s+disease+neuroimaging+initiative+subjects&doi=10.1002%2Fana.21610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects</span></div><div class="casAuthors">Shaw, Leslie M.; Vanderstichele, Hugo; Knapik-Czajka, Malgorzata; Clark, Christopher M.; Aisen, Paul S.; Petersen, Ronald C.; Blennow, Kaj; Soares, Holly; Simon, Adam; Lewczuk, Piotr; Dean, Robert; Siemers, Eric; Potter, William; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Develop a cerebrospinal fluid biomarker signature for mild Alzheimer's disease (AD) in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects.  Amyloid-β 1 to 42 peptide (Aβ1-42), total tau (t-tau), and tau phosphorylated at the threonine 181 were measured in (1) cerebrospinal fluid (CSF) samples obtained during baseline evaluation of 100 mild AD, 196 mild cognitive impairment, and 114 elderly cognitively normal (NC) subjects in ADNI; and (2) independent 56 autopsy-confirmed AD cases and 52 age-matched elderly NCs using a multiplex immunoassay.  Detection of an AD CSF profile for t-tau and Aβ1-42 in ADNI subjects was achieved using receiver operating characteristic cut points and logistic regression models derived from the autopsy-confirmed CSF data.  CSF Aβ1-42 was the most sensitive biomarker for AD in the autopsy cohort of CSF samples: receiver operating characteristic area under the curve of 0.913 and sensitivity for AD detection of 96.4%.  In the ADNI cohort, a logistic regression model for Aβ1-42, t-tau, and APOε4 allele count provided the best assessment delineation of mild AD.  An AD-like baseline CSF profile for t-tau/Aβ1-42 was detected in 33 of 37 ADNI mild cognitive impairment subjects who converted to probable AD during the first year of the study.  The CSF biomarker signature of AD defined by Aβ1-42 and t-tau in the autopsy-confirmed AD cohort and confirmed in the cohort followed in ADNI for 12 mo detects mild AD in a large, multisite, prospective clin. investigation, and this signature appears to predict conversion from mild cognitive impairment to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-txCTOcg12LVg90H21EOLACvtfcHk0lhv5iHxvPJuNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVylsLY%253D&md5=de148229e43926670d8a56f9b020039a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fana.21610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21610%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DKnapik-Czajka%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DLewczuk%26aufirst%3DP.%26aulast%3DDean%26aufirst%3DR.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Neuroimaging%252C%2520I.%2520Cerebrospinal%2520fluid%2520biomarker%2520signature%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520neuroimaging%2520initiative%2520subjects%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D403%26epage%3D413%26doi%3D10.1002%2Fana.21610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eZCTiM9J3bzPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wattez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermersch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghozali, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallet-Bianco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Menza, C.</span><span> </span><span class="NLM_article-title">The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span><span class="refDoi"> DOI: 10.1212/WNL.52.6.1158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2FWNL.52.6.1158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1158-1165&author=A.+Delacourteauthor=J.+P.+Davidauthor=N.+Sergeantauthor=L.+Bueeauthor=A.+Wattezauthor=P.+Vermerschauthor=F.+Ghozaliauthor=C.+Fallet-Biancoauthor=F.+Pasquierauthor=F.+Lebertauthor=H.+Petitauthor=C.+Di+Menza&title=The+biochemical+pathway+of+neurofibrillary+degeneration+in+aging+and+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.52.6.1158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1212%2FWNL.52.6.1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.52.6.1158%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DWattez%26aufirst%3DA.%26aulast%3DVermersch%26aufirst%3DP.%26aulast%3DGhozali%26aufirst%3DF.%26aulast%3DFallet-Bianco%26aufirst%3DC.%26aulast%3DPasquier%26aufirst%3DF.%26aulast%3DLebert%26aufirst%3DF.%26aulast%3DPetit%26aufirst%3DH.%26aulast%3DDi%2BMenza%26aufirst%3DC.%26atitle%3DThe%2520biochemical%2520pathway%2520of%2520neurofibrillary%2520degeneration%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1158%26epage%3D1165%26doi%3D10.1212%2FWNL.52.6.1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1002/ana.410410106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.410410106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=9005861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADyaK2s7lvVGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=17-24&author=T.+Gomez-Islaauthor=R.+Hollisterauthor=H.+Westauthor=S.+Muiauthor=J.+H.+Growdonauthor=R.+C.+Petersenauthor=J.+E.+Parisiauthor=B.+T.+Hyman&title=Neuronal+loss+correlates+with+but+exceeds+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fana.410410106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease</span></div><div class="casAuthors">Gomez-Isla T; Hollister R; West H; Mui S; Growdon J H; Petersen R C; Parisi J E; Hyman B T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">To assess the relationship between dementia, neuronal loss, and neuropathological findings in Alzheimer's disease (AD), we counted the number of neurons, senile plaques, and neurofibrillary tangles in a high-order association cortex.  We studied the superior temporal sulcus of 34 individuals with AD and 17 nondemented control subjects, using statistically unbiased, stereological counting techniques.  The number of superior temporal sulcus neurons in nondemented control subjects was stable across the sixth to ninth decades.  In AD, more than 50% of the neurons were lost.  Both neuronal loss and neurofibrillary tangles increased in parallel with the duration and severity of illness, but the amount of neuronal loss exceeded by manyfold the amount of neurofibrillary tangles accumulated.  In contrast to the correlation between neurofibrillary tangles and neuronal loss, the number of senile plaques and the percentage of the superior temporal sulcus that was covered by Abeta (amyloid burden) were not related to neuronal loss, number of neurofibrillary tangles, or duration of disease.  Neither the amount nor the rate of neuronal loss in the superior temporal sulcus in AD correlated with apolipoprotein E genotype.  These data suggest that neuronal loss in association areas such as the superior temporal sulcus contributes directly to cognitive impairment in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRb4pZx19FriEh5eUSa2oe_fW6udTcc2eZCTiM9J3bzPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7lvVGjsw%253D%253D&md5=77d2cb983d20b2a7cfe60426e4f55a50</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fana.410410106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410410106%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Isla%26aufirst%3DT.%26aulast%3DHollister%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DH.%26aulast%3DMui%26aufirst%3DS.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeuronal%2520loss%2520correlates%2520with%2520but%2520exceeds%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D1997%26volume%3D41%26spage%3D17%26epage%3D24%26doi%3D10.1002%2Fana.410410106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nelson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafuzoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulette, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltjer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span> </span><span class="NLM_article-title">Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1097/NEN.0b013e31825018f7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1097%2FNEN.0b013e31825018f7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22487856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=362-381&author=P.+T.+Nelsonauthor=I.+Alafuzoffauthor=E.+H.+Bigioauthor=C.+Bourasauthor=H.+Braakauthor=N.+J.+Cairnsauthor=R.+J.+Castellaniauthor=B.+J.+Crainauthor=P.+Daviesauthor=K.+Del+Trediciauthor=C.+Duyckaertsauthor=M.+P.+Froschauthor=V.+Haroutunianauthor=P.+R.+Hofauthor=C.+M.+Huletteauthor=B.+T.+Hymanauthor=T.+Iwatsuboauthor=K.+A.+Jellingerauthor=G.+A.+Jichaauthor=E.+Kovariauthor=W.+A.+Kukullauthor=J.+B.+Leverenzauthor=S.+Loveauthor=I.+R.+Mackenzieauthor=D.+M.+Mannauthor=E.+Masliahauthor=A.+C.+McKeeauthor=T.+J.+Montineauthor=J.+C.+Morrisauthor=J.+A.+Schneiderauthor=J.+A.+Sonnenauthor=D.+R.+Thalauthor=J.+Q.+Trojanowskiauthor=J.+C.+Troncosoauthor=T.+Wisniewskiauthor=R.+L.+Woltjerauthor=T.+G.+Beach&title=Correlation+of+Alzheimer+disease+neuropathologic+changes+with+cognitive+status%3A+a+review+of+the+literature&doi=10.1097%2FNEN.0b013e31825018f7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Alzheimer disease neuropathologic changes with cognitive status:  a review of the literature</span></div><div class="casAuthors">Nelson Peter T; Alafuzoff Irina; Bigio Eileen H; Bouras Constantin; Braak Heiko; Cairns Nigel J; Castellani Rudolph J; Crain Barbara J; Davies Peter; Del Tredici Kelly; Duyckaerts Charles; Frosch Matthew P; Haroutunian Vahram; Hof Patrick R; Hulette Christine M; Hyman Bradley T; Iwatsubo Takeshi; Jellinger Kurt A; Jicha Gregory A; Kovari Eniko; Kukull Walter A; Leverenz James B; Love Seth; Mackenzie Ian R; Mann David M; Masliah Eliezer; McKee Ann C; Montine Thomas J; Morris John C; Schneider Julie A; Sonnen Joshua A; Thal Dietmar R; Trojanowski John Q; Troncoso Juan C; Wisniewski Thomas; Woltjer Randall L; Beach Thomas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research.  Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations.  Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes.  Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD.  Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways.  We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment.  We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles.  Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfBiLIW6MJ0v9pSBfyDvp7fW6udTcc2ebTsFwov2HYq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D&md5=172e31ea54410212b1d60f7ff6f1d4d6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31825018f7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31825018f7%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DP.%2BT.%26aulast%3DAlafuzoff%26aufirst%3DI.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DCrain%26aufirst%3DB.%2BJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DHulette%26aufirst%3DC.%2BM.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DKovari%26aufirst%3DE.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DMackenzie%26aufirst%3DI.%2BR.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DSonnen%26aufirst%3DJ.%2BA.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26atitle%3DCorrelation%2520of%2520Alzheimer%2520disease%2520neuropathologic%2520changes%2520with%2520cognitive%2520status%253A%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D362%26epage%3D381%26doi%3D10.1097%2FNEN.0b013e31825018f7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Whitwell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephs, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarci, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przybelski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senjem, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1212/01.wnl.0000324924.91351.7d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.wnl.0000324924.91351.7d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=743-749&author=J.+L.+Whitwellauthor=K.+A.+Josephsauthor=M.+E.+Murrayauthor=K.+Kantarciauthor=S.+A.+Przybelskiauthor=S.+D.+Weigandauthor=P.+Vemuriauthor=M.+L.+Senjemauthor=J.+E.+Parisiauthor=D.+S.+Knopmanauthor=B.+F.+Boeveauthor=R.+C.+Petersenauthor=D.+W.+Dicksonauthor=C.+R.+Jack&title=MRI+correlates+of+neurofibrillary+tangle+pathology+at+autopsy%3A+a+voxel-based+morphometry+study&doi=10.1212%2F01.wnl.0000324924.91351.7d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000324924.91351.7d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000324924.91351.7d%26sid%3Dliteratum%253Aachs%26aulast%3DWhitwell%26aufirst%3DJ.%2BL.%26aulast%3DJosephs%26aufirst%3DK.%2BA.%26aulast%3DMurray%26aufirst%3DM.%2BE.%26aulast%3DKantarci%26aufirst%3DK.%26aulast%3DPrzybelski%26aufirst%3DS.%2BA.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DSenjem%26aufirst%3DM.%2BL.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DJack%26aufirst%3DC.%2BR.%26atitle%3DMRI%2520correlates%2520of%2520neurofibrillary%2520tangle%2520pathology%2520at%2520autopsy%253A%2520a%2520voxel-based%2520morphometry%2520study%26jtitle%3DNeurology%26date%3D2008%26volume%3D71%26spage%3D743%26epage%3D749%26doi%3D10.1212%2F01.wnl.0000324924.91351.7d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using <sup>18</sup>F-THK5105 PET</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1093/brain/awu064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1093%2Fbrain%2Fawu064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24681664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2cros1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=1762-1771&author=N.+Okamuraauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=R.+Haradaauthor=P.+Yatesauthor=S.+Pejoskaauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=V.+L.+Villemagne&title=Non-invasive+assessment+of+Alzheimer%E2%80%99s+disease+neurofibrillary+pathology+using+18F-THK5105+PET&doi=10.1093%2Fbrain%2Fawu064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Fodero-Tavoletti Michelle T; Villemagne Victor L; Mulligan Rachel S; Yates Paul; Pejoska Svetlana; Rowe Christopher C; Kudo Yukitsuka; Masters Colin L; Yanai Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">1762-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Non-invasive imaging of tau pathology in the living brain would be useful for accurately diagnosing Alzheimer's disease, tracking disease progression, and evaluating the treatment efficacy of disease-specific therapeutics.  In this study, we evaluated the clinical usefulness of a novel tau-imaging positron emission tomography tracer 18F-THK5105 in 16 human subjects including eight patients with Alzheimer's disease (three male and five females, 66-82 years) and eight healthy elderly controls (three male and five females, 63-76 years).  All participants underwent neuropsychological examination and 3D magnetic resonance imaging, as well as both 18F-THK5105 and 11C-Pittsburgh compound B positron emission tomography scans.  Standard uptake value ratios at 90-100 min and 40-70 min post-injection were calculated for 18F-THK5105 and 11C-Pittsburgh compound B, respectively, using the cerebellar cortex as the reference region.  As a result, significantly higher 18F-THK5105 retention was observed in the temporal, parietal, posterior cingulate, frontal and mesial temporal cortices of patients with Alzheimer's disease compared with healthy control subjects.  In patients with Alzheimer's disease, the inferior temporal cortex, which is an area known to contain high densities of neurofibrillary tangles in the Alzheimer's disease brain, showed prominent 18F-THK5105 retention.  Compared with high frequency (100%) of 18F-THK5105 retention in the temporal cortex of patients with Alzheimer's disease, frontal 18F-THK5105 retention was less frequent (37.5%) and was only observed in cases with moderate-to-severe Alzheimer's disease.  In contrast, 11C-Pittsburgh compound B retention was highest in the posterior cingulate cortex, followed by the ventrolateral prefrontal, anterior cingulate, and superior temporal cortices, and did not correlate with 18F-THK5105 retention in the neocortex.  In healthy control subjects, 18F-THK5105 retention was ∼10% higher in the mesial temporal cortex than in the neocortex.  Notably, unlike 11C-Pittsburgh compound B, 18F-THK5105 retention was significantly correlated with cognitive parameters, hippocampal and whole brain grey matter volumes, which was consistent with findings from previous post-mortem studies showing significant correlations of neurofibrillary tangle density with dementia severity or neuronal loss.  From these results, 18F-THK5105 positron emission tomography is considered to be useful for the non-invasive assessment of tau pathology in the living brain.  This technique would be applicable to the longitudinal evaluation of tau deposition and allow a better understanding of the pathophysiology of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG1J2RMpsyPH6HPRus0rAafW6udTcc2ebTsFwov2HYq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cros1Oisw%253D%253D&md5=a04efc4d12888ed003006d4868a183af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu064%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DNon-invasive%2520assessment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520pathology%2520using%252018F-THK5105%2520PET%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D1762%26epage%3D1771%26doi%3D10.1093%2Fbrain%2Fawu064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.2967/jnumed.112.117341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.112.117341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23857514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.112.117341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Furumoto, Shozo; Harada, Ryuichi; Tago, Tetsuro; Yoshikawa, Takeo; Fodero-Tavoletti, Michelle; Mulligan, Rachel S.; Villemagne, Victor L.; Akatsu, Hiroyasu; Yamamoto, Takayuki; Arai, Hiroyuki; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1420-1427</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Neurofibrillary tangles in Alzheimer disease (AD) brains are composed of the microtubule-assocd. protein tau.  Noninvasive monitoring of tau protein aggregates in the living brain will provide useful information regarding tau pathophysiol. in AD.  However, no PET probes are currently available for selective detection of tau pathol. in AD.  We have previously reported 18F-labeled THK-523 (18F-6-(2-fluoroethoxy)-2-(4-aminophenyl)quinoline) as a tau imaging radiotracer candidate for PET.  After compd. optimization, we developed novel 18F-labeled arylquinoline derivs., 18F-THK-5105 and 18F-THK-5117, for use as tau imaging PET tracers.  Methods: 18F-labeled compds. were prepd. from the corresponding tosylated precursors.  The binding affinity of compds. to synthetic tau aggregates and tau-rich AD brain homogenates was detd. by satn. and competition binding assays.  The binding selectivity of compds. to tau pathol. was evaluated by autoradiog. of AD brain sections.  The pharmacokinetics of compds. were assessed in biodistribution studies in normal mice.  A 14-d toxicity study with i.v. administration of compds. was performed using rats and mice.  Results: In vitro binding assays demonstrated higher binding affinity of THK-5105 and THK-5117 than THK-523 to tau protein aggregates and tau-rich AD brain homogenates.  Autoradiog. analyses of AD brain sections showed that these radiotracers preferentially bound to neurofibrillary tangles and neuropil threads, which colocalized with Gallyas-pos. and immunoreactive tau protein deposits.  The distribution of this radiotracer binding in AD brain sections was completely different from that of 11C-Pittsburgh compd. B, showing preferential binding to amyloid plaques.  Furthermore, these derivs. demonstrated abundant initial brain uptake and faster clearance in normal mice than 18F-THK-523 and other reported 18F-labeled radiotracers.  THK-5105 and THK-5117 showed no toxic effects related to the administration of these compds. in mice and rats and no significant binding for various neuroreceptors, ion channels, and transporters at 1-μM concns.  Conclusion: 18F-labeled THK-5105 and THK-5117 are promising candidates as PET tau imaging radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmleWUvjowbVg90H21EOLACvtfcHk0lhDCMAwsbF6eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L&md5=58ac191b3581c5e4896b999343b6a193</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.117341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.117341%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427%26doi%3D10.2967%2Fjnumed.112.117341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1007/s00259-015-3035-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00259-015-3035-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=25792456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1052-1061&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=%5B18F%5DTHK-5117+PET+for+assessing+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-015-3035-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-1061</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia.  The purpose of the study was to evaluate the clin. utility of [18F]THK-5117 as a highly selective tau imaging radiotracer.  Methods: We initially evaluated in vitro binding of [3H]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD).  In clin. PET studies, [18F]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls.  Ten subjects underwent an addnl. [11C]PiB PET scan within 2 wk.  Results: In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB.  In clin. PET studies, [18F]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects.  Compared with [11C]PiB, [18F]THK-5117 retention was higher in the medial temporal cortex.  Conclusion: These findings suggest that [18F]THK-5117 provides regional information on neurofibrillary pathol. in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZcAg2f1webVg90H21EOLACvtfcHk0lhDCMAwsbF6eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D&md5=4c35d238f7026cb33833f28549e760d5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3035-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3035-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D%255B18F%255DTHK-5117%2520PET%2520for%2520assessing%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D42%26spage%3D1052%26epage%3D1061%26doi%3D10.1007%2Fs00259-015-3035-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Xia, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.+F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2ebvRN5BHLnzDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.%2BF.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3s3hsVOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.+Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF-18%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span></div><div class="casAuthors">Chien David T; Bahri Shadfar; Szardenings A Katrin; Walsh Joseph C; Mu Fanrong; Su Min-Ying; Shankle William R; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomography imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPDlccQmubRwpJitSxOdIlfW6udTcc2ebvRN5BHLnzDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3hsVOktQ%253D%253D&md5=6fd50cd6fbcc8578092f72d5233e9ff4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.%2BY.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF-18%255D-T807%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+K.+Szardeningsauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.+Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2ebvRN5BHLnzDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.%2BY.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC38jgtl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies&doi=10.3233%2FJAD-2012-120712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang Wei; Arteaga Janna; Cashion Daniel K; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Szardenings A Katrin; Wang Eric; Walsh Joseph C; Xia Chunfang; Yu Chul; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathological hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a number of amyloid-β positron emission tomography (PET) tracers currently in different stages of clinical development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compounds utilizing a unique screening process.  A competitive autoradiography assay was set up to test compounds for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compound [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclinical in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSE6tDb3P-XJTEwO064Z95rfW6udTcc2eYBa3F8APbsQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jgtl2hsw%253D%253D&md5=d9dbcbe1d4c18000898c61615faa1be0</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612%26doi%3D10.3233%2FJAD-2012-120712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.+R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.+K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0lhW_ARxSdtMCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujishiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span> </span><span class="NLM_article-title">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of <sup>11</sup>C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span><span class="refDoi"> DOI: 10.2967/jnumed.114.139550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.114.139550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1532-1538&author=H.+Hashimotoauthor=K.+Kawamuraauthor=N.+Igarashiauthor=M.+Takeiauthor=T.+Fujishiroauthor=Y.+Aiharaauthor=S.+Shiomiauthor=M.+Mutoauthor=T.+Itoauthor=K.+Furutsukaauthor=T.+Yamasakiauthor=J.+Yuiauthor=L.+Xieauthor=M.+Onoauthor=A.+Hatoriauthor=K.+Nemotoauthor=T.+Suharaauthor=M.+Higuchiauthor=M.+R.+Zhang&title=Radiosynthesis%2C+photoisomerization%2C+biodistribution%2C+and+metabolite+analysis+of+11C-PBB3+as+a+clinically+useful+PET+probe+for+imaging+of+tau+pathology&doi=10.2967%2Fjnumed.114.139550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span></div><div class="casAuthors">Hashimoto, Hiroki; Kawamura, Kazunori; Igarashi, Nobuyuki; Takei, Makoto; Fujishiro, Tomoya; Aihara, Yoshiharu; Shiomi, Satoshi; Muto, Masatoshi; Ito, Takehito; Furutsuka, Kenji; Yamasaki, Tomoteru; Yui, Joji; Xie, Lin; Ono, Maiko; Hatori, Akiko; Nemoto, Kazuyoshi; Suhara, Tetsuya; Higuchi, Makoto; Zhang, Ming-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1532-1538</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol (11C-PBB3) is a clin. useful PET probe that we developed for in vivo imaging of tau pathol. in the human brain.  To ensure the availability of this probe among multiple PET facilities, in the present study we established protocols for the radiosynthesis and quality control of 11C-PBB3 and for the characterization of its photoisomerization, biodistribution, and metab.  Methods: 11C-PBB3 was synthesized by reaction of the tert-butyldimethylsilyl desmethyl precursor (1) with 11C-Me iodide using potassium hydroxide as a base, followed by deprotection.  Photoisomerization of 11C-PBB3 under fluorescent light was detd.  The biodistribution and metabolite anal. of 11C-PBB3 was detd. in mice using the dissection method.  Results: 11C-PBB3 was synthesized with 15.4% ± 2.8% radiochem. yield (decay-cor., n = 50) based on the cyclotron-produced 11C-CO2 and showed an averaged synthesis time of 35 min from the end of bombardment.  The radiochem. purity and specific activity of 11C-PBB3 were 98.0% ± 2.3% and 180.2 ± 44.3 GBq/μmol, resp., at the end of synthesis (n = 50).  11C-PBB3 showed rapid photoisomerization, and its radiochem. purity decreased to approx. 50% at 10 min after exposure to fluorescent light.  After the fluorescent light was switched off, 11C-PBB3 retained more than 95% radiochem. purity over 60 min.  A suitable brain uptake (1.92% injected dose/g tissue) of radioactivity was obsd. at 1 min after the probe injection, which was followed by rapid washout from the brain tissue.  More than 70% of total radioactivity in the mouse brain homogenate at 5 min after injection represented the unchanged 11C-PBB3, despite its rapid metab. in the plasma.  Conclusion: 11C-PBB3 was produced with sufficient radioactivity and high quality, demonstrating its clin. utility.  The present results of radiosynthesis, photoisomerization, biodistribution, and metabolite anal. could be helpful for the reliable prodn. and application of 11C-PBB3 in diverse PET facilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU4w4Hc1F_UbVg90H21EOLACvtfcHk0ljTXEEW_hSbCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSrurrO&md5=4c888d96eb8afd4447e0c00a4f72460a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.139550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.139550%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DN.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFujishiro%26aufirst%3DT.%26aulast%3DAihara%26aufirst%3DY.%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DFurutsuka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DRadiosynthesis%252C%2520photoisomerization%252C%2520biodistribution%252C%2520and%2520metabolite%2520analysis%2520of%252011C-PBB3%2520as%2520a%2520clinically%2520useful%2520PET%2520probe%2520for%2520imaging%2520of%2520tau%2520pathology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1532%26epage%3D1538%26doi%3D10.2967%2Fjnumed.114.139550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">Evaluation of [<sup>11</sup>C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1021/ml300216t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300216t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=936-941&author=X.+Shaoauthor=G.+M.+Carpenterauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=M.+Fawazauthor=A.+F.+Brooksauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+Scott&title=Evaluation+of+%5B11C%5DN-Methyl+Lansoprazole+as+a+Radiopharmaceutical+for+PET+Imaging+of+Tau+Neurofibrillary+Tangles&doi=10.1021%2Fml300216t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [11C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span></div><div class="casAuthors">Shao, Xia; Carpenter, Garrett M.; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Fawaz, Maria; Brooks, Allen F.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">936-941</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[11C]N-Me lansoprazole ([11C]NML, 3) was synthesized and evaluated as a radiopharmaceutical for quantifying tau neurofibrillary tangle (NFT) burden using positron emission tomog. (PET) imaging. [11C]NML was synthesized from com. available lansoprazole in 4.6% radiochem. yield (noncorrected RCY, based upon [11C]MeI), 99% radiochem. purity, and 16095 Ci/mmol specific activity (n = 5).  Log P was detd. to be 2.18.  A lack of brain uptake in rodent microPET imaging revealed [11C]NML to be a substrate for the rodent permeability-glycoprotein 1 (PGP) transporter, but this could be overcome by pretreating with cyclosporin A to block the PGP.  Contrastingly, [11C]NML was not found to be a substrate for the primate PGP, and microPET imaging in rhesus revealed [11C]NML uptake in the healthy primate brain of ∼1600 nCi/cc max. at 3 min followed by rapid egress to 500 nCi/cc.  Comparative autoradiog. between wild-type rats and transgenic rats expressing human tau (hTau +/+) revealed 12% higher uptake of [11C]NML in the cortex of brains expressing human tau.  Further autoradiog. with tau pos. brain samples from progressive supranuclear palsy (PSP) patients revealed colocalization of [11C]NML with tau NFTs identified using modified Bielschowsky staining.  Finally, satn. binding expts. with heparin-induced tau confirmed Kd and Bmax values of [11C]NML as 700 pM and 0.214 fmol/μg, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXJkNjeWv4rVg90H21EOLACvtfcHk0ljTXEEW_hSbCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI&md5=a1fd3561aca6b2d9366271582e9bf60f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fml300216t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300216t%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DX.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DFawaz%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B11C%255DN-Methyl%2520Lansoprazole%2520as%2520a%2520Radiopharmaceutical%2520for%2520PET%2520Imaging%2520of%2520Tau%2520Neurofibrillary%2520Tangles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D936%26epage%3D941%26doi%3D10.1021%2Fml300216t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fawaz, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodnick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer’s disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/cn500103u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500103u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=718-730&author=M.+V.+Fawazauthor=A.+F.+Brooksauthor=M.+E.+Rodnickauthor=G.+M.+Carpenterauthor=X.+Shaoauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=B.+G.+Hockleyauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+Scott&title=High+affinity+radiopharmaceuticals+based+upon+lansoprazole+for+PET+imaging+of+aggregated+tau+in+Alzheimer%E2%80%99s+disease+and+progressive+supranuclear+palsy%3A+synthesis%2C+preclinical+evaluation%2C+and+lead+selection&doi=10.1021%2Fcn500103u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection</span></div><div class="casAuthors">Fawaz, Maria V.; Brooks, Allen F.; Rodnick, Melissa E.; Carpenter, Garrett M.; Shao, Xia; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Hockley, Brian G.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-730</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormally aggregated tau is the hallmark pathol. of tauopathy neurodegenerative disorders and is a target for development of both diagnostic tools and therapeutic strategies across the tauopathy disease spectrum.  Development of carbon-11- or fluorine-18-labeled radiotracers with appropriate affinity and specificity for tau would allow noninvasive quantification of tau burden using positron emission tomog. (PET) imaging.  We have synthesized [18F]lansoprazole, [11C]N-Me lansoprazole, and [18F]N-Me lansoprazole and identified them as high affinity radiotracers for tau with low to subnanomolar binding affinities.  Herein, we report radiosyntheses and extensive preclin. evaluation with the aim of selecting a lead radiotracer for translation into human PET imaging trials.  We demonstrate that [18F]N-Me lansoprazole, on account of the favorable half-life of fluorine-18 and its rapid brain entry in nonhuman primates, favorable kinetics, low white matter binding, and selectivity for binding to tau over amyloid, is the lead compd. for progression into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpII8L0rzeJ2LVg90H21EOLACvtfcHk0ljTXEEW_hSbCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D&md5=2b2c7c0e014296ec6865430167067066</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn500103u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500103u%26sid%3Dliteratum%253Aachs%26aulast%3DFawaz%26aufirst%3DM.%2BV.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DRodnick%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DHockley%26aufirst%3DB.%2BG.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DHigh%2520affinity%2520radiopharmaceuticals%2520based%2520upon%2520lansoprazole%2520for%2520PET%2520imaging%2520of%2520aggregated%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520progressive%2520supranuclear%2520palsy%253A%2520synthesis%252C%2520preclinical%2520evaluation%252C%2520and%2520lead%2520selection%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D718%26epage%3D730%26doi%3D10.1021%2Fcn500103u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Riss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1039/c3md00017f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+Williamsonauthor=T.+Fryerauthor=Y.+Hongauthor=J.+Baronauthor=F.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology&doi=10.1039%2Fc3md00017f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%26aulast%3DFryer%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DBaron%26aufirst%3DJ.%26aulast%3DAigbirhio%26aufirst%3DF.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855%26doi%3D10.1039%2Fc3md00017f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1021/cn200002t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains&doi=10.1021%2Fcn200002t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0lgu8KL2x2mkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275%26doi%3D10.1021%2Fcn200002t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5700</span><span class="NLM_x">–</span> <span class="NLM_lpage">5703</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.bmcl.2012.06.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5700-5703&author=H.+Watanabeauthor=M.+Onoauthor=H.+Kimuraauthor=K.+Matsumuraauthor=M.+Yoshimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+oxindole+derivatives+for+imaging+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.06.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.086%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520oxindole%2520derivatives%2520for%2520imaging%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5700%26epage%3D5703%26doi%3D10.1016%2Fj.bmcl.2012.06.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Phenyldiazenyl benzothiazole derivatives as probes for <i>in vivo</i> imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1039/c1md00034a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2Fc1md00034a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=596-600&author=K.+Matsumuraauthor=M.+Onoauthor=H.+Hayashiauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=K.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Phenyldiazenyl+benzothiazole+derivatives+as+probes+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains&doi=10.1039%2Fc1md00034a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc1md00034a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00034a%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPhenyldiazenyl%2520benzothiazole%2520derivatives%2520as%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D596%26epage%3D600%26doi%3D10.1039%2Fc1md00034a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3356</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.bmc.2013.02.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23601814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVamsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3356-3362&author=K.+Matsumuraauthor=M.+Onoauthor=M.+Yoshimuraauthor=H.+Kimuraauthor=H.+Watanabeauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+styryl+benzimidazole+derivatives+as+probes+for+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2013.02.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease</span></div><div class="casAuthors">Matsumura, Kenji; Ono, Masahiro; Yoshimura, Masashi; Kimura, Hiroyuki; Watanabe, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3356-3362</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This paper describes the synthesis and biol. evaluation of styrylbenzimidazole (SBIM) derivs. as agents for imaging neurofibrillary tangles (NFT) in patients with Alzheimer's disease (AD).  SBIM derivs. were prepd. with 4-iodobenzene-1,2-diamine and substituted cinnamaldehydes.  In binding expts. using recombinant tau and Aβ1-42 aggregates, SBIM-3 showed higher affinity for the tau aggregates than Aβ1-42 aggregates (ratio of Kd values was 2.73).  In in vitro autoradiog. and fluorescent staining, [125I]SBIM-3 (or SBIM-3) bound NFT in sections of AD brain tissue.  In biodistribution expts. using normal mice, all [125I]SBIM derivs. showed high initial uptake into (3.20-4.11%ID/g at 2 min after the injection) and rapid clearance from (0.12-0.33%ID/g at 60 min after the injection) the brain.  In conclusion, appropriate structural modifications of SBIM derivs. could lead to more useful agents for the in vivo imaging of NFT in AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQbIJXXTqoNrVg90H21EOLACvtfcHk0lgO6aUzA5umDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVamsr4%253D&md5=abba071beffe5a7bd035ebab09269396</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.054%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520styryl%2520benzimidazole%2520derivatives%2520as%2520probes%2520for%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3356%26epage%3D3362%26doi%3D10.1016%2Fj.bmc.2013.02.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikuni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <sup>123</sup>I-labeled pyridyl benzoxazole derivatives: novel β-amyloid imaging probes for single-photon emission computed tomography</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.1039/C4RA10742J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2FC4RA10742J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1009-1015&author=H.+Watanabeauthor=M.+Onoauthor=S.+Iikuniauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+123I-labeled+pyridyl+benzoxazole+derivatives%3A+novel+%CE%B2-amyloid+imaging+probes+for+single-photon+emission+computed+tomography&doi=10.1039%2FC4RA10742J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 123I-labeled pyridyl benzoxazole derivatives: novel β-amyloid imaging probes for single-photon emission computed tomography</span></div><div class="casAuthors">Watanabe, Hiroyuki; Ono, Masahiro; Iikuni, Shimpei; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In vivo imaging of β-amyloid (Aβ) plaques by non-invasive techniques such as positron emission tomog. (PET) and single-photon emission computed tomog. (SPECT) may facilitate early diagnosis and drug discovery for the treatment of Alzheimer's disease (AD).  SPECT is known as a more useful modality than PET in terms of routine diagnostic use, but there have been no reports on attractive probes in clin. studies.  In this study, we synthesized and evaluated novel 123I-labeled pyridyl benzoxazole (PBOX) derivs. as SPECT probes for imaging Aβ plaques in vivo.  The PBOX derivs. showed affinity for Aβ(1-42) aggregates in vitro (Ki = 6.9-138 nM).  In biodistibution expts. in normal mice, all these derivs. showed high initial uptake into (4.6-6.6% ID g-1 at 2 min) and rapid clearance (0.3-1.3% ID g-1 at 60 min) from the brain.  Furthermore, [125I]9 clearly labeled Aβ plaques in in vitro autoradiog. of postmortem AD brain sections.  SPECT/CT study with [123I]9 displayed higher radioactivity in Tg2576 mice than wild-type mice.  In addn., ex vivo autoradiograms of brain sections from Tg2576 mice after the injection of [123I]9 showed selective binding of Aβ plaques.  In conclusion, [123I]9 may be a potential SPECT probe for imaging Aβ plaques in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7CXn1IXocLVg90H21EOLACvtfcHk0lgO6aUzA5umDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtbjI&md5=fd2f03d124f85b6c853212ed8f9e013c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC4RA10742J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4RA10742J%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DIikuni%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520123I-labeled%2520pyridyl%2520benzoxazole%2520derivatives%253A%2520novel%2520%25CE%25B2-amyloid%2520imaging%2520probes%2520for%2520single-photon%2520emission%2520computed%2520tomography%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D1009%26epage%3D1015%26doi%3D10.1039%2FC4RA10742J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikuni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Development of novel <sup>123</sup>I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74104</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1371%2Fjournal.pone.0074104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74104&author=M.+Onoauthor=Y.+Chengauthor=H.+Kimuraauthor=H.+Watanabeauthor=K.+Matsumuraauthor=M.+Yoshimuraauthor=S.+Iikuniauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Development+of+novel+123I-labeled+pyridyl+benzofuran+derivatives+for+SPECT+imaging+of+%CE%B2-amyloid+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0074104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074104%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DIikuni%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520novel%2520123I-labeled%2520pyridyl%2520benzofuran%2520derivatives%2520for%2520SPECT%2520imaging%2520of%2520%25CE%25B2-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74104%26doi%3D10.1371%2Fjournal.pone.0074104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipem, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, G.</span><span> </span><span class="NLM_article-title">Photoisomerization of trans-2-[4′-(dimethylamino)styryl]benzothiazole</span> <span class="citation_source-journal">Photochem. Photobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1111/j.1751-1097.2012.01227.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1111%2Fj.1751-1097.2012.01227.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22924651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=247-252&author=A.+Mishraauthor=A.+Thangamaniauthor=S.+Chatterjeeauthor=F.+A.+Chipemauthor=G.+Krishnamoorthy&title=Photoisomerization+of+trans-2-%5B4%E2%80%B2-%28dimethylamino%29styryl%5Dbenzothiazole&doi=10.1111%2Fj.1751-1097.2012.01227.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Photoisomerization of trans-2-[4'-(dimethylamino)styryl]benzothiazole</span></div><div class="casAuthors">Mishra, Anasuya; Thangamani, Arumugam; Chatterjee, Soumya; Chipem, Francis A. S.; Krishnamoorthy, Govindarajan</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photoreaction of trans-2-[4'-(dimethylamino)styryl]benzothiazole (t-DMASBT) under direct irradn. has been investigated in dioxane, chloroform, methanol and glycerol to understand the mechanism of photoisomerization.  Contrary to an earlier report, isomerization takes place in all these solvents including glycerol.  The results show that restriction on photoisomerization leads to the increase in fluorescence quantum yield in glycerol.  The results are consistent with the theor. simulated potential energy surface reported earlier using time-dependent d. functional theory (TDDFT) calcns.  DFT calcns. on cis isomers under isolated condition have suggested that cis-B conformer is more stable than cis-A conformer due to hydrogen-bonding interaction.  In the ground state, cis-DMASBT is predominantly present as cis-B.  The fluorescence spectra of the irradiated t-DMASBT suggested that photoisomerization follows not the adiabatic path as proposed by S. K. Saha et al., but the nonadiabatic path.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3iZd_vahSSrVg90H21EOLACvtfcHk0lg06WYQI6FwUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ylsLY%253D&md5=6e94b8d6277c6eb12ada116d6c468d54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2012.01227.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2012.01227.x%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DThangamani%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DChipem%26aufirst%3DF.%2BA.%26aulast%3DKrishnamoorthy%26aufirst%3DG.%26atitle%3DPhotoisomerization%2520of%2520trans-2-%255B4%25E2%2580%25B2-%2528dimethylamino%2529styryl%255Dbenzothiazole%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2013%26volume%3D89%26spage%3D247%26epage%3D252%26doi%3D10.1111%2Fj.1751-1097.2012.01227.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Lewis, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokumatsu, K.</span><span> </span><span class="NLM_article-title">Molecular structure and photochemistry of (<i>E</i>)- and (<i>Z</i>)-2-(2-(2-pyridyl)ethenyl)indole. A case of hydrogen bond dependent one-way photoisomerization</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3029</span><span class="NLM_x">–</span> <span class="NLM_lpage">3036</span><span class="refDoi"> DOI: 10.1021/ja00116a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00116a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=3029-3036&author=F.+D.+Lewisauthor=B.+A.+Yoonauthor=T.+Araiauthor=T.+Iwasakiauthor=K.+Tokumatsu&title=Molecular+structure+and+photochemistry+of+%28E%29-+and+%28Z%29-2-%282-%282-pyridyl%29ethenyl%29indole.+A+case+of+hydrogen+bond+dependent+one-way+photoisomerization&doi=10.1021%2Fja00116a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00116a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00116a008%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DF.%2BD.%26aulast%3DYoon%26aufirst%3DB.%2BA.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DIwasaki%26aufirst%3DT.%26aulast%3DTokumatsu%26aufirst%3DK.%26atitle%3DMolecular%2520structure%2520and%2520photochemistry%2520of%2520%2528E%2529-%2520and%2520%2528Z%2529-2-%25282-%25282-pyridyl%2529ethenyl%2529indole.%2520A%2520case%2520of%2520hydrogen%2520bond%2520dependent%2520one-way%2520photoisomerization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D3029%26epage%3D3036%26doi%3D10.1021%2Fja00116a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.3233/JAD-2010-1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-2010-1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FmtlajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2010-1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Rojo Leonel E; Alzate-Morales Jans; Saavedra Ivan N; Davies Peter; Maccioni Ricardo B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We describe the interactions of two benzimidazole derivatives, astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compounds, with important medical applications in the treatment of allergies and gastrointestinal disorders respectively, specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-beta polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochemical studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: i) in vitro by parallel artificial membrane permeability assay followed by experimental Log P determinations; and ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concentration ratios for these compounds were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are positively correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3LzL_5H7rpeIHSmpohpd0fW6udTcc2eZqcjz0e4ZBu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FmtlajsQ%253D%253D&md5=0cde76ef256596028059014926c12e71</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1262%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedra%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589%26doi%3D10.3233%2FJAD-2010-1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Differentiating Alzheimer disease-associated aggregates with small molecules</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/j.nbd.2007.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.nbd.2007.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=17761424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=251-260&author=N.+S.+Honsonauthor=R.+L.+Johnsonauthor=W.+Huangauthor=J.+Ingleseauthor=C.+P.+Austinauthor=J.+Kuret&title=Differentiating+Alzheimer+disease-associated+aggregates+with+small+molecules&doi=10.1016%2Fj.nbd.2007.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating Alzheimer disease-associated aggregates with small molecules</span></div><div class="casAuthors">Honson, Nicolette S.; Johnson, Ronald L.; Huang, Wenwei; Inglese, James; Austin, Christopher P.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease is diagnosed postmortem by the d. and spatial distribution of β-amyloid plaques and tau-bearing neurofibrillary tangles.  The major protein component of each lesion adopts cross-β-sheet conformation capable of binding small mols. with submicromolar affinity.  In many cases, however, Alzheimer pathol. overlaps with Lewy body disease, characterized by the accumulation of a third cross-β-sheet forming protein, α-synuclein.  To det. the feasibility of distinguishing tau aggregates from β-amyloid and α-synuclein aggregates with small mol. probes, a library contg. 72,455 small mols. was screened for antagonists of tau-aggregate-mediated changes in Thioflavin S fluorescence, followed by secondary screens to distinguish the relative affinity for each substrate protein.  Results showed that > 10-fold binding selectivity among substrates could be achieved, with mols. selective for tau aggregates contg. at least three arom. or rigid moieties connected by two rotatable bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9wia16OfSrVg90H21EOLACvtfcHk0lg06WYQI6FwUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO&md5=70434cbb21ca7e4380e06bf5113ee868</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2007.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2007.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DDifferentiating%2520Alzheimer%2520disease-associated%2520aggregates%2520with%2520small%2520molecules%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2007%26volume%3D28%26spage%3D251%26epage%3D260%26doi%3D10.1016%2Fj.nbd.2007.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Quinoline and benzimidazole derivatives: candidate probes for <i>in vivo</i> imaging of tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10857</span><span class="NLM_x">–</span> <span class="NLM_lpage">10862</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1738-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1523%2FJNEUROSCI.1738-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=16306398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10857-10862&author=N.+Okamuraauthor=T.+Suemotoauthor=S.+Furumotoauthor=M.+Suzukiauthor=H.+Shimadzuauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Fujiwaraauthor=M.+Nemotoauthor=M.+Maruyamaauthor=H.+Araiauthor=K.+Yanaiauthor=T.+Sawadaauthor=Y.+Kudo&title=Quinoline+and+benzimidazole+derivatives%3A+candidate+probes+for+in+vivo+imaging+of+tau+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.1738-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Suemoto, Takahiro; Furumoto, Shozo; Suzuki, Masako; Shimadzu, Hiroshi; Akatsu, Hiroyasu; Yamamoto, Takayuki; Fujiwara, Hironori; Nemoto, Miyako; Maruyama, Masahiro; Arai, Hiroyuki; Yanai, Kazuhiko; Sawada, Tohru; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10857-10862</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques predominantly comprise hyperphosphorylated tau protein and represent pathol. characteristics of Alzheimer's disease (AD).  These lesions occur before the presentation of clin. symptoms and correlate with the severity of dementia.  In vivo detection of these lesions would thus prove useful for preclin. diagnosis of AD and for tracking disease progression.  The present study introduces three novel compds., 4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine (BF-126), 2-[(4-methylamino)phenyl]quinoline (BF-158), and 2-(4-aminophenyl)quinoline (BF-170), as candidate probes for in vivo imaging of tau pathol. in the AD brain.  When solns. of these compds. are injected i.v. into normal mice, these agents exhibit excellent brain uptake and rapid clearance from normal brain tissue.  These compds. display relatively lower binding affinity to β-amyloid fibrils and higher binding affinity to tau fibrils, compared with previously reported probe BF-168.  In neuropathol. examn. using AD brain sections, BF-126, BF-158, and BF-170 clearly visualize NFTs, neuropil threads, and paired helical filament-type neuritis.  Autoradiog. using 11C-labeled BF-158 further demonstrated labeling of NFTs in AD brain sections.  These findings suggest the potential usefulness of quinoline and benzimidazole derivs. for in vivo imaging of tau pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1dHoJmFJtNLVg90H21EOLACvtfcHk0lhfLX44RtGTJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K&md5=4b0bc18420a2429789d47bcb91eeb11c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1738-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1738-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DSuemoto%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemoto%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DQuinoline%2520and%2520benzimidazole%2520derivatives%253A%2520candidate%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10857%26epage%3D10862%26doi%3D10.1523%2FJNEUROSCI.1738-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer’s disease brain</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1007/s11307-013-0667-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs11307-013-0667-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23868612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=19-27&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Yoshikawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Use+of+a+benzimidazole+derivative+BF-188+in+fluorescence+multispectral+imaging+for+selective+visualization+of+tau+protein+fibrils+in+the+Alzheimer%E2%80%99s+disease+brain&doi=10.1007%2Fs11307-013-0667-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain</span></div><div class="casAuthors">Harada Ryuichi; Okamura Nobuyuki; Furumoto Shozo; Yoshikawa Takeo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Selective visualization of amyloid-β and tau protein deposits will help to understand the pathophysiology of Alzheimer's disease (AD).  Here, we introduce a novel fluorescent probe that can distinguish between these two deposits by multispectral fluorescence imaging technique.  PROCEDURES:  Fluorescence spectral analysis was performed using AD brain sections stained with novel fluorescence compounds.  Competitive binding assay using [(3)H]-PiB was performed to evaluate the binding affinity of BF-188 for synthetic amyloid-β (Aβ) and tau fibrils.  RESULTS:  In AD brain sections, BF-188 clearly stained Aβ and tau protein deposits with different fluorescence spectra.  In vitro binding assays indicated that BF-188 bound to both amyloid-β and tau fibrils with high affinity (K i  < 10 nM).  In addition, BF-188 showed an excellent blood-brain barrier permeability in mice.  CONCLUSION:  Multispectral imaging with BF-188 could potentially be used for selective in vivo imaging of tau deposits as well as amyloid-β in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkJCOOHC_nB-3MPKNEWB5RfW6udTcc2eaErHVb6SRSb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D&md5=2b4d4aa9b23c8430946fc594d392a108</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0667-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0667-2%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DUse%2520of%2520a%2520benzimidazole%2520derivative%2520BF-188%2520in%2520fluorescence%2520multispectral%2520imaging%2520for%2520selective%2520visualization%2520of%2520tau%2520protein%2520fibrils%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D19%26epage%3D27%26doi%3D10.1007%2Fs11307-013-0667-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1016/j.tips.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood-brain+barrier+and+surviving+metabolism&doi=10.1016%2Fj.tips.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0lhfLX44RtGTJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood-brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440%26doi%3D10.1016%2Fj.tips.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Snellman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Picon, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaparanta-Solin, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of [<sup>18</sup>F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1795</span><span class="refDoi"> DOI: 10.1007/s00259-012-2178-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00259-012-2178-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22801729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1784-1795&author=A.+Snellmanauthor=J.+Rokkaauthor=F.+R.+Lopez-Piconauthor=O.+Eskolaauthor=I.+Wilsonauthor=G.+Farrarauthor=M.+Scheininauthor=O.+Solinauthor=J.+O.+Rinneauthor=M.+Haaparanta-Solin&title=Pharmacokinetics+of+%5B18F%5Dflutemetamol+in+wild-type+rodents+and+its+binding+to+beta+amyloid+deposits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-012-2178-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Snellman, Anniina; Rokka, Johanna; Lopez-Picon, Francisco R.; Eskola, Olli; Wilson, Ian; Farrar, Gill; Scheinin, Mika; Solin, Olof; Rinne, Juha O.; Haaparanta-Solin, Merja</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1784-1795</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The aim of this study was to investigate the potential of [18F]flutemetamol as a preclin. PET tracer for imaging β-amyloid (Aβ) deposition by comparing its pharmacokinetics to those of [11C]Pittsburgh compd. B ([11C]PIB) in wild-type Sprague Dawley rats and C57Bl/6N mice.  In addn., binding of [18F]flutemetamol to Aβ deposits was studied in the Tg2576 transgenic mouse model of Alzheimer's disease.  Methods: [18F]Flutemetamol biodistribution was evaluated using ex vivo PET methods and in vivo PET imaging in wild-type rats and mice.  Metab. and binding of [11C]PIB and [18F]flutemetamol to plasma proteins were analyzed using thin-layer chromatog. and ultrafiltration methods, resp.  Radiation dose ests. were calcd. from rat ex vivo biodistribution data.  The binding of [18F]flutemetamol to Aβ deposits was also studied using ex vivo and in vitro autoradiog.  The location of Aβ deposits in the brain was detd. with thioflavine S staining and immunohistochem.  Results: The pharmacokinetics of [18F]flutemetamol resembled that of [11C]PIB in rats and mice.  In vivo studies showed that both tracers readily entered the brain, and were excreted via the hepatobiliary pathway in both rats and mice.  The metab. of [18F]flutemetamol into radioactive metabolites was faster than that of [11C]PIB. [18F]Flutemetamol cleared more slowly from the brain than [11C]PIB, particularly from white matter, in line with its higher lipophilicity.  ED ests. for [11C]PIB and [18F]flutemetamol were 2.28 and 6.65 μSv/MBq, resp.  Autoradiographs showed [18F]flutemetamol binding to fibrillar Aβ deposits in the brain of Tg2576 mice.  Conclusion: Based on its pharmacokinetic profile, [18F]flutemetamol showed potential as a PET tracer for preclin. imaging.  It showed good brain uptake and was bound to Aβ deposits in the brain of Tg2576 mice.  However, its high lipophilicity might complicate the anal. of PET data, particularly in small-animal imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ikaBJMflNbVg90H21EOLACvtfcHk0lgWAlv7KiQQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqsLjE&md5=4dcf576bc25da98fa04bb177076bef6e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2178-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2178-9%26sid%3Dliteratum%253Aachs%26aulast%3DSnellman%26aufirst%3DA.%26aulast%3DRokka%26aufirst%3DJ.%26aulast%3DLopez-Picon%26aufirst%3DF.%2BR.%26aulast%3DEskola%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DFarrar%26aufirst%3DG.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DSolin%26aufirst%3DO.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DHaaparanta-Solin%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520of%2520%255B18F%255Dflutemetamol%2520in%2520wild-type%2520rodents%2520and%2520its%2520binding%2520to%2520beta%2520amyloid%2520deposits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2012%26volume%3D39%26spage%3D1784%26epage%3D1795%26doi%3D10.1007%2Fs00259-012-2178-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ramachandra Reddy Putta, Simin Chun, Seung Hyun Choi, Seok Beom Lee, Dong-Chan Oh, <span class="NLM_string-name hlFld-ContribAuthor">Suckchang Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(0)-Catalyzed Transfer Hydrogenative Condensation of Nitroarenes with Alcohols: A Straightforward Approach to Benzoxazoles, Benzothiazoles, and Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (23)
                                     , 15396-15405. <a href="https://doi.org/10.1021/acs.joc.0c02191" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02191%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIron%2525280%252529-Catalyzed%252BTransfer%252BHydrogenative%252BCondensation%252Bof%252BNitroarenes%252Bwith%252BAlcohols%25253A%252BA%252BStraightforward%252BApproach%252Bto%252BBenzoxazoles%25252C%252BBenzothiazoles%25252C%252Band%252BBenzimidazoles%26aulast%3DPutta%26aufirst%3DRamachandra%2BReddy%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10092020%26date%3D02112020%26volume%3D85%26issue%3D23%26spage%3D15396%26epage%3D15405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Watanabe, Haruka Tatsumi, Sho Kaide, Yoichi Shimizu, Shimpei Iikuni, <span class="NLM_string-name hlFld-ContribAuthor">Masahiro Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 120-126. <a href="https://doi.org/10.1021/acsmedchemlett.9b00456" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00456%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BRadioiodinated%252B6%25252C5%25252C6-Tricyclic%252BCompounds%252Bfor%252Bthe%252BDevelopment%252Bof%252BTau%252BImaging%252BProbes%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01102019%26date%3D06012020%26date%3D09012020%26volume%3D11%26issue%3D2%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ulhas
N. Patel, Rahul A. Jagtap, <span class="NLM_string-name hlFld-ContribAuthor">Benudhar Punji</span>. </span><span class="cited-content_cbyCitation_article-title">Scope and Mechanistic Aspect of Nickel-Catalyzed Alkenylation of Benzothiazoles and Related Azoles with Styryl Bromides. </span><span class="cited-content_cbyCitation_journal-name">Organometallics</span><span> <strong>2019,</strong> <em>38 </em>
                                    (12)
                                     , 2422-2430. <a href="https://doi.org/10.1021/acs.organomet.9b00060" title="DOI URL">https://doi.org/10.1021/acs.organomet.9b00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.organomet.9b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.organomet.9b00060%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganometallics%26atitle%3DScope%252Band%252BMechanistic%252BAspect%252Bof%252BNickel-Catalyzed%252BAlkenylation%252Bof%252BBenzothiazoles%252Band%252BRelated%252BAzoles%252Bwith%252BStyryl%252BBromides%26aulast%3DPatel%26aufirst%3DUlhas%2BN.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29012019%26date%3D11062019%26volume%3D38%26issue%3D12%26spage%3D2422%26epage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Watanabe, Masashi Yoshimura, Kohei Sano, Yoichi Shimizu, Sho Kaide, Yuji Nakamoto, Kaori Togashi, Masahiro Ono, <span class="NLM_string-name hlFld-ContribAuthor">Hideo Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Novel 18F-Labeled Phenoxymethylpyridine Derivatives as Amylin Imaging Probes. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (12)
                                     , 5574-5584. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00756" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00756%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DCharacterization%252Bof%252BNovel%252B18F-Labeled%252BPhenoxymethylpyridine%252BDerivatives%252Bas%252BAmylin%252BImaging%252BProbes%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16072018%26date%3D29102018%26date%3D09102018%26date%3D08112018%26volume%3D15%26issue%3D12%26spage%3D5574%26epage%3D5584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sho Kaide, Masahiro Ono, Hiroyuki Watanabe, Ayane Kitada, Masashi Yoshimura, Yoichi Shimizu, Masafumi Ihara, <span class="NLM_string-name hlFld-ContribAuthor">Hideo Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 478-483. <a href="https://doi.org/10.1021/acsmedchemlett.8b00092" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00092%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BRadioiodinated%252BBenzoimidazopyridine%252BDerivatives%252Bfor%252BDetection%252Bof%252BTau%252BPathology%26aulast%3DKaide%26aufirst%3DSho%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22022018%26date%3D29032018%26date%3D10042018%26volume%3D9%26issue%3D5%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Taisuke  Ariyoshi</span>, <span class="hlFld-ContribAuthor ">Rikako  Katayanagi</span>, and <span class="hlFld-ContribAuthor ">Hideo  Saji</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1656-1662. <a href="https://doi.org/10.1021/acschemneuro.6b00450" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00450%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BBenzothiazole%252BDerivatives%252Bas%252BFluorescent%252BProbes%252Bfor%252BDetection%252Bof%252B%2525CE%2525B2-Amyloid%252Band%252B%2525CE%2525B1-Synuclein%252BAggregates%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22122016%26date%3D28042017%26date%3D03052017%26date%3D16082017%26volume%3D8%26issue%3D8%26spage%3D1656%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wai Chung  Fu</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>, <span class="hlFld-ContribAuthor ">Chau Ming  So</span>, <span class="hlFld-ContribAuthor ">Shun Man  Wong</span>, <span class="hlFld-ContribAuthor ">Aiwen  Lei</span>, and <span class="hlFld-ContribAuthor ">Fuk Yee  Kwong</span>  . </span><span class="cited-content_cbyCitation_article-title">Catalytic Direct C2-Alkenylation of Oxazoles at Parts per Million Levels of Palladium/PhMezole-Phos Complex. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (20)
                                     , 5300-5303. <a href="https://doi.org/10.1021/acs.orglett.6b02619" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02619%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DCatalytic%252BDirect%252BC2-Alkenylation%252Bof%252BOxazoles%252Bat%252BParts%252Bper%252BMillion%252BLevels%252Bof%252BPalladium%25252FPhMezole-Phos%252BComplex%26aulast%3DFu%26aufirst%3DWai%2BChung%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01092016%26date%3D11102016%26date%3D21102016%26volume%3D18%26issue%3D20%26spage%3D5300%26epage%3D5303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramanian  Tamil Selvan</span>, <span class="hlFld-ContribAuthor ">Roopa  Ravichandar</span>, <span class="hlFld-ContribAuthor ">Krishna  Kanta Ghosh</span>, <span class="hlFld-ContribAuthor ">Anand  Mohan</span>, <span class="hlFld-ContribAuthor ">Pachaiyappan  Mahalakshmi</span>, <span class="hlFld-ContribAuthor ">Balázs  Gulyás</span>, <span class="hlFld-ContribAuthor ">Parasuraman  Padmanabhan</span>. </span><span class="cited-content_cbyCitation_article-title">Coordination chemistry of ligands: Insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>430 </em>, 213659. <a href="https://doi.org/10.1016/j.ccr.2020.213659" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213659%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DCoordination%252Bchemistry%252Bof%252Bligands%25253A%252BInsights%252Binto%252Bthe%252Bdesign%252Bof%252Bamyloid%252Bbeta%25252Ftau-PET%252Bimaging%252Bprobes%252Band%252Bnanoparticles-based%252Btherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DTamil%2BSelvan%26aufirst%3DSubramanian%26date%3D2021%26volume%3D430%26spage%3D213659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Meng  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Shan-Hong  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Zhong</span>, <span class="hlFld-ContribAuthor ">Yao  Chen</span>, <span class="hlFld-ContribAuthor ">Zi-Zhen  Guo</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lin</span>, <span class="hlFld-ContribAuthor ">Yun  Lei</span>, <span class="hlFld-ContribAuthor ">Ai-Lin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Integrated paper-based 3D platform for long-term cell culture and in situ cell viability monitoring of Alzheimer's disease cell model. </span><span class="cited-content_cbyCitation_journal-name">Talanta</span><span> <strong>2021,</strong> <em>223 </em>, 121738. <a href="https://doi.org/10.1016/j.talanta.2020.121738" title="DOI URL">https://doi.org/10.1016/j.talanta.2020.121738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.talanta.2020.121738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.talanta.2020.121738%26sid%3Dliteratum%253Aachs%26jtitle%3DTalanta%26atitle%3DIntegrated%252Bpaper-based%252B3D%252Bplatform%252Bfor%252Blong-term%252Bcell%252Bculture%252Band%252Bin%252Bsitu%252Bcell%252Bviability%252Bmonitoring%252Bof%252BAlzheimer%252527s%252Bdisease%252Bcell%252Bmodel%26aulast%3DLiu%26aufirst%3DMeng-Meng%26date%3D2021%26volume%3D223%26spage%3D121738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hayrettin Ozan  Gulcan</span>, <span class="hlFld-ContribAuthor ">Açelya  Mavideniz</span>, <span class="hlFld-ContribAuthor ">Mustafa Fethi  Sahin</span>, <span class="hlFld-ContribAuthor ">Ilkay Erdogan  Orhan</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (18)
                                     , 3260-3278. <a href="https://doi.org/10.2174/0929867326666190124123208" title="DOI URL">https://doi.org/10.2174/0929867326666190124123208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190124123208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190124123208%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole-derived%252BCompounds%252BDesigned%252Bfor%252BDifferent%252BTargets%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGulcan%26aufirst%3DHayrettin%2BOzan%26date%3D2019%26volume%3D26%26issue%3D18%26spage%3D3260%26epage%3D3278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Kan  Wang</span>, <span class="hlFld-ContribAuthor ">Kaixiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Bin  Dai</span>, <span class="hlFld-ContribAuthor ">Jiapei  Dai</span>, <span class="hlFld-ContribAuthor ">Yi  Liang</span>, <span class="hlFld-ContribAuthor ">Mengchao  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 291-301. <a href="https://doi.org/10.1016/j.ejmech.2019.05.065" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.065%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbioevaluation%252Bof%252Btechnetium-99%2525E2%252580%2525AFm%252B%25252F%252Brhenium%252Blabeled%252Bphenylquinoxaline%252Bderivatives%252Bas%252BTau%252Bimaging%252Bprobes%26aulast%3DYang%26aufirst%3DFan%26date%3D2019%26volume%3D177%26spage%3D291%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Bai</span>, <span class="hlFld-ContribAuthor ">Jia  Xie</span>, <span class="hlFld-ContribAuthor ">Yajing  Xing</span>, <span class="hlFld-ContribAuthor ">Li-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Jiuqing  Xie</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Mingyao  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Zhengfang  Yi</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of methylpyrimidine-fused tricyclic diterpene analogs as novel oral anti-late-onset hypogonadism agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 21-40. <a href="https://doi.org/10.1016/j.ejmech.2019.05.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bmethylpyrimidine-fused%252Btricyclic%252Bditerpene%252Banalogs%252Bas%252Bnovel%252Boral%252Banti-late-onset%252Bhypogonadism%252Bagents%26aulast%3DBai%26aufirst%3DJie%26date%3D2019%26volume%3D176%26spage%3D21%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chinduluri  Sravani</span>, <span class="hlFld-ContribAuthor ">Mohsin Y.  Lone</span>, <span class="hlFld-ContribAuthor ">Prakash C.  Jha</span>, <span class="hlFld-ContribAuthor ">K.I.  Sathiyanarayanan</span>, <span class="hlFld-ContribAuthor ">Akella  Sivaramakrishna</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and photophysical studies on 2‑styryl phenanthro[9,10‑d]oxazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2019,</strong> <em>210 </em>, 171-180. <a href="https://doi.org/10.1016/j.saa.2018.10.055" title="DOI URL">https://doi.org/10.1016/j.saa.2018.10.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2018.10.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2018.10.055%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DSynthesis%252Band%252Bphotophysical%252Bstudies%252Bon%252B2%2525E2%252580%252591styryl%252Bphenanthro%25255B9%25252C10%2525E2%252580%252591d%25255Doxazole%252Bderivatives%26aulast%3DSravani%26aufirst%3DChinduluri%26date%3D2019%26volume%3D210%26spage%3D171%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengyu  Li</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Takahashi</span>, <span class="hlFld-ContribAuthor ">Tejashwi  Shrestha</span>, <span class="hlFld-ContribAuthor ">Eiji  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Tomoyasu  Matsubara</span>, <span class="hlFld-ContribAuthor ">Masayasu  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Maruyama</span>. </span><span class="cited-content_cbyCitation_article-title">4′,6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits. </span><span class="cited-content_cbyCitation_journal-name">Journal of Histochemistry & Cytochemistry</span><span> <strong>2018,</strong> <em>66 </em>
                                    (10)
                                     , 737-751. <a href="https://doi.org/10.1369/0022155418793600" title="DOI URL">https://doi.org/10.1369/0022155418793600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1369/0022155418793600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1369%2F0022155418793600%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Histochemistry%2520%2526%2520Cytochemistry%26atitle%3D4%2525E2%252580%2525B2%25252C6-Diamidino-2-Phenylindole%252BDistinctly%252BLabels%252BTau%252BDeposits%26aulast%3DLi%26aufirst%3DChengyu%26date%3D2018%26date%3D2018%26volume%3D66%26issue%3D10%26spage%3D737%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Kaide</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakamoto</span>, <span class="hlFld-ContribAuthor ">Kaori  Togashi</span>, <span class="hlFld-ContribAuthor ">Aiko  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Hanaoka</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Conversion of iodine to fluorine-18 based on iodinated chalcone and evaluation for β-amyloid PET imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3352-3358. <a href="https://doi.org/10.1016/j.bmc.2018.05.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DConversion%252Bof%252Biodine%252Bto%252Bfluorine-18%252Bbased%252Bon%252Biodinated%252Bchalcone%252Band%252Bevaluation%252Bfor%252B%2525CE%2525B2-amyloid%252BPET%252Bimaging%26aulast%3DKaide%26aufirst%3DSho%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3352%26epage%3D3358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnanka Shekhar  Gayen</span>, <span class="hlFld-ContribAuthor ">Nirbhik  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Saikat  Khamarui</span>, <span class="hlFld-ContribAuthor ">Pradip Kumar  Tarafdar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Iodosobenzene-Mediated Construction of Heterocyclic Scaffolds: Transition-Metal-Free Approaches and Scope. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (4)
                                     , 425-439. <a href="https://doi.org/10.1002/ejoc.201701306" title="DOI URL">https://doi.org/10.1002/ejoc.201701306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701306%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252BIodosobenzene-Mediated%252BConstruction%252Bof%252BHeterocyclic%252BScaffolds%25253A%252BTransition-Metal-Free%252BApproaches%252Band%252BScope%26aulast%3DGayen%26aufirst%3DKrishnanka%2BShekhar%26date%3D2018%26date%3D2017%26volume%3D2018%26issue%3D4%26spage%3D425%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianlin  Yang</span>, <span class="hlFld-ContribAuthor ">Qing  Xu</span>, <span class="hlFld-ContribAuthor ">Chao  Dong</span>, <span class="hlFld-ContribAuthor ">Li-Biao  Han</span>, <span class="hlFld-ContribAuthor ">Ruwei  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed Dehydrative Cyclization of 1-(2-Hydroxyphenyl)propargyl Alcohols with P(O)H Compounds for the Synthesis of 2-Phosphorylmethylbenzofurans. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (2)
                                     , 334-345. <a href="https://doi.org/10.1002/adsc.201701368" title="DOI URL">https://doi.org/10.1002/adsc.201701368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201701368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201701368%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper-Catalyzed%252BDehydrative%252BCyclization%252Bof%252B1-%2525282-Hydroxyphenyl%252529propargyl%252BAlcohols%252Bwith%252BP%252528O%252529H%252BCompounds%252Bfor%252Bthe%252BSynthesis%252Bof%252B2-Phosphorylmethylbenzofurans%26aulast%3DZhang%26aufirst%3DMing%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D2%26spage%3D334%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Long  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng-He  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advance in oxazole-based medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>144 </em>, 444-492. <a href="https://doi.org/10.1016/j.ejmech.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvance%252Bin%252Boxazole-based%252Bmedicinal%252Bchemistry%26aulast%3DZhang%26aufirst%3DHui-Zhen%26date%3D2018%26volume%3D144%26spage%3D444%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Taisuke  Ariyoshi</span>, <span class="hlFld-ContribAuthor ">Akihiko  Ozaki</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel radioiodinated benzimidazole derivatives for imaging α-synuclein aggregates. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6398-6403. <a href="https://doi.org/10.1016/j.bmc.2017.10.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bradioiodinated%252Bbenzimidazole%252Bderivatives%252Bfor%252Bimaging%252B%2525CE%2525B1-synuclein%252Baggregates%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6398%26epage%3D6403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wan  Xu</span>, <span class="hlFld-ContribAuthor ">Meng-Tian  Zeng</span>, <span class="hlFld-ContribAuthor ">Sha-Sha  Liu</span>, <span class="hlFld-ContribAuthor ">Yue-Sheng  Li</span>, <span class="hlFld-ContribAuthor ">Zhi-Bing  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Copper catalyzed synthesis of benzoxazoles and benzothiazoles via tandem manner. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (45)
                                     , 4289-4292. <a href="https://doi.org/10.1016/j.tetlet.2017.09.089" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.09.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.09.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.09.089%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCopper%252Bcatalyzed%252Bsynthesis%252Bof%252Bbenzoxazoles%252Band%252Bbenzothiazoles%252Bvia%252Btandem%252Bmanner%26aulast%3DXu%26aufirst%3DWan%26date%3D2017%26volume%3D58%26issue%3D45%26spage%3D4289%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Meng-Tian  Zeng</span>, <span class="hlFld-ContribAuthor ">Wan  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi-Bing  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective synthesis of 2-aminobenzoxazoles and 2-mercaptobenzoxazoles by using o-aminophenols as starting material. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (46)
                                     , 4352-4356. <a href="https://doi.org/10.1016/j.tetlet.2017.09.092" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.09.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.09.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.09.092%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Bsynthesis%252Bof%252B2-aminobenzoxazoles%252Band%252B2-mercaptobenzoxazoles%252Bby%252Busing%252Bo-aminophenols%252Bas%252Bstarting%252Bmaterial%26aulast%3DLiu%26aufirst%3DMin%26date%3D2017%26volume%3D58%26issue%3D46%26spage%3D4352%26epage%3D4356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>. </span><span class="cited-content_cbyCitation_article-title">Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain. </span><span class="cited-content_cbyCitation_journal-name">YAKUGAKU ZASSHI</span><span> <strong>2017,</strong> <em>137 </em>
                                    (11)
                                     , 1361-1365. <a href="https://doi.org/10.1248/yakushi.17-00156" title="DOI URL">https://doi.org/10.1248/yakushi.17-00156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/yakushi.17-00156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fyakushi.17-00156%26sid%3Dliteratum%253Aachs%26jtitle%3DYAKUGAKU%2520ZASSHI%26atitle%3DDevelopment%252Bof%252BSPECT%252BProbes%252Bfor%252BIn%252BVivo%252BImaging%252Bof%252B%2525CE%2525B2-Amyloid%252Band%252BTau%252BAggregates%252Bin%252Bthe%252BAlzheimer%252527s%252BDisease%252BBrain%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2017%26volume%3D137%26issue%3D11%26spage%3D1361%26epage%3D1365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Giacomelli</span>, <span class="hlFld-ContribAuthor ">Simona  Daniele</span>, <span class="hlFld-ContribAuthor ">Claudia  Martini</span>. </span><span class="cited-content_cbyCitation_article-title">Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2017,</strong> <em>131 </em>, 1-15. <a href="https://doi.org/10.1016/j.bcp.2017.01.017" title="DOI URL">https://doi.org/10.1016/j.bcp.2017.01.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2017.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2017.01.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DPotential%252Bbiomarkers%252Band%252Bnovel%252Bpharmacological%252Btargets%252Bin%252Bprotein%252Baggregation-related%252Bneurodegenerative%252Bdiseases%26aulast%3DGiacomelli%26aufirst%3DChiara%26date%3D2017%26volume%3D131%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gao  Wei</span>, <span class="hlFld-ContribAuthor ">Yalan  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao-Long  He</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Mingyao  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Luo</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of heterocyclic ring-fused tricyclic diterpene analogs as novel inhibitors of RANKL-induced osteoclastogenesis and bone resorption. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>131 </em>, 48-67. <a href="https://doi.org/10.1016/j.ejmech.2017.03.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bheterocyclic%252Bring-fused%252Btricyclic%252Bditerpene%252Banalogs%252Bas%252Bnovel%252Binhibitors%252Bof%252BRANKL-induced%252Bosteoclastogenesis%252Band%252Bbone%252Bresorption%26aulast%3DWei%26aufirst%3DGao%26date%3D2017%26volume%3D131%26spage%3D48%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao-Yu  Yang</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Hai-Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Guo-Rong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  He</span>. </span><span class="cited-content_cbyCitation_article-title">D-A-D fluorogenic probe for the rapid imaging of amyloid β plaques in vivo. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2017,</strong> <em>136 </em>, 224-228. <a href="https://doi.org/10.1016/j.dyepig.2016.08.054" title="DOI URL">https://doi.org/10.1016/j.dyepig.2016.08.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2016.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2016.08.054%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DD-A-D%252Bfluorogenic%252Bprobe%252Bfor%252Bthe%252Brapid%252Bimaging%252Bof%252Bamyloid%252B%2525CE%2525B2%252Bplaques%252Bin%2525C2%2525A0vivo%26aulast%3DYang%26aufirst%3DHao-Yu%26date%3D2017%26volume%3D136%26spage%3D224%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Tao  Dou</span>, <span class="hlFld-ContribAuthor ">Wei  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Peng  He</span>, <span class="hlFld-ContribAuthor ">Jianhua  Su</span>, <span class="hlFld-ContribAuthor ">He  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Vibration-Induced-Emission (VIE) for imaging amyloid β fibrils. </span><span class="cited-content_cbyCitation_journal-name">Faraday Discussions</span><span> <strong>2017,</strong> <em>196 </em>, 395-402. <a href="https://doi.org/10.1039/C6FD00156D" title="DOI URL">https://doi.org/10.1039/C6FD00156D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6FD00156D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6FD00156D%26sid%3Dliteratum%253Aachs%26jtitle%3DFaraday%2520Discussions%26atitle%3DVibration-Induced-Emission%252B%252528VIE%252529%252Bfor%252Bimaging%252Bamyloid%252B%2525CE%2525B2%252Bfibrils%26aulast%3DDou%26aufirst%3DWei-Tao%26date%3D2017%26date%3D2017%26volume%3D196%26spage%3D395%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauro  Safir Filho</span>, <span class="hlFld-ContribAuthor ">Sebastien  Fiorucci</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Martin</span>, <span class="hlFld-ContribAuthor ">Rachid  Benhida</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and photophysical studies of styryl-based push–pull fluorophores with remarkable solvatofluorochromism. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (22)
                                     , 13760-13772. <a href="https://doi.org/10.1039/C7NJ03142D" title="DOI URL">https://doi.org/10.1039/C7NJ03142D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NJ03142D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NJ03142D%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bphotophysical%252Bstudies%252Bof%252Bstyryl-based%252Bpush%2525E2%252580%252593pull%252Bfluorophores%252Bwith%252Bremarkable%252Bsolvatofluorochromism%26aulast%3DSafir%2BFilho%26aufirst%3DMauro%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D22%26spage%3D13760%26epage%3D13772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Molecular Imaging. </span><span class="cited-content_cbyCitation_journal-name">Biological & Pharmaceutical Bulletin</span><span> <strong>2017,</strong> <em>40 </em>
                                    (10)
                                     , 1605-1615. <a href="https://doi.org/10.1248/bpb.b17-00505" title="DOI URL">https://doi.org/10.1248/bpb.b17-00505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.b17-00505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.b17-00505%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520%2526%2520Pharmaceutical%2520Bulletin%26atitle%3DIn%252BVivo%252BMolecular%252BImaging%26aulast%3DSaji%26aufirst%3DHideo%26date%3D2017%26volume%3D40%26issue%3D10%26spage%3D1605%26epage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana A.  Olszewska</span>, <span class="hlFld-ContribAuthor ">Roisin  Lonergan</span>, <span class="hlFld-ContribAuthor ">Emer M.  Fallon</span>, <span class="hlFld-ContribAuthor ">Tim  Lynch</span>. </span><span class="cited-content_cbyCitation_article-title">Genetics of Frontotemporal Dementia. </span><span class="cited-content_cbyCitation_journal-name">Current Neurology and Neuroscience Reports</span><span> <strong>2016,</strong> <em>16 </em>
                                    (12)
                                     <a href="https://doi.org/10.1007/s11910-016-0707-9" title="DOI URL">https://doi.org/10.1007/s11910-016-0707-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11910-016-0707-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11910-016-0707-9%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neurology%2520and%2520Neuroscience%2520Reports%26atitle%3DGenetics%252Bof%252BFrontotemporal%252BDementia%26aulast%3DOlszewska%26aufirst%3DDiana%2BA.%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Ayane  Kitada</span>, <span class="hlFld-ContribAuthor ">Kenji  Matsumura</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep34197" title="DOI URL">https://doi.org/10.1038/srep34197</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep34197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep34197%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DHighly%252BSelective%252BTau-SPECT%252BImaging%252BProbes%252Bfor%252BDetection%252Bof%252BNeurofibrillary%252BTangles%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DOno%26aufirst%3DMasahiro%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. S. M.  Sundaram</span>, <span class="hlFld-ContribAuthor ">Dhruva D.  Dhavale</span>, <span class="hlFld-ContribAuthor ">Julie L.  Prior</span>, <span class="hlFld-ContribAuthor ">Ping  Yan</span>, <span class="hlFld-ContribAuthor ">John  Cirrito</span>, <span class="hlFld-ContribAuthor ">Nigam P.  Rath</span>, <span class="hlFld-ContribAuthor ">Richard  Laforest</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Cairns</span>, <span class="hlFld-ContribAuthor ">Jin-Moo  Lee</span>, <span class="hlFld-ContribAuthor ">Paul T.  Kotzbauer</span>, <span class="hlFld-ContribAuthor ">Vijay  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep35636" title="DOI URL">https://doi.org/10.1038/srep35636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep35636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep35636%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFluselenamyl%25253A%252BA%252BNovel%252BBenzoselenazole%252BDerivative%252Bfor%252BPET%252BDetection%252Bof%252BAmyloid%252BPlaques%252B%252528A%2525CE%2525B2%252529%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSundaram%26aufirst%3DG.%2BS.%2BM.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Katsutoshi  Furukawa</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Yanai</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Arai</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the development of tau PET radiotracers and their clinical applications. </span><span class="cited-content_cbyCitation_journal-name">Ageing Research Reviews</span><span> <strong>2016,</strong> <em>30 </em>, 107-113. <a href="https://doi.org/10.1016/j.arr.2015.12.010" title="DOI URL">https://doi.org/10.1016/j.arr.2015.12.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arr.2015.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arr.2015.12.010%26sid%3Dliteratum%253Aachs%26jtitle%3DAgeing%2520Research%2520Reviews%26atitle%3DAdvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Btau%252BPET%252Bradiotracers%252Band%252Btheir%252Bclinical%252Bapplications%26aulast%3DOkamura%26aufirst%3DNobuyuki%26date%3D2016%26volume%3D30%26spage%3D107%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Yanai</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Arai</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">Characteristics of Tau and Its Ligands in PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     , 7. <a href="https://doi.org/10.3390/biom6010007" title="DOI URL">https://doi.org/10.3390/biom6010007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom6010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom6010007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCharacteristics%252Bof%252BTau%252Band%252BIts%252BLigands%252Bin%252BPET%252BImaging%26aulast%3DHarada%26aufirst%3DRyuichi%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy for this work (A). Chemical structure of phenylethenyl and (3-pyridinyl)ethenyl benzothiazole (B), benzoxazole (C), benzofuran (D), benzothiophene (E), and benzimidazole (F) derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzothiazole Derivatives (A) and Their Precursors (B)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Phenylethenyl (A) and (3-Pyridinyl)ethenyl (B) Benzoxazole Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzofuran Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Routes for Phenylethenyl and (3-Pyridinyl)ethenyl Benzothiophene Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Routes for Phenylethenyl Benzimidazole Derivatives (A), Their Precursors (B), (3-Pyridinyl)ethenyl Benzimidazole Derivatives (C), and Their Precursors (D)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Immunohistochemical staining with antibodies against Aβ<sub>1–42</sub> (BC05: A and C) and phosphorylated tau (AT8: B and D) in sections of the frontal lobe (A and B) and temporal lobe (C and D) from an AD patient (76-year-old male).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Two Radiolabeling Methods of Heterocyclic Phenylethenyl and (3-Pyridinyl)ethenyl Derivatives</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>3</b> (A and B), [<sup>125</sup>I]<b>4</b> (C and D), [<sup>125</sup>I]<b>28</b> (E and F), [<sup>125</sup>I]<b>22</b> (G and H), [<sup>125</sup>I]<b>43</b> (I and J), [<sup>125</sup>I]<b>44</b> (K and L), [<sup>125</sup>I]<b>59</b> (M and N), [<sup>125</sup>I]<b>60</b> (O and P), [<sup>125</sup>I]SBIM-3 (Q and R), and [<sup>125</sup>I]<b>70</b> (S and T) in brain sections from the AD patient. A, C, E, G, I, K, M, O, Q, and S are the sections from the temporal lobe. B, D, F, H, J, L, N, P, R, and T are the sections from the frontal lobe.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>5</b> (A and B), [<sup>125</sup>I]<b>6</b> (C and D), [<sup>125</sup>I]<b>23</b> (E and F), [<sup>125</sup>I]<b>29</b> (G and H), [<sup>125</sup>I]<b>45</b> (I and J), [<sup>125</sup>I]<b>46</b> (K and L), [<sup>125</sup>I]<b>61</b> (M and N), [<sup>125</sup>I]<b>62</b> (O and P), [<sup>125</sup>I]<b>64</b> (Q and R), and [<sup>125</sup>I]<b>71</b> (S and T) in brain sections from the AD patient. A, C, E, G, I, K, M, O, Q, and S are the sections from the temporal lobe. B, D, F, H, J, L, N, P, R, and T are the sections from the frontal lobe. U, V, and W are high magnification images of <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D, panel Q from this figure, and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/medium/jm-2015-004409_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Radioactivity of [<sup>125</sup>I]<b>64</b> that accumulated in the cortexes of the frontal and temporal lobes (green columns) and the percent areas of immunostaining for tau (blue columns) and Aβ (red columns) in the same region. The cortexes of the frontal and temporal lobes were divided into four (a, b, c, and d) and six (e, f, g, h, i, and j) regions, respectively. The regions a, b, c, and d are gyrus cinguli, gyrus rectus, gyrus orbitalis, and gyrus frontalis inferior, respectively. The regions e, f, g, h, i, and j are gyrus temporalis transversalis, gyrus temporalis superior, gyrus temporalis medius, gyrus temporalis inferior, gyrus parahippocampalis, and hippocampus, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-18/acs.jmedchem.5b00440/20150918/images/large/jm-2015-004409_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00440&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i106">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Brookmeyer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegler-Graham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrighi, H. M.</span><span> </span><span class="NLM_article-title">Forecasting the global burden of Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/j.jalz.2007.04.381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.jalz.2007.04.381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19595937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=186-191&author=R.+Brookmeyerauthor=E.+Johnsonauthor=K.+Ziegler-Grahamauthor=H.+M.+Arrighi&title=Forecasting+the+global+burden+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2007.04.381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Forecasting the global burden of Alzheimer's disease</span></div><div class="casAuthors">Brookmeyer Ron; Johnson Elizabeth; Ziegler-Graham Kathryn; Arrighi H Michael</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our goal was to forecast the global burden of Alzheimer's disease and evaluate the potential impact of interventions that delay disease onset or progression.  METHODS:  A stochastic, multistate model was used in conjunction with United Nations worldwide population forecasts and data from epidemiological studies of the risks of Alzheimer's disease.  RESULTS:  In 2006, the worldwide prevalence of Alzheimer's disease was 26.6 million.  By 2050, the prevalence will quadruple, by which time 1 in 85 persons worldwide will be living with the disease.  We estimate about 43% of prevalent cases need a high level of care, equivalent to that of a nursing home.  If interventions could delay both disease onset and progression by a modest 1 year, there would be nearly 9.2 million fewer cases of the disease in 2050, with nearly the entire decline attributable to decreases in persons needing a high level of care.  CONCLUSIONS:  We face a looming global epidemic of Alzheimer's disease as the world's population ages.  Modest advances in therapeutic and preventive strategies that lead to even small delays in the onset and progression of Alzheimer's disease can significantly reduce the global burden of this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScBQJ_4Qj7YMSzjBFCN0BJfW6udTcc2eZOD9_vs8dB1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mvot1yjtQ%253D%253D&md5=f89fab48e87760875e35c68876a42664</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.04.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.04.381%26sid%3Dliteratum%253Aachs%26aulast%3DBrookmeyer%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DZiegler-Graham%26aufirst%3DK.%26aulast%3DArrighi%26aufirst%3DH.%2BM.%26atitle%3DForecasting%2520the%2520global%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2007%26volume%3D3%26spage%3D186%26epage%3D191%26doi%3D10.1016%2Fj.jalz.2007.04.381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Felsenstein, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candelario, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindler, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span> </span><span class="NLM_article-title">Regenerative medicine in Alzheimer’s disease</span> <span class="citation_source-journal">Transl Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span><span class="refDoi"> DOI: 10.1016/j.trsl.2013.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.trsl.2013.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24286919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2c3hslWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2014&pages=432-438&author=K.+M.+Felsensteinauthor=K.+M.+Candelarioauthor=D.+A.+Steindlerauthor=D.+R.+Borchelt&title=Regenerative+medicine+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.trsl.2013.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Regenerative medicine in Alzheimer's disease</span></div><div class="casAuthors">Felsenstein Kevin M; Candelario Kate M; Steindler Dennis A; Borchelt David R</div><div class="citationInfo"><span class="NLM_cas:title">Translational research : the journal of laboratory and clinical medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Identifying novel, effective therapeutics for Alzheimer's disease (AD) is one of the major unmet medical needs for the coming decade.  Because the current paradigm for developing and testing disease-modifying AD therapies is protracted and likely to be even longer, with the shift toward earlier intervention in preclinical AD, it is an open issue whether we can develop, test, and widely deploy a novel therapy in time to help the current at-risk generation if we continue to follow the standard paradigms of discovery and drug development.  There is an imperative need to find safe and effective preventive measures that can be distributed rapidly to stem the coming wave of AD that will potentially engulf the next generation.  We can define regenerative medicine broadly as approaches that use stem cell-based therapies or approaches that seek to modulate inherent neurogenesis.  Neurogenesis, although most active during prenatal development, has been shown to continue in several small parts of the brain, including the hippocampus and the subventricular zone, suggesting its potential to reverse cognitive deficits.  If AD pathology affects neurogenesis, then it follows that conditions that stimulate endogenous neurogenesis (eg, environmental stimuli, physical activity, trophic factors, cytokines, and drugs) may help to promote the regenerative and recovery process.  Herein, we review the complex logistics of potentially implementing neurogenesis-based therapeutic strategies for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQupbKU3HIWG_9pSBfyDvp7fW6udTcc2eZOD9_vs8dB1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3hslWgtg%253D%253D&md5=2ff49da967dde5b3db399f6d73e5a9d3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.trsl.2013.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.trsl.2013.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelsenstein%26aufirst%3DK.%2BM.%26aulast%3DCandelario%26aufirst%3DK.%2BM.%26aulast%3DSteindler%26aufirst%3DD.%2BA.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26atitle%3DRegenerative%2520medicine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTransl%2520Res.%26date%3D2014%26volume%3D163%26spage%3D432%26epage%3D438%26doi%3D10.1016%2Fj.trsl.2013.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/S1474-4422(09)70299-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS1474-4422%2809%2970299-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20083042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=119-128&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=L.+M.+Shawauthor=P.+S.+Aisenauthor=M.+W.+Weinerauthor=R.+C.+Petersenauthor=J.+Q.+Trojanowski&title=Hypothetical+model+of+dynamic+biomarkers+of+the+Alzheimer%E2%80%99s+pathological+cascade&doi=10.1016%2FS1474-4422%2809%2970299-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade</span></div><div class="casAuthors">Jack, Clifford R., Jr.; Knopman, David S.; Jagust, William J.; Shaw, Leslie M.; Aisen, Paul S.; Weiner, Michael W.; Petersen, Ronald C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Currently available evidence strongly supports the position that the initiating event in Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately leading to formation of Aβ plaques in the brain.  This process occurs while individuals are still cognitively normal.  Biomarkers of brain β-amyloidosis are redns. in CSF Aβ42 and increased amyloid PET tracer retention.  After a lag period, which varies from patient to patient, neuronal dysfunction and neurodegeneration become the dominant pathol. processes.  Biomarkers of neuronal injury and neurodegeneration are increased CSF tau and structural MRI measures of cerebral atrophy.  Neurodegeneration is accompanied by synaptic dysfunction, which is indicated by decreased fluorodeoxyglucose uptake on PET.  We propose a model that relates disease stage to AD biomarkers in which Aβ biomarkers become abnormal first, before neurodegenerative biomarkers and cognitive symptoms, and neurodegenerative biomarkers become abnormal later, and correlate with clin. symptom severity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOnmdY1Eeez7Vg90H21EOLACvtfcHk0ljPnapnWnA1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFeru74%253D&md5=5337b3e576ab1e8c58292c2572fb62f6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970299-6%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DHypothetical%2520model%2520of%2520dynamic%2520biomarkers%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520pathological%2520cascade%26jtitle%3DLancet%2520Neurol.%26date%3D2010%26volume%3D9%26spage%3D119%26epage%3D128%26doi%3D10.1016%2FS1474-4422%2809%2970299-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Development of positron emission tomography β-amyloid plaque imaging agents</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1053/j.semnuclmed.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1053%2Fj.semnuclmed.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23026364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=423-432&author=C.+A.+Mathisauthor=N.+S.+Masonauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Development+of+positron+emission+tomography+%CE%B2-amyloid+plaque+imaging+agents&doi=10.1053%2Fj.semnuclmed.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of positron emission tomography β-amyloid plaque imaging agents</span></div><div class="casAuthors">Mathis Chester A; Mason N Scott; Lopresti Brian J; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">For 100 years, β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) have been recognized as the neuropathological hallmarks of Alzheimer's disease (AD), and their presence or absence could only be assessed postmortem using stains and dyes that identified these microscopic structures.  Approximately 10 years ago, the first successful Aβ plaque-specific positron emission tomography (PET) imaging study was conducted in a living human subject clinically diagnosed with probable AD using the (11)C-labeled radiopharmaceutical Pittsburgh Compound B (PiB).  Laboratory studies and preclinical evaluations to design PiB began a decade earlier than the first human PiB PET study and involved chemical modifications of different well-known dyes that bound specifically to the extended β-pleated sheets that comprise the fibrils of amyloid proteins such as Aβ plaques, NFTs, α-synuclein deposits, and prions.  These preclinical studies were conducted in our laboratories at the University of Pittsburgh, starting with Congo red derivatives, followed by Chrysamine G derivatives, followed by X-series compounds, and finally with neutral derivatives of thioflavin-T.  The in vitro and in vivo evaluations of the different derivatives as candidate PET radioligands for imaging Aβ plaques and neurofibrillary tangles in human brain are described in this review, along with the specific evaluation criteria by which the candidate radioligands were judged.  Out of these studies came PiB, a PET radioligand that binds selectively and with high affinity to only fibrillar forms of Aβ.  PiB has been used in many different human research protocols throughout the world and has demonstrated the usefulness of assessing the Aβ plaque status of subjects many years before the clinical diagnosis of probable AD.  Recently, longer-lived (18)F-radiolabeled Aβ-selective radiopharmaceuticals have been developed.  It is likely that the full clinical impact of these imaging agents will be realized by identifying presymptomatic subjects who would benefit from early drug treatments with future disease-modifying AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5GsYnd2H3WtyzdcP07UmufW6udTcc2eY7oWo2bNRblrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D&md5=e9c01e3c4335a6b85dd838c64277e0ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DDevelopment%2520of%2520positron%2520emission%2520tomography%2520%25CE%25B2-amyloid%2520plaque%2520imaging%2520agents%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D42%26spage%3D423%26epage%3D432%26doi%3D10.1053%2Fj.semnuclmed.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobrega, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westaway, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoeff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title"><sup>11</sup>C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer’s disease</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">571</span><span class="refDoi"> DOI: 10.1016/S0969-8051(03)00049-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0969-8051%2803%2900049-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=12900282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFynsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=565-571&author=M.+Onoauthor=A.+Wilsonauthor=J.+Nobregaauthor=D.+Westawayauthor=P.+Verhoeffauthor=Z.+P.+Zhuangauthor=M.+P.+Kungauthor=H.+F.+Kung&title=11C-labeled+stilbene+derivatives+as+A%CE%B2-aggregate-specific+PET+imaging+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0969-8051%2803%2900049-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">11C-labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer's disease</span></div><div class="casAuthors">Ono, Masahiro; Wilson, Alan; Nobrega, Jose; Westaway, David; Verhoeff, Paul; Zhuang, Zhi-Ping; Kung, Mei-Ping; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-571</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A series of stilbene derivs. as potential diagnostic imaging agents targeting amyloid plaques in Alzheimer's disease (AD) were synthesized and evaluated.  The syntheses of the stilbenes were successfully achieved by a simple Wadsworth-Emmons reaction between di-Et (4-nitrobenzyl)phosphonate and 4-methoxybenzaldehyde. 4-N,N-dimethylamino-4'-methyoxy and the corresponding 4-N-monomethylamino-, 4'-hydroxy stilbenes showed good binding affinities towards Aβ aggregates in vitro (Ki < 10 nM).  The 11C labeled 4-N-methylamino-4'-hydroxystilbene, [11C]4, was prepd. by 11C methylation of 4-amino-4'-hydroxystilbene.  The [11C]4 displayed a moderate lipophilicity (log P = 2.36), and showed a very good brain penetration and washout from normal rat brain after an iv injection.  In vitro autoradiog. of transgenic AD mouse brain sections showed a high specific labeling of β-amyloid plaques, whereas the control sections showed no binding.  Taken together the data suggest that a relatively simple stilbene deriv., [11C]4, N-[11C]methylamino-4'-hydroxystilbene, may be useful as a positron emission tomog. (PET) imaging agent for mapping Aβ plaques in the brain of patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_fzcBd7sevLVg90H21EOLACvtfcHk0lgICq3xoaesfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFynsbw%253D&md5=18d2f044489140a061da96846d1cc46a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2803%2900049-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252803%252900049-0%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DNobrega%26aufirst%3DJ.%26aulast%3DWestaway%26aufirst%3DD.%26aulast%3DVerhoeff%26aufirst%3DP.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3D11C-labeled%2520stilbene%2520derivatives%2520as%2520A%25CE%25B2-aggregate-specific%2520PET%2520imaging%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2003%26volume%3D30%26spage%3D565%26epage%3D571%26doi%3D10.1016%2FS0969-8051%2803%2900049-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waragai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Amyloid PET in mild cognitive impairment and Alzheimer’s disease with BF-227: comparison to FDG-PET</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.1007/s00415-009-5396-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00415-009-5396-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19946781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1CktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=2010&pages=721-727&author=K.+Furukawaauthor=N.+Okamuraauthor=M.+Tashiroauthor=M.+Waragaiauthor=S.+Furumotoauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudoauthor=H.+Arai&title=Amyloid+PET+in+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease+with+BF-227%3A+comparison+to+FDG-PET&doi=10.1007%2Fs00415-009-5396-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET in mild cognitive impairment and Alzheimer's disease with BF-227: comparison to FDG-PET</span></div><div class="casAuthors">Furukawa, Katsutoshi; Okamura, Nobuyuki; Tashiro, Manabu; Waragai, Masaaki; Furumoto, Shozo; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka; Arai, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">721-727</span>CODEN:
                <span class="NLM_cas:coden">JNRYA9</span>;
        ISSN:<span class="NLM_cas:issn">0340-5354</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We recently developed a novel PET tracer, 11C-labeled 2-(2-[2-dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole ([11C]BF-227), and had success with in vivo detection of amyloid plaques in Alzheimer's disease (AD) brains (Kudo et al. in J Nucl Med 8:553-561, 2007).  We applied this tracer to subjects with mild cognitive impairment (MCI) and AD in order to elucidate the status of amyloid plaque deposition in MCI and compared the diagnostic performance of BF-227-PET with that of FDG-PET in AD cases.  We studied 12 aged normal (AN) subjects, 15 MCIs and 15 ADs with PET using [11C]BF-227.  PET images were obtained after administration of BF-227 and the regional standardized uptake value (SUV) and the ratio of regional to cerebellar SUV were calcd. as an index of BF-227 binding.  AD patients showed increased uptake of [11C]BF-227 in the neocortical areas and striatum as well as decreased glucose metab. in temporoparietal, posterior cingulate and medial temporal areas.  MCI subjects showed a significant increase in BF-227 uptake in the neocortical areas similar to AD, and the most significant difference of BF-227 retention was obsd. in the parietal lobe if its retentions for MCI were compared to those for AD and AN.  On the other hand, glucose hypometabolism in MCI was confined to cingulate and medial temporal cortices.  Neocortical BF-227 uptake neg. correlated with glucose metab.  Receiver operating characteristic (ROC) anal. indicated higher specificity and sensitivity with BF-227-PET than those with FDG-PET for differential diagnosis between AD and normal control.  We conclude that [11C]BF-227-PET has a possibility to be a useful technol. for early detection of AD pathol. and also even in the MCI stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquDEyzTS1_hbVg90H21EOLACvtfcHk0lgICq3xoaesfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1CktL4%253D&md5=edca72231634343ed69f65e0b752d89b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00415-009-5396-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00415-009-5396-8%26sid%3Dliteratum%253Aachs%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DWaragai%26aufirst%3DM.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DAmyloid%2520PET%2520in%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520BF-227%253A%2520comparison%2520to%2520FDG-PET%26jtitle%3DJ.%2520Neurol.%26date%3D2010%26volume%3D257%26spage%3D721%26epage%3D727%26doi%3D10.1007%2Fs00415-009-5396-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Vandenberghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanoiu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasselbalch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraux, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelissen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owenius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurfjell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span><span class="refDoi"> DOI: 10.1002/ana.22068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.22068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20687209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3cjpsleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2010&pages=319-329&author=R.+Vandenbergheauthor=K.+Van+Laereauthor=A.+Ivanoiuauthor=E.+Salmonauthor=C.+Bastinauthor=E.+Triauauthor=S.+Hasselbalchauthor=I.+Lawauthor=A.+Andersenauthor=A.+Kornerauthor=L.+Minthonauthor=G.+Garrauxauthor=N.+Nelissenauthor=G.+Bormansauthor=C.+Buckleyauthor=R.+Oweniusauthor=L.+Thurfjellauthor=G.+Farrarauthor=D.+J.+Brooks&title=18F-flutemetamol+amyloid+imaging+in+Alzheimer+disease+and+mild+cognitive+impairment%3A+a+phase+2+trial&doi=10.1002%2Fana.22068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial</span></div><div class="casAuthors">Vandenberghe Rik; Van Laere Koen; Ivanoiu Adrian; Salmon Eric; Bastin Christine; Triau Eric; Hasselbalch Steen; Law Ian; Andersen Allan; Korner Alex; Minthon Lennart; Garraux Gaetan; Nelissen Natalie; Bormans Guy; Buckley Chris; Owenius Rikard; Thurfjell Lennart; Farrar Gill; Brooks David J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The most widely studied positron emission tomography ligand for in vivo beta-amyloid imaging is (11)C-Pittsburgh compound B ((11)C-PIB).  Its availability, however, is limited by the need for an on-site cyclotron.  Validation of the (18)F-labeled PIB derivative (18)F-flutemetamol could significantly enhance access to this novel technology.  METHODS:  Twenty-seven patients with early-stage clinically probable Alzheimer disease (AD), 20 with amnestic mild cognitive impairment (MCI), and 15 cognitively intact healthy volunteers (HVs) above and 10 HVs below 55 years of age participated.  The primary endpoint was the efficacy of blinded visual assessments of (18)F-flutemetamol scans in assigning subjects to a raised versus normal uptake category, with clinical diagnosis as the standard of truth (SOT).  As secondary objectives, we determined the correlation between the regional standardized uptake value ratios (SUVRs) for (18)F-flutemetamol and its parent molecule (11)C-PIB in 20 of the AD subjects and 20 of the MCI patients.  We also determined test-retest variability of (18)F-flutemetamol SUVRs in 5 of the AD subjects.  RESULTS:  Blinded visual assessments of (18)F-flutemetamol scans assigned 25 of 27 scans from AD subjects and 1 of 15 scans from the elderly HVs to the raised category, corresponding to a sensitivity of 93.1% and a specificity of 93.3% against the SOT.  Correlation coefficients between cortical (18)F-flutemetamol SUVRs and (11)C-PIB SUVRs ranged from 0.89 to 0.92.  Test-retest variabilities of regional SUVRs were 1 to 4%.  INTERPRETATION:  (18)F-Flutemetamol performs similarly to the (11)C-PIB parent molecule within the same subjects and provides high test-retest replicability and potentially much wider accessibility for clinical and research use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8869ZYPKnLP_I8Jvzw4xCfW6udTcc2eZ5PsdDmhDmC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjpsleisg%253D%253D&md5=1cef58b91f2f25d7d48fef9d352c64b0</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fana.22068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22068%26sid%3Dliteratum%253Aachs%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DIvanoiu%26aufirst%3DA.%26aulast%3DSalmon%26aufirst%3DE.%26aulast%3DBastin%26aufirst%3DC.%26aulast%3DTriau%26aufirst%3DE.%26aulast%3DHasselbalch%26aufirst%3DS.%26aulast%3DLaw%26aufirst%3DI.%26aulast%3DAndersen%26aufirst%3DA.%26aulast%3DKorner%26aufirst%3DA.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DGarraux%26aufirst%3DG.%26aulast%3DNelissen%26aufirst%3DN.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DBuckley%26aufirst%3DC.%26aulast%3DOwenius%26aufirst%3DR.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DFarrar%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3D18F-flutemetamol%2520amyloid%2520imaging%2520in%2520Alzheimer%2520disease%2520and%2520mild%2520cognitive%2520impairment%253A%2520a%2520phase%25202%2520trial%26jtitle%3DAnn.%2520Neurol.%26date%3D2010%26volume%3D68%26spage%3D319%26epage%3D329%26doi%3D10.1002%2Fana.22068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F stilbenes and styrylpyridines for PET imaging of Aβ plaques in Alzheimer’s disease: a miniperspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1021/jm901039z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901039z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12hs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=933-941&author=H.+F.+Kungauthor=S.+R.+Choiauthor=W.+Quauthor=W.+Zhangauthor=D.+Skovronsky&title=18F+stilbenes+and+styrylpyridines+for+PET+imaging+of+A%CE%B2+plaques+in+Alzheimer%E2%80%99s+disease%3A+a+miniperspective&doi=10.1021%2Fjm901039z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">18F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer's Disease: A Miniperspective</span></div><div class="casAuthors">Kung, Hank F.; Choi, Seok Rye; Qu, Wenchao; Zhang, Wei; Skovronsky, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">933-941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors discuss progress in th use of 18F stilbenes and styrylpyridines as PET imaging agents for β-amyloid and the diagnosis of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRBBwwer3WhLVg90H21EOLACvtfcHk0lgiT5neJLKfDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12hs7%252FM&md5=9f39e880eb3170222b301369020a66e7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm901039z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901039z%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DChoi%26aufirst%3DS.%2BR.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSkovronsky%26aufirst%3DD.%26atitle%3D18F%2520stilbenes%2520and%2520styrylpyridines%2520for%2520PET%2520imaging%2520of%2520A%25CE%25B2%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520miniperspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D933%26epage%3D941%26doi%3D10.1021%2Fjm901039z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedell, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilker, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hefti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitter, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krautkramer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doraiswamy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleisher, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadowsky, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zehntner, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Group, A. A. S.</span><span> </span><span class="NLM_article-title">Use of florbetapir-PET for imaging β-amyloid pathology</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span><span class="refDoi"> DOI: 10.1001/jama.2010.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1001%2Fjama.2010.2008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2011&pages=275-283&author=C.+M.+Clarkauthor=J.+A.+Schneiderauthor=B.+J.+Bedellauthor=T.+G.+Beachauthor=W.+B.+Bilkerauthor=M.+A.+Mintunauthor=M.+J.+Pontecorvoauthor=F.+Heftiauthor=A.+P.+Carpenterauthor=M.+L.+Flitterauthor=M.+J.+Krautkramerauthor=H.+F.+Kungauthor=R.+E.+Colemanauthor=P.+M.+Doraiswamyauthor=A.+S.+Fleisherauthor=M.+N.+Sabbaghauthor=C.+H.+Sadowskyauthor=E.+P.+Reimanauthor=S.+P.+Zehntnerauthor=D.+M.+Skovronskyauthor=A.+A.+S.+Group&title=Use+of+florbetapir-PET+for+imaging+%CE%B2-amyloid+pathology&doi=10.1001%2Fjama.2010.2008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1001%2Fjama.2010.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.2010.2008%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DBedell%26aufirst%3DB.%2BJ.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DBilker%26aufirst%3DW.%2BB.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26aulast%3DHefti%26aufirst%3DF.%26aulast%3DCarpenter%26aufirst%3DA.%2BP.%26aulast%3DFlitter%26aufirst%3DM.%2BL.%26aulast%3DKrautkramer%26aufirst%3DM.%2BJ.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DColeman%26aufirst%3DR.%2BE.%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DFleisher%26aufirst%3DA.%2BS.%26aulast%3DSabbagh%26aufirst%3DM.%2BN.%26aulast%3DSadowsky%26aufirst%3DC.%2BH.%26aulast%3DReiman%26aufirst%3DE.%2BP.%26aulast%3DZehntner%26aufirst%3DS.%2BP.%26aulast%3DSkovronsky%26aufirst%3DD.%2BM.%26aulast%3DGroup%26aufirst%3DA.%2BA.%2BS.%26atitle%3DUse%2520of%2520florbetapir-PET%2520for%2520imaging%2520%25CE%25B2-amyloid%2520pathology%26jtitle%3DJAMA%26date%3D2011%26volume%3D305%26spage%3D275%26epage%3D283%26doi%3D10.1001%2Fjama.2010.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kung, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuang, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">IMPY: an improved thioflavin-T derivative for <i>in vivo</i> labeling of β-amyloid plaques</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">956</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.1016/S0006-8993(02)03436-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0006-8993%2802%2903436-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=12445687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslamsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=956&publication_year=2002&pages=202-210&author=M.+P.+Kungauthor=C.+Houauthor=Z.+P.+Zhuangauthor=B.+Zhangauthor=D.+Skovronskyauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=H.+F.+Kung&title=IMPY%3A+an+improved+thioflavin-T+derivative+for+in+vivo+labeling+of+%CE%B2-amyloid+plaques&doi=10.1016%2FS0006-8993%2802%2903436-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques</span></div><div class="casAuthors">Kung, Mei-Ping; Hou, Catherine; Zhuang, Zhi-Ping; Zhang, Bin; Skovronsky, Daniel; Trojanowski, John Q.; Lee, Virginia M.-Y.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">956</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-210</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Development of small mol. probes for in vivo labeling and detection of β-amyloid (Aβ) plaques in patients of Alzheimer's disease (AD) is of significant scientific interest, and it may also assist the development of drugs targeting Aβ plaques for treatment of AD.  A novel probe, [123I/125I]IMPY, 6-iodo-2-(4'-dimethylamino-)phenyl-imidazo[1,2-a]pyridine, was successfully prepd. with an iododestannylation reaction catalyzed by hydrogen peroxide.  The modified thioflavin-T deriv. displayed a good binding affinity for preformed synthetic Aβ40 aggregates in soln. (Ki=15±5 nM) and showed selective plaque labeling on postmortem AD brain sections.  Biodistribution study in normal mice after an iv injection of [125I]IMPY exhibited excellent brain uptake (2.9% initial dose/brain at 2 min) and fast washout (0.2% initial dose/brain at 60 min).  These properties are highly desirable for amyloid plaque imaging agents.  In vivo plaque labeling was evaluated in a transgenic mouse model (Tg2576) engineered to produce excess amyloid plaques in the brain.  Ex vivo autoradiograms of brain sections of the Tg 2576 mouse obtained at 4 h after an i.v. injection of [125I]IMPY clearly displayed a distinct plaque labeling with a low background activity.  When the same brain section was stained with a fluorescent dye, thioflavin-S, the same Aβ plaques showed prominent fluorescent labeling consistent with the results of the autoradiogram.  In conclusion, these findings clearly suggest that radioiodinated IMPY demonstrates desirable characteristics for in vivo labeling of Aβ plaques and it may be useful as a mol. imaging agent to study amyloidogenesis in the brain of living AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI2dGp5YDjNbVg90H21EOLACvtfcHk0ljThvaKUnLrlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslamsLo%253D&md5=80674965784bfb672f0050c624f16140</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903436-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903436-4%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DM.%2BP.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DZhuang%26aufirst%3DZ.%2BP.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DIMPY%253A%2520an%2520improved%2520thioflavin-T%2520derivative%2520for%2520in%2520vivo%2520labeling%2520of%2520%25CE%25B2-amyloid%2520plaques%26jtitle%3DBrain%2520Res.%26date%3D2002%26volume%3D956%26spage%3D202%26epage%3D210%26doi%3D10.1016%2FS0006-8993%2802%2903436-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cselenyi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span><span class="refDoi"> DOI: 10.2967/jnumed.112.114785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.112.114785" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=880-886&author=C.+C.+Roweauthor=S.+Pejoskaauthor=R.+S.+Mulliganauthor=G.+Jonesauthor=J.+G.+Chanauthor=S.+Svenssonauthor=Z.+Cselenyiauthor=C.+L.+Mastersauthor=V.+L.+Villemagne&title=Head-to-head+comparison+of+11C-PiB+and+18F-AZD4694+%28NAV4694%29+for+%CE%B2-amyloid+imaging+in+aging+and+dementia&doi=10.2967%2Fjnumed.112.114785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.114785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.114785%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DJ.%2BG.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DCselenyi%26aufirst%3DZ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DHead-to-head%2520comparison%2520of%252011C-PiB%2520and%252018F-AZD4694%2520%2528NAV4694%2529%2520for%2520%25CE%25B2-amyloid%2520imaging%2520in%2520aging%2520and%2520dementia%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D880%26epage%3D886%26doi%3D10.2967%2Fjnumed.112.114785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yousefi, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arzberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Reutern, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzezga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaiger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wester, H. J.</span><span> </span><span class="NLM_article-title">Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1021/cn5001827</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn5001827" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2MzlvFCntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=428-437&author=B.+H.+Yousefiauthor=A.+Manookauthor=T.+Grimmerauthor=T.+Arzbergerauthor=B.+von+Reuternauthor=G.+Henriksenauthor=A.+Drzezgaauthor=S.+Forsterauthor=M.+Schwaigerauthor=H.+J.+Wester&title=Characterization+and+first+human+investigation+of+FIBT%2C+a+novel+fluorinated+A%CE%B2+plaque+neuroimaging+PET+radioligand&doi=10.1021%2Fcn5001827"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span></div><div class="casAuthors">Yousefi Behrooz Hooshyar; Manook Andre; Grimmer Timo; Arzberger Thomas; von Reutern Boris; Henriksen Gjermund; Drzezga Alexander; Forster Stefan; Schwaiger Markus; Wester Hans-Jurgen; Yousefi Behrooz Hooshyar; Manook Andre; Grimmer Timo; Arzberger Thomas; von Reutern Boris; Henriksen Gjermund; Drzezga Alexander; Forster Stefan; Schwaiger Markus; Wester Hans-Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS chemical neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Imidazo[2,1-b]benzothiazoles (IBTs) are a promising novel class of amyloid positron emission tomography (PET) radiopharmaceuticals for diagnosis of neurodegenerative disorders like Alzheimer's disease (AD).  Their good in vivo imaging properties have previously been shown in preclinical studies.  Among IBTs, fluorinated [(18)F]FIBT was selected for further characterization and advancement toward use in humans. [(18)F]FIBT characteristics were analyzed in relation to Pittsburgh compound B (PiB) as reference ligand. [(18)F]FIBT and [(3)H]PiB were coinjected to an APP/PS1 mouse for ex vivo dual-label autoradiographic correlation.  Acute dose toxicity of FIBT was examined in two groups of healthy mice.  Preexisting in vivo stability and biodistribution studies in mice were complemented with analogous studies in rats. [(18)F]FIBT was titrated against postmortem human AD brain homogenate in a saturation binding assay previously performed with [(3)H]PiB.  Binding of [(18)F]FIBT to human AD brain was further analyzed by in vitro incubation of human AD brain sections in comparison to [(11)C]PiB in relation to standard immunohistochemistry.  Finally, [(18)F]FIBT was administered to two human subjects for a dynamic 90 min PET/MR brain investigation.  Ex vivo autoradiography confirmed good uptake of [(18)F]FIBT to mouse brain and its excellent correlation to [(3)H]PiB binding.  No toxicity of FIBT could be found in mice at a concentration of 33.3 nmol/kg.  As in mice, [(18)F]FIBT was showing high in vivo stability in rats and comparable regional brain biodistribution dynamics to [(3)H]PiB.  Radioligand saturation binding confirmed at least one high-affinity binding component of [(18)F]FIBT around 1 nM.  Good binding of FIBT relative to PiB was further confirmed in binding assays and autoradiographies using post-mortem AD brain.  First use of [(18)F]FIBT in humans successfully yielded clinical [(18)F]FIBT PET/MR images with very good contrast.  In summary, [(18)F]FIBT has been characterized to be a new lead compound with improved binding characteristics and pharmacokinetics on its own as well as in comparison to PiB.  A pilot human PET investigation provided high-quality images with a plausible tracer distribution pattern.  Detailed clinical investigations are needed to confirm these first results and to explore the specific qualities of [(18)F]FIBT PET for dementia imaging in relation to established ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzH6fM48tHLUNHe_gFldTbfW6udTcc2ebzA8obyaOtkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzlvFCntw%253D%253D&md5=7b45c9345ace413b3546e906c4c0dc58</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fcn5001827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn5001827%26sid%3Dliteratum%253Aachs%26aulast%3DYousefi%26aufirst%3DB.%2BH.%26aulast%3DManook%26aufirst%3DA.%26aulast%3DGrimmer%26aufirst%3DT.%26aulast%3DArzberger%26aufirst%3DT.%26aulast%3Dvon%2BReutern%26aufirst%3DB.%26aulast%3DHenriksen%26aufirst%3DG.%26aulast%3DDrzezga%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DS.%26aulast%3DSchwaiger%26aufirst%3DM.%26aulast%3DWester%26aufirst%3DH.%2BJ.%26atitle%3DCharacterization%2520and%2520first%2520human%2520investigation%2520of%2520FIBT%252C%2520a%2520novel%2520fluorinated%2520A%25CE%25B2%2520plaque%2520neuroimaging%2520PET%2520radioligand%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D428%26epage%3D437%26doi%3D10.1021%2Fcn5001827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senjem, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiung, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunter, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Neuroimaging, I. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer’s disease: implications for sequence of pathological events in Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.1093/brain/awp062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1093%2Fbrain%2Fawp062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2009&pages=1355-1365&author=C.+R.+Jackauthor=V.+J.+Loweauthor=S.+D.+Weigandauthor=H.+J.+Wisteauthor=M.+L.+Senjemauthor=D.+S.+Knopmanauthor=M.+M.+Shiungauthor=J.+L.+Gunterauthor=B.+F.+Boeveauthor=B.+J.+Kempauthor=M.+Weinerauthor=R.+C.+Petersen&title=Alzheimer%E2%80%99s+Disease+Neuroimaging%2C+I.+Serial+PIB+and+MRI+in+normal%2C+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease%3A+implications+for+sequence+of+pathological+events+in+Alzheimer%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawp062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawp062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawp062%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DLowe%26aufirst%3DV.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DSenjem%26aufirst%3DM.%2BL.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DShiung%26aufirst%3DM.%2BM.%26aulast%3DGunter%26aufirst%3DJ.%2BL.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DKemp%26aufirst%3DB.%2BJ.%26aulast%3DWeiner%26aufirst%3DM.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Neuroimaging%252C%2520I.%2520Serial%2520PIB%2520and%2520MRI%2520in%2520normal%252C%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520implications%2520for%2520sequence%2520of%2520pathological%2520events%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2009%26volume%3D132%26spage%3D1355%26epage%3D1365%26doi%3D10.1093%2Fbrain%2Fawp062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larossa, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheline, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dence, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span><span class="refDoi"> DOI: 10.1212/01.wnl.0000228230.26044.a4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.wnl.0000228230.26044.a4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=446-452&author=M.+A.+Mintunauthor=G.+N.+Larossaauthor=Y.+I.+Shelineauthor=C.+S.+Denceauthor=S.+Y.+Leeauthor=R.+H.+Machauthor=W.+E.+Klunkauthor=C.+A.+Mathisauthor=S.+T.+DeKoskyauthor=J.+C.+Morris&title=%5B11C%5DPIB+in+a+nondemented+population%3A+potential+antecedent+marker+of+Alzheimer+disease&doi=10.1212%2F01.wnl.0000228230.26044.a4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000228230.26044.a4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000228230.26044.a4%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DLarossa%26aufirst%3DG.%2BN.%26aulast%3DSheline%26aufirst%3DY.%2BI.%26aulast%3DDence%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DS.%2BY.%26aulast%3DMach%26aufirst%3DR.%2BH.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26atitle%3D%255B11C%255DPIB%2520in%2520a%2520nondemented%2520population%253A%2520potential%2520antecedent%2520marker%2520of%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26spage%3D446%26epage%3D452%26doi%3D10.1212%2F01.wnl.0000228230.26044.a4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Aizenstein, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebes, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsopelas, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziolko, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snitz, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houck, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halligan, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Frequent amyloid deposition without significant cognitive impairment among the elderly</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1509</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span><span class="refDoi"> DOI: 10.1001/archneur.65.11.1509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1001%2Farchneur.65.11.1509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19001171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjt1Crtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1509-1517&author=H.+J.+Aizensteinauthor=R.+D.+Nebesauthor=J.+A.+Saxtonauthor=J.+C.+Priceauthor=C.+A.+Mathisauthor=N.+D.+Tsopelasauthor=S.+K.+Ziolkoauthor=J.+A.+Jamesauthor=B.+E.+Snitzauthor=P.+R.+Houckauthor=W.+Biauthor=A.+D.+Cohenauthor=B.+J.+Loprestiauthor=S.+T.+DeKoskyauthor=E.+M.+Halliganauthor=W.+E.+Klunk&title=Frequent+amyloid+deposition+without+significant+cognitive+impairment+among+the+elderly&doi=10.1001%2Farchneur.65.11.1509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent amyloid deposition without significant cognitive impairment among the elderly</span></div><div class="casAuthors">Aizenstein Howard Jay; Nebes Robert D; Saxton Judith A; Price Julie C; Mathis Chester A; Tsopelas Nicholas D; Ziolko Scott K; James Jeffrey A; Snitz Beth E; Houck Patricia R; Bi Wenzhu; Cohen Ann D; Lopresti Brian J; DeKosky Steven T; Halligan Edythe M; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1509-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To characterize the prevalence of amyloid deposition in a clinically unimpaired elderly population, as assessed by Pittsburgh Compound B (PiB) positron emission tomography (PET) imaging, and its relationship to cognitive function, measured with a battery of neuropsychological tests.  DESIGN:  Subjects underwent cognitive testing and PiB PET imaging (15 mCi for 90 minutes with an ECAT HR+ scanner).  Logan graphical analysis was applied to estimate regional PiB retention distribution volume, normalized to a cerebellar reference region volume, to yield distribution volume ratios (DVRs).  SETTING:  University medical center.  PARTICIPANTS:  From a community-based sample of volunteers, 43 participants aged 65 to 88 years who did not meet diagnostic criteria for Alzheimer disease or mild cognitive impairment were included.  MAIN OUTCOME MEASURES:  Regional PiB retention and cognitive test performance.  RESULTS:  Of 43 clinically unimpaired elderly persons imaged, 9 (21%) showed evidence of early amyloid deposition in at least 1 brain area using an objectively determined DVR cutoff.  Demographic characteristics did not differ significantly between amyloid-positive and amyloid-negative participants, and neurocognitive performance was not significantly worse among amyloid-positive compared with amyloid-negative participants.  CONCLUSIONS:  Amyloid deposition can be identified among cognitively normal elderly persons during life, and the prevalence of asymptomatic amyloid deposition may be similar to that of symptomatic amyloid deposition.  In this group of participants without clinically significant impairment, amyloid deposition was not associated with worse cognitive function, suggesting that an elderly person with a significant amyloid burden can remain cognitively normal.  However, this finding is based on relatively small numbers and needs to be replicated in larger cohorts.  Longitudinal follow-up of these subjects will be required to support the potential of PiB imaging to identify preclinical Alzheimer disease, or, alternatively, to show that amyloid deposition is not sufficient to cause Alzheimer disease within some specified period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrc8iIT-fqA-b6AVA-44PTfW6udTcc2ebbJsMUfyBV1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjt1Crtg%253D%253D&md5=a583c1fce52c4ee0a7851f3fb1a98a7f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1001%2Farchneur.65.11.1509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.65.11.1509%26sid%3Dliteratum%253Aachs%26aulast%3DAizenstein%26aufirst%3DH.%2BJ.%26aulast%3DNebes%26aufirst%3DR.%2BD.%26aulast%3DSaxton%26aufirst%3DJ.%2BA.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DTsopelas%26aufirst%3DN.%2BD.%26aulast%3DZiolko%26aufirst%3DS.%2BK.%26aulast%3DJames%26aufirst%3DJ.%2BA.%26aulast%3DSnitz%26aufirst%3DB.%2BE.%26aulast%3DHouck%26aufirst%3DP.%2BR.%26aulast%3DBi%26aufirst%3DW.%26aulast%3DCohen%26aufirst%3DA.%2BD.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DHalligan%26aufirst%3DE.%2BM.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DFrequent%2520amyloid%2520deposition%2520without%2520significant%2520cognitive%2520impairment%2520among%2520the%2520elderly%26jtitle%3DArch.%2520Neurol.%26date%3D2008%26volume%3D65%26spage%3D1509%26epage%3D1517%26doi%3D10.1001%2Farchneur.65.11.1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1038/nrd2896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1038%2Fnrd2896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20431570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification&doi=10.1038%2Fnrd2896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: strategies for disease modification</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the largest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  However, in recent years, several approaches aimed at inhibiting disease progression have advanced to clin. trials.  Among these, strategies targeting the prodn. and clearance of the amyloid-β peptide - a cardinal feature of Alzheimer's disease that is thought to be important in disease pathogenesis - are the most advanced.  Approaches aimed at modulating the abnormal aggregation of tau filaments (another key feature of the disease), and those targeting metabolic dysfunction, are also being evaluated in the clinic.  This article discusses recent progress with each of these strategies, with a focus on anti-amyloid strategies, highlighting the lessons learned and the challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM0fsdJQ-z7Vg90H21EOLACvtfcHk0lieGripa7ZSwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D&md5=281ba27137d2a1fa173d5dde1dcbe772</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd2896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2896%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398%26doi%3D10.1038%2Fnrd2896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Sting of Alzheimer’s failures offset by upcoming prevention trials</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">660</span><span class="refDoi"> DOI: 10.1038/nrd3842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1038%2Fnrd3842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=657-660&author=A.+Mullard&title=Sting+of+Alzheimer%E2%80%99s+failures+offset+by+upcoming+prevention+trials&doi=10.1038%2Fnrd3842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnrd3842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3842%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DSting%2520of%2520Alzheimer%25E2%2580%2599s%2520failures%2520offset%2520by%2520upcoming%2520prevention%2520trials%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D657%26epage%3D660%26doi%3D10.1038%2Fnrd3842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gilman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovira, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forette, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orgogozo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Team, A. N. S.</span><span> </span><span class="NLM_article-title">Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1553</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1212/01.WNL.0000159740.16984.3C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.WNL.0000159740.16984.3C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=1553-1562&author=S.+Gilmanauthor=M.+Kollerauthor=R.+S.+Blackauthor=L.+Jenkinsauthor=S.+G.+Griffithauthor=N.+C.+Foxauthor=L.+Eisnerauthor=L.+Kirbyauthor=M.+B.+Roviraauthor=F.+Foretteauthor=J.+M.+Orgogozoauthor=A.+N.+S.+Team&title=Clinical+effects+of+A%CE%B2+immunization+%28AN1792%29+in+patients+with+AD+in+an+interrupted+trial&doi=10.1212%2F01.WNL.0000159740.16984.3C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1212%2F01.WNL.0000159740.16984.3C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.WNL.0000159740.16984.3C%26sid%3Dliteratum%253Aachs%26aulast%3DGilman%26aufirst%3DS.%26aulast%3DKoller%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DR.%2BS.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DGriffith%26aufirst%3DS.%2BG.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DEisner%26aufirst%3DL.%26aulast%3DKirby%26aufirst%3DL.%26aulast%3DRovira%26aufirst%3DM.%2BB.%26aulast%3DForette%26aufirst%3DF.%26aulast%3DOrgogozo%26aufirst%3DJ.%2BM.%26aulast%3DTeam%26aufirst%3DA.%2BN.%2BS.%26atitle%3DClinical%2520effects%2520of%2520A%25CE%25B2%2520immunization%2520%2528AN1792%2529%2520in%2520patients%2520with%2520AD%2520in%2520an%2520interrupted%2520trial%26jtitle%3DNeurology%26date%3D2005%26volume%3D64%26spage%3D1553%26epage%3D1562%26doi%3D10.1212%2F01.WNL.0000159740.16984.3C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boche, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadegarfar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neal, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zotova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. A.</span><span> </span><span class="NLM_article-title">Long-term effects of Aβ<sub>42</sub> immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1016/S0140-6736(08)61075-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS0140-6736%2808%2961075-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=18640458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=216-223&author=C.+Holmesauthor=D.+Bocheauthor=D.+Wilkinsonauthor=G.+Yadegarfarauthor=V.+Hopkinsauthor=A.+Bayerauthor=R.+W.+Jonesauthor=R.+Bullockauthor=S.+Loveauthor=J.+W.+Nealauthor=E.+Zotovaauthor=J.+A.+Nicoll&title=Long-term+effects+of+A%CE%B242+immunisation+in+Alzheimer%E2%80%99s+disease%3A+follow-up+of+a+randomised%2C+placebo-controlled+phase+I+trial&doi=10.1016%2FS0140-6736%2808%2961075-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term effects of Aβ42 immunization in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial</span></div><div class="casAuthors">Holmes, Clive; Boche, Delphine; Wilkinson, David; Yadegarfar, Ghasem; Hopkins, Vivienne; Bayer, Anthony; Jones, Roy W.; Bullock, Roger; Love, Seth; Neal, James W.; Zotova, Elina; Nicoll, James A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">9634</span>),
    <span class="NLM_cas:pages">216-223</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Immunization of patients with Alzheimer's disease with full-length amyloid-β peptide (Aβ42) can clear amyloid plaques from the brain.  Our aim was to assess the relation between Aβ42 immune response, degree of plaque removal, and long-term clin. outcomes.  In June, 2003, consent for long-term clin. follow-up, post-mortem neuropathol. examn., or both, was sought from 80 patients (or their carers) who had entered a phase I randomized, placebo-controlled trial of immunization with Aβ42 (AN1792, Elan Pharmaceuticals) in Sept., 2000.  The follow-up study was completed in Sept., 2006.  Plaques were assessed in terms of the percentage area of the cortex with Aβ immunostaining (Aβ load) and in terms of characteristic histol. features reflecting plaque removal.  Survival of all 80 individuals until severe dementia or death was assessed with a Cox proportional hazard model.  Twenty participants-15 in the AN1792 group, five in the placebo group-died before follow-up started.  A further 22 patients-19 in the AN1792 group, three in the placebo group-died during follow-up.  Nine of the deceased patients, all in the AN1792 group, had given consent for post-mortem anal.; one of these who did not die with Alzheimer's disease was excluded.  In the remaining eight participants who received immunization and who were examd. neuropathol., mean Aβ load was lower than in an unimmunized control group that was matched for age at death (2.1% [SE 0.7] in treated participants vs 5.1% [0.9] in controls; mean difference 3.0%, 95% CI 0.6-5.4; p=0.02).  Although there was considerable variation in Aβ load and degree of plaque removal among immunized participants, the degree of plaque removal varied significantly with mean antibody response attained during the treatment study period (Kruskal-Wallis p=0.02).  Seven of the eight immunized patients who underwent post-mortem assessment, including those with virtually complete plaque removal, had severe end stage dementia before death.  In the whole cohort, there was no evidence of improved survival (hazard ratio 0.93, 95% CI 0.43-3.11; p=0.86) or of an improvement in the time to severe dementia (1.18, 0.45-3.11; p=0.73) in the AN1792 group vs. the placebo group.  Although immunization with Aβ42 resulted in clearance of amyloid plaques in patients with Alzheimer's disease, this clearance did not prevent progressive neurodegeneration.  Alzheimer's Research Trust, Medical Research Council.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUUUTVhBpFGbVg90H21EOLACvtfcHk0lggGUtk489kyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslWkt74%253D&md5=df6930a3270378deacfe5ee43f3f155f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2808%2961075-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252808%252961075-2%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DBoche%26aufirst%3DD.%26aulast%3DWilkinson%26aufirst%3DD.%26aulast%3DYadegarfar%26aufirst%3DG.%26aulast%3DHopkins%26aufirst%3DV.%26aulast%3DBayer%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DR.%2BW.%26aulast%3DBullock%26aufirst%3DR.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DNeal%26aufirst%3DJ.%2BW.%26aulast%3DZotova%26aufirst%3DE.%26aulast%3DNicoll%26aufirst%3DJ.%2BA.%26atitle%3DLong-term%2520effects%2520of%2520A%25CE%25B242%2520immunisation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520follow-up%2520of%2520a%2520randomised%252C%2520placebo-controlled%2520phase%2520I%2520trial%26jtitle%3DLancet%26date%3D2008%26volume%3D372%26spage%3D216%26epage%3D223%26doi%3D10.1016%2FS0140-6736%2808%2961075-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankratz, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2FS1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2FS1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0lj-ieqVj_i4qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderstichele, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapik-Czajka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewczuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Neuroimaging, I. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1002/ana.21610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.21610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19296504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=403-413&author=L.+M.+Shawauthor=H.+Vandersticheleauthor=M.+Knapik-Czajkaauthor=C.+M.+Clarkauthor=P.+S.+Aisenauthor=R.+C.+Petersenauthor=K.+Blennowauthor=H.+Soaresauthor=A.+Simonauthor=P.+Lewczukauthor=R.+Deanauthor=E.+Siemersauthor=W.+Potterauthor=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Alzheimer%E2%80%99s+Disease+Neuroimaging%2C+I.+Cerebrospinal+fluid+biomarker+signature+in+Alzheimer%E2%80%99s+disease+neuroimaging+initiative+subjects&doi=10.1002%2Fana.21610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects</span></div><div class="casAuthors">Shaw, Leslie M.; Vanderstichele, Hugo; Knapik-Czajka, Malgorzata; Clark, Christopher M.; Aisen, Paul S.; Petersen, Ronald C.; Blennow, Kaj; Soares, Holly; Simon, Adam; Lewczuk, Piotr; Dean, Robert; Siemers, Eric; Potter, William; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Develop a cerebrospinal fluid biomarker signature for mild Alzheimer's disease (AD) in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects.  Amyloid-β 1 to 42 peptide (Aβ1-42), total tau (t-tau), and tau phosphorylated at the threonine 181 were measured in (1) cerebrospinal fluid (CSF) samples obtained during baseline evaluation of 100 mild AD, 196 mild cognitive impairment, and 114 elderly cognitively normal (NC) subjects in ADNI; and (2) independent 56 autopsy-confirmed AD cases and 52 age-matched elderly NCs using a multiplex immunoassay.  Detection of an AD CSF profile for t-tau and Aβ1-42 in ADNI subjects was achieved using receiver operating characteristic cut points and logistic regression models derived from the autopsy-confirmed CSF data.  CSF Aβ1-42 was the most sensitive biomarker for AD in the autopsy cohort of CSF samples: receiver operating characteristic area under the curve of 0.913 and sensitivity for AD detection of 96.4%.  In the ADNI cohort, a logistic regression model for Aβ1-42, t-tau, and APOε4 allele count provided the best assessment delineation of mild AD.  An AD-like baseline CSF profile for t-tau/Aβ1-42 was detected in 33 of 37 ADNI mild cognitive impairment subjects who converted to probable AD during the first year of the study.  The CSF biomarker signature of AD defined by Aβ1-42 and t-tau in the autopsy-confirmed AD cohort and confirmed in the cohort followed in ADNI for 12 mo detects mild AD in a large, multisite, prospective clin. investigation, and this signature appears to predict conversion from mild cognitive impairment to AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-txCTOcg12LVg90H21EOLACvtfcHk0lj-ieqVj_i4qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVylsLY%253D&md5=de148229e43926670d8a56f9b020039a</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fana.21610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21610%26sid%3Dliteratum%253Aachs%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVanderstichele%26aufirst%3DH.%26aulast%3DKnapik-Czajka%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DSoares%26aufirst%3DH.%26aulast%3DSimon%26aufirst%3DA.%26aulast%3DLewczuk%26aufirst%3DP.%26aulast%3DDean%26aufirst%3DR.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Neuroimaging%252C%2520I.%2520Cerebrospinal%2520fluid%2520biomarker%2520signature%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520neuroimaging%2520initiative%2520subjects%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D65%26spage%3D403%26epage%3D413%26doi%3D10.1002%2Fana.21610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eaCEFS7f1k6R7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sergeant, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wattez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermersch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghozali, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallet-Bianco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Menza, C.</span><span> </span><span class="NLM_article-title">The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span><span class="refDoi"> DOI: 10.1212/WNL.52.6.1158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2FWNL.52.6.1158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=1158-1165&author=A.+Delacourteauthor=J.+P.+Davidauthor=N.+Sergeantauthor=L.+Bueeauthor=A.+Wattezauthor=P.+Vermerschauthor=F.+Ghozaliauthor=C.+Fallet-Biancoauthor=F.+Pasquierauthor=F.+Lebertauthor=H.+Petitauthor=C.+Di+Menza&title=The+biochemical+pathway+of+neurofibrillary+degeneration+in+aging+and+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.52.6.1158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1212%2FWNL.52.6.1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.52.6.1158%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DDavid%26aufirst%3DJ.%2BP.%26aulast%3DSergeant%26aufirst%3DN.%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DWattez%26aufirst%3DA.%26aulast%3DVermersch%26aufirst%3DP.%26aulast%3DGhozali%26aufirst%3DF.%26aulast%3DFallet-Bianco%26aufirst%3DC.%26aulast%3DPasquier%26aufirst%3DF.%26aulast%3DLebert%26aufirst%3DF.%26aulast%3DPetit%26aufirst%3DH.%26aulast%3DDi%2BMenza%26aufirst%3DC.%26atitle%3DThe%2520biochemical%2520pathway%2520of%2520neurofibrillary%2520degeneration%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1999%26volume%3D52%26spage%3D1158%26epage%3D1165%26doi%3D10.1212%2FWNL.52.6.1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollister, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1002/ana.410410106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1002%2Fana.410410106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=9005861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADyaK2s7lvVGjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=17-24&author=T.+Gomez-Islaauthor=R.+Hollisterauthor=H.+Westauthor=S.+Muiauthor=J.+H.+Growdonauthor=R.+C.+Petersenauthor=J.+E.+Parisiauthor=B.+T.+Hyman&title=Neuronal+loss+correlates+with+but+exceeds+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fana.410410106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease</span></div><div class="casAuthors">Gomez-Isla T; Hollister R; West H; Mui S; Growdon J H; Petersen R C; Parisi J E; Hyman B T</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">To assess the relationship between dementia, neuronal loss, and neuropathological findings in Alzheimer's disease (AD), we counted the number of neurons, senile plaques, and neurofibrillary tangles in a high-order association cortex.  We studied the superior temporal sulcus of 34 individuals with AD and 17 nondemented control subjects, using statistically unbiased, stereological counting techniques.  The number of superior temporal sulcus neurons in nondemented control subjects was stable across the sixth to ninth decades.  In AD, more than 50% of the neurons were lost.  Both neuronal loss and neurofibrillary tangles increased in parallel with the duration and severity of illness, but the amount of neuronal loss exceeded by manyfold the amount of neurofibrillary tangles accumulated.  In contrast to the correlation between neurofibrillary tangles and neuronal loss, the number of senile plaques and the percentage of the superior temporal sulcus that was covered by Abeta (amyloid burden) were not related to neuronal loss, number of neurofibrillary tangles, or duration of disease.  Neither the amount nor the rate of neuronal loss in the superior temporal sulcus in AD correlated with apolipoprotein E genotype.  These data suggest that neuronal loss in association areas such as the superior temporal sulcus contributes directly to cognitive impairment in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRb4pZx19FriEh5eUSa2oe_fW6udTcc2eaCEFS7f1k6R7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s7lvVGjsw%253D%253D&md5=77d2cb983d20b2a7cfe60426e4f55a50</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fana.410410106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410410106%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Isla%26aufirst%3DT.%26aulast%3DHollister%26aufirst%3DR.%26aulast%3DWest%26aufirst%3DH.%26aulast%3DMui%26aufirst%3DS.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeuronal%2520loss%2520correlates%2520with%2520but%2520exceeds%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D1997%26volume%3D41%26spage%3D17%26epage%3D24%26doi%3D10.1002%2Fana.410410106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nelson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafuzoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulette, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltjer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span> </span><span class="NLM_article-title">Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1097/NEN.0b013e31825018f7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1097%2FNEN.0b013e31825018f7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22487856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=362-381&author=P.+T.+Nelsonauthor=I.+Alafuzoffauthor=E.+H.+Bigioauthor=C.+Bourasauthor=H.+Braakauthor=N.+J.+Cairnsauthor=R.+J.+Castellaniauthor=B.+J.+Crainauthor=P.+Daviesauthor=K.+Del+Trediciauthor=C.+Duyckaertsauthor=M.+P.+Froschauthor=V.+Haroutunianauthor=P.+R.+Hofauthor=C.+M.+Huletteauthor=B.+T.+Hymanauthor=T.+Iwatsuboauthor=K.+A.+Jellingerauthor=G.+A.+Jichaauthor=E.+Kovariauthor=W.+A.+Kukullauthor=J.+B.+Leverenzauthor=S.+Loveauthor=I.+R.+Mackenzieauthor=D.+M.+Mannauthor=E.+Masliahauthor=A.+C.+McKeeauthor=T.+J.+Montineauthor=J.+C.+Morrisauthor=J.+A.+Schneiderauthor=J.+A.+Sonnenauthor=D.+R.+Thalauthor=J.+Q.+Trojanowskiauthor=J.+C.+Troncosoauthor=T.+Wisniewskiauthor=R.+L.+Woltjerauthor=T.+G.+Beach&title=Correlation+of+Alzheimer+disease+neuropathologic+changes+with+cognitive+status%3A+a+review+of+the+literature&doi=10.1097%2FNEN.0b013e31825018f7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Alzheimer disease neuropathologic changes with cognitive status:  a review of the literature</span></div><div class="casAuthors">Nelson Peter T; Alafuzoff Irina; Bigio Eileen H; Bouras Constantin; Braak Heiko; Cairns Nigel J; Castellani Rudolph J; Crain Barbara J; Davies Peter; Del Tredici Kelly; Duyckaerts Charles; Frosch Matthew P; Haroutunian Vahram; Hof Patrick R; Hulette Christine M; Hyman Bradley T; Iwatsubo Takeshi; Jellinger Kurt A; Jicha Gregory A; Kovari Eniko; Kukull Walter A; Leverenz James B; Love Seth; Mackenzie Ian R; Mann David M; Masliah Eliezer; McKee Ann C; Montine Thomas J; Morris John C; Schneider Julie A; Sonnen Joshua A; Thal Dietmar R; Trojanowski John Q; Troncoso Juan C; Wisniewski Thomas; Woltjer Randall L; Beach Thomas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research.  Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations.  Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes.  Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD.  Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways.  We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment.  We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles.  Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfBiLIW6MJ0v9pSBfyDvp7fW6udTcc2eZx7QHagou28bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D&md5=172e31ea54410212b1d60f7ff6f1d4d6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31825018f7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31825018f7%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DP.%2BT.%26aulast%3DAlafuzoff%26aufirst%3DI.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DCrain%26aufirst%3DB.%2BJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DHulette%26aufirst%3DC.%2BM.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DKovari%26aufirst%3DE.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DMackenzie%26aufirst%3DI.%2BR.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DSonnen%26aufirst%3DJ.%2BA.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26atitle%3DCorrelation%2520of%2520Alzheimer%2520disease%2520neuropathologic%2520changes%2520with%2520cognitive%2520status%253A%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D362%26epage%3D381%26doi%3D10.1097%2FNEN.0b013e31825018f7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Whitwell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephs, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarci, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przybelski, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senjem, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span> </span><span class="NLM_article-title">MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1212/01.wnl.0000324924.91351.7d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1212%2F01.wnl.0000324924.91351.7d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=743-749&author=J.+L.+Whitwellauthor=K.+A.+Josephsauthor=M.+E.+Murrayauthor=K.+Kantarciauthor=S.+A.+Przybelskiauthor=S.+D.+Weigandauthor=P.+Vemuriauthor=M.+L.+Senjemauthor=J.+E.+Parisiauthor=D.+S.+Knopmanauthor=B.+F.+Boeveauthor=R.+C.+Petersenauthor=D.+W.+Dicksonauthor=C.+R.+Jack&title=MRI+correlates+of+neurofibrillary+tangle+pathology+at+autopsy%3A+a+voxel-based+morphometry+study&doi=10.1212%2F01.wnl.0000324924.91351.7d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1212%2F01.wnl.0000324924.91351.7d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252F01.wnl.0000324924.91351.7d%26sid%3Dliteratum%253Aachs%26aulast%3DWhitwell%26aufirst%3DJ.%2BL.%26aulast%3DJosephs%26aufirst%3DK.%2BA.%26aulast%3DMurray%26aufirst%3DM.%2BE.%26aulast%3DKantarci%26aufirst%3DK.%26aulast%3DPrzybelski%26aufirst%3DS.%2BA.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DSenjem%26aufirst%3DM.%2BL.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DJack%26aufirst%3DC.%2BR.%26atitle%3DMRI%2520correlates%2520of%2520neurofibrillary%2520tangle%2520pathology%2520at%2520autopsy%253A%2520a%2520voxel-based%2520morphometry%2520study%26jtitle%3DNeurology%26date%3D2008%26volume%3D71%26spage%3D743%26epage%3D749%26doi%3D10.1212%2F01.wnl.0000324924.91351.7d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using <sup>18</sup>F-THK5105 PET</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span><span class="refDoi"> DOI: 10.1093/brain/awu064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1093%2Fbrain%2Fawu064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24681664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC2cros1Oisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=1762-1771&author=N.+Okamuraauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=R.+Haradaauthor=P.+Yatesauthor=S.+Pejoskaauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=V.+L.+Villemagne&title=Non-invasive+assessment+of+Alzheimer%E2%80%99s+disease+neurofibrillary+pathology+using+18F-THK5105+PET&doi=10.1093%2Fbrain%2Fawu064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Fodero-Tavoletti Michelle T; Villemagne Victor L; Mulligan Rachel S; Yates Paul; Pejoska Svetlana; Rowe Christopher C; Kudo Yukitsuka; Masters Colin L; Yanai Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">Pt 6</span>),
    <span class="NLM_cas:pages">1762-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Non-invasive imaging of tau pathology in the living brain would be useful for accurately diagnosing Alzheimer's disease, tracking disease progression, and evaluating the treatment efficacy of disease-specific therapeutics.  In this study, we evaluated the clinical usefulness of a novel tau-imaging positron emission tomography tracer 18F-THK5105 in 16 human subjects including eight patients with Alzheimer's disease (three male and five females, 66-82 years) and eight healthy elderly controls (three male and five females, 63-76 years).  All participants underwent neuropsychological examination and 3D magnetic resonance imaging, as well as both 18F-THK5105 and 11C-Pittsburgh compound B positron emission tomography scans.  Standard uptake value ratios at 90-100 min and 40-70 min post-injection were calculated for 18F-THK5105 and 11C-Pittsburgh compound B, respectively, using the cerebellar cortex as the reference region.  As a result, significantly higher 18F-THK5105 retention was observed in the temporal, parietal, posterior cingulate, frontal and mesial temporal cortices of patients with Alzheimer's disease compared with healthy control subjects.  In patients with Alzheimer's disease, the inferior temporal cortex, which is an area known to contain high densities of neurofibrillary tangles in the Alzheimer's disease brain, showed prominent 18F-THK5105 retention.  Compared with high frequency (100%) of 18F-THK5105 retention in the temporal cortex of patients with Alzheimer's disease, frontal 18F-THK5105 retention was less frequent (37.5%) and was only observed in cases with moderate-to-severe Alzheimer's disease.  In contrast, 11C-Pittsburgh compound B retention was highest in the posterior cingulate cortex, followed by the ventrolateral prefrontal, anterior cingulate, and superior temporal cortices, and did not correlate with 18F-THK5105 retention in the neocortex.  In healthy control subjects, 18F-THK5105 retention was ∼10% higher in the mesial temporal cortex than in the neocortex.  Notably, unlike 11C-Pittsburgh compound B, 18F-THK5105 retention was significantly correlated with cognitive parameters, hippocampal and whole brain grey matter volumes, which was consistent with findings from previous post-mortem studies showing significant correlations of neurofibrillary tangle density with dementia severity or neuronal loss.  From these results, 18F-THK5105 positron emission tomography is considered to be useful for the non-invasive assessment of tau pathology in the living brain.  This technique would be applicable to the longitudinal evaluation of tau deposition and allow a better understanding of the pathophysiology of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSG1J2RMpsyPH6HPRus0rAafW6udTcc2eY7iCneNWFXBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cros1Oisw%253D%253D&md5=a04efc4d12888ed003006d4868a183af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu064%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DNon-invasive%2520assessment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520pathology%2520using%252018F-THK5105%2520PET%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D1762%26epage%3D1771%26doi%3D10.1093%2Fbrain%2Fawu064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.2967/jnumed.112.117341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.112.117341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23857514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.112.117341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Furumoto, Shozo; Harada, Ryuichi; Tago, Tetsuro; Yoshikawa, Takeo; Fodero-Tavoletti, Michelle; Mulligan, Rachel S.; Villemagne, Victor L.; Akatsu, Hiroyasu; Yamamoto, Takayuki; Arai, Hiroyuki; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1420-1427</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Neurofibrillary tangles in Alzheimer disease (AD) brains are composed of the microtubule-assocd. protein tau.  Noninvasive monitoring of tau protein aggregates in the living brain will provide useful information regarding tau pathophysiol. in AD.  However, no PET probes are currently available for selective detection of tau pathol. in AD.  We have previously reported 18F-labeled THK-523 (18F-6-(2-fluoroethoxy)-2-(4-aminophenyl)quinoline) as a tau imaging radiotracer candidate for PET.  After compd. optimization, we developed novel 18F-labeled arylquinoline derivs., 18F-THK-5105 and 18F-THK-5117, for use as tau imaging PET tracers.  Methods: 18F-labeled compds. were prepd. from the corresponding tosylated precursors.  The binding affinity of compds. to synthetic tau aggregates and tau-rich AD brain homogenates was detd. by satn. and competition binding assays.  The binding selectivity of compds. to tau pathol. was evaluated by autoradiog. of AD brain sections.  The pharmacokinetics of compds. were assessed in biodistribution studies in normal mice.  A 14-d toxicity study with i.v. administration of compds. was performed using rats and mice.  Results: In vitro binding assays demonstrated higher binding affinity of THK-5105 and THK-5117 than THK-523 to tau protein aggregates and tau-rich AD brain homogenates.  Autoradiog. analyses of AD brain sections showed that these radiotracers preferentially bound to neurofibrillary tangles and neuropil threads, which colocalized with Gallyas-pos. and immunoreactive tau protein deposits.  The distribution of this radiotracer binding in AD brain sections was completely different from that of 11C-Pittsburgh compd. B, showing preferential binding to amyloid plaques.  Furthermore, these derivs. demonstrated abundant initial brain uptake and faster clearance in normal mice than 18F-THK-523 and other reported 18F-labeled radiotracers.  THK-5105 and THK-5117 showed no toxic effects related to the administration of these compds. in mice and rats and no significant binding for various neuroreceptors, ion channels, and transporters at 1-μM concns.  Conclusion: 18F-labeled THK-5105 and THK-5117 are promising candidates as PET tau imaging radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmleWUvjowbVg90H21EOLACvtfcHk0ljtcz1Z6eQY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L&md5=58ac191b3581c5e4896b999343b6a193</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.117341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.117341%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427%26doi%3D10.2967%2Fjnumed.112.117341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1007/s00259-015-3035-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00259-015-3035-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=25792456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1052-1061&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=%5B18F%5DTHK-5117+PET+for+assessing+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-015-3035-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-1061</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia.  The purpose of the study was to evaluate the clin. utility of [18F]THK-5117 as a highly selective tau imaging radiotracer.  Methods: We initially evaluated in vitro binding of [3H]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD).  In clin. PET studies, [18F]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls.  Ten subjects underwent an addnl. [11C]PiB PET scan within 2 wk.  Results: In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB.  In clin. PET studies, [18F]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects.  Compared with [11C]PiB, [18F]THK-5117 retention was higher in the medial temporal cortex.  Conclusion: These findings suggest that [18F]THK-5117 provides regional information on neurofibrillary pathol. in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZcAg2f1webVg90H21EOLACvtfcHk0ljtcz1Z6eQY3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D&md5=4c35d238f7026cb33833f28549e760d5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3035-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3035-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D%255B18F%255DTHK-5117%2520PET%2520for%2520assessing%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D42%26spage%3D1052%26epage%3D1061%26doi%3D10.1007%2Fs00259-015-3035-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Xia, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.+F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eZQ9pO52vOelbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.%2BF.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3s3hsVOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.+Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF-18%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span></div><div class="casAuthors">Chien David T; Bahri Shadfar; Szardenings A Katrin; Walsh Joseph C; Mu Fanrong; Su Min-Ying; Shankle William R; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomography imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPDlccQmubRwpJitSxOdIlfW6udTcc2eZQ9pO52vOelbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3hsVOktQ%253D%253D&md5=6fd50cd6fbcc8578092f72d5233e9ff4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.%2BY.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF-18%255D-T807%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+K.+Szardeningsauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.+Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2ea_Uk1wCeIU77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.%2BY.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC38jgtl2hsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies&doi=10.3233%2FJAD-2012-120712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang Wei; Arteaga Janna; Cashion Daniel K; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Szardenings A Katrin; Wang Eric; Walsh Joseph C; Xia Chunfang; Yu Chul; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathological hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a number of amyloid-β positron emission tomography (PET) tracers currently in different stages of clinical development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compounds utilizing a unique screening process.  A competitive autoradiography assay was set up to test compounds for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compound [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclinical in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSE6tDb3P-XJTEwO064Z95rfW6udTcc2ea_Uk1wCeIU77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jgtl2hsw%253D%253D&md5=d9dbcbe1d4c18000898c61615faa1be0</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612%26doi%3D10.3233%2FJAD-2012-120712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.+R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.+K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0lgPKBPXC6QiQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.%2BK.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujishiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span> </span><span class="NLM_article-title">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of <sup>11</sup>C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span><span class="refDoi"> DOI: 10.2967/jnumed.114.139550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.2967%2Fjnumed.114.139550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=24963128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1532-1538&author=H.+Hashimotoauthor=K.+Kawamuraauthor=N.+Igarashiauthor=M.+Takeiauthor=T.+Fujishiroauthor=Y.+Aiharaauthor=S.+Shiomiauthor=M.+Mutoauthor=T.+Itoauthor=K.+Furutsukaauthor=T.+Yamasakiauthor=J.+Yuiauthor=L.+Xieauthor=M.+Onoauthor=A.+Hatoriauthor=K.+Nemotoauthor=T.+Suharaauthor=M.+Higuchiauthor=M.+R.+Zhang&title=Radiosynthesis%2C+photoisomerization%2C+biodistribution%2C+and+metabolite+analysis+of+11C-PBB3+as+a+clinically+useful+PET+probe+for+imaging+of+tau+pathology&doi=10.2967%2Fjnumed.114.139550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span></div><div class="casAuthors">Hashimoto, Hiroki; Kawamura, Kazunori; Igarashi, Nobuyuki; Takei, Makoto; Fujishiro, Tomoya; Aihara, Yoshiharu; Shiomi, Satoshi; Muto, Masatoshi; Ito, Takehito; Furutsuka, Kenji; Yamasaki, Tomoteru; Yui, Joji; Xie, Lin; Ono, Maiko; Hatori, Akiko; Nemoto, Kazuyoshi; Suhara, Tetsuya; Higuchi, Makoto; Zhang, Ming-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1532-1538</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol (11C-PBB3) is a clin. useful PET probe that we developed for in vivo imaging of tau pathol. in the human brain.  To ensure the availability of this probe among multiple PET facilities, in the present study we established protocols for the radiosynthesis and quality control of 11C-PBB3 and for the characterization of its photoisomerization, biodistribution, and metab.  Methods: 11C-PBB3 was synthesized by reaction of the tert-butyldimethylsilyl desmethyl precursor (1) with 11C-Me iodide using potassium hydroxide as a base, followed by deprotection.  Photoisomerization of 11C-PBB3 under fluorescent light was detd.  The biodistribution and metabolite anal. of 11C-PBB3 was detd. in mice using the dissection method.  Results: 11C-PBB3 was synthesized with 15.4% ± 2.8% radiochem. yield (decay-cor., n = 50) based on the cyclotron-produced 11C-CO2 and showed an averaged synthesis time of 35 min from the end of bombardment.  The radiochem. purity and specific activity of 11C-PBB3 were 98.0% ± 2.3% and 180.2 ± 44.3 GBq/μmol, resp., at the end of synthesis (n = 50).  11C-PBB3 showed rapid photoisomerization, and its radiochem. purity decreased to approx. 50% at 10 min after exposure to fluorescent light.  After the fluorescent light was switched off, 11C-PBB3 retained more than 95% radiochem. purity over 60 min.  A suitable brain uptake (1.92% injected dose/g tissue) of radioactivity was obsd. at 1 min after the probe injection, which was followed by rapid washout from the brain tissue.  More than 70% of total radioactivity in the mouse brain homogenate at 5 min after injection represented the unchanged 11C-PBB3, despite its rapid metab. in the plasma.  Conclusion: 11C-PBB3 was produced with sufficient radioactivity and high quality, demonstrating its clin. utility.  The present results of radiosynthesis, photoisomerization, biodistribution, and metabolite anal. could be helpful for the reliable prodn. and application of 11C-PBB3 in diverse PET facilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU4w4Hc1F_UbVg90H21EOLACvtfcHk0ljeL6QfFPr3Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSrurrO&md5=4c888d96eb8afd4447e0c00a4f72460a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.139550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.139550%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DN.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFujishiro%26aufirst%3DT.%26aulast%3DAihara%26aufirst%3DY.%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DFurutsuka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DRadiosynthesis%252C%2520photoisomerization%252C%2520biodistribution%252C%2520and%2520metabolite%2520analysis%2520of%252011C-PBB3%2520as%2520a%2520clinically%2520useful%2520PET%2520probe%2520for%2520imaging%2520of%2520tau%2520pathology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1532%26epage%3D1538%26doi%3D10.2967%2Fjnumed.114.139550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">Evaluation of [<sup>11</sup>C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span><span class="refDoi"> DOI: 10.1021/ml300216t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300216t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=936-941&author=X.+Shaoauthor=G.+M.+Carpenterauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=M.+Fawazauthor=A.+F.+Brooksauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+Scott&title=Evaluation+of+%5B11C%5DN-Methyl+Lansoprazole+as+a+Radiopharmaceutical+for+PET+Imaging+of+Tau+Neurofibrillary+Tangles&doi=10.1021%2Fml300216t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [11C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span></div><div class="casAuthors">Shao, Xia; Carpenter, Garrett M.; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Fawaz, Maria; Brooks, Allen F.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">936-941</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[11C]N-Me lansoprazole ([11C]NML, 3) was synthesized and evaluated as a radiopharmaceutical for quantifying tau neurofibrillary tangle (NFT) burden using positron emission tomog. (PET) imaging. [11C]NML was synthesized from com. available lansoprazole in 4.6% radiochem. yield (noncorrected RCY, based upon [11C]MeI), 99% radiochem. purity, and 16095 Ci/mmol specific activity (n = 5).  Log P was detd. to be 2.18.  A lack of brain uptake in rodent microPET imaging revealed [11C]NML to be a substrate for the rodent permeability-glycoprotein 1 (PGP) transporter, but this could be overcome by pretreating with cyclosporin A to block the PGP.  Contrastingly, [11C]NML was not found to be a substrate for the primate PGP, and microPET imaging in rhesus revealed [11C]NML uptake in the healthy primate brain of ∼1600 nCi/cc max. at 3 min followed by rapid egress to 500 nCi/cc.  Comparative autoradiog. between wild-type rats and transgenic rats expressing human tau (hTau +/+) revealed 12% higher uptake of [11C]NML in the cortex of brains expressing human tau.  Further autoradiog. with tau pos. brain samples from progressive supranuclear palsy (PSP) patients revealed colocalization of [11C]NML with tau NFTs identified using modified Bielschowsky staining.  Finally, satn. binding expts. with heparin-induced tau confirmed Kd and Bmax values of [11C]NML as 700 pM and 0.214 fmol/μg, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXJkNjeWv4rVg90H21EOLACvtfcHk0ljeL6QfFPr3Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI&md5=a1fd3561aca6b2d9366271582e9bf60f</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fml300216t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300216t%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DX.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DFawaz%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B11C%255DN-Methyl%2520Lansoprazole%2520as%2520a%2520Radiopharmaceutical%2520for%2520PET%2520Imaging%2520of%2520Tau%2520Neurofibrillary%2520Tangles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D936%26epage%3D941%26doi%3D10.1021%2Fml300216t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fawaz, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodnick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J.</span><span> </span><span class="NLM_article-title">High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer’s disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span><span class="refDoi"> DOI: 10.1021/cn500103u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500103u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=718-730&author=M.+V.+Fawazauthor=A.+F.+Brooksauthor=M.+E.+Rodnickauthor=G.+M.+Carpenterauthor=X.+Shaoauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=B.+G.+Hockleyauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+Scott&title=High+affinity+radiopharmaceuticals+based+upon+lansoprazole+for+PET+imaging+of+aggregated+tau+in+Alzheimer%E2%80%99s+disease+and+progressive+supranuclear+palsy%3A+synthesis%2C+preclinical+evaluation%2C+and+lead+selection&doi=10.1021%2Fcn500103u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection</span></div><div class="casAuthors">Fawaz, Maria V.; Brooks, Allen F.; Rodnick, Melissa E.; Carpenter, Garrett M.; Shao, Xia; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Hockley, Brian G.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-730</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormally aggregated tau is the hallmark pathol. of tauopathy neurodegenerative disorders and is a target for development of both diagnostic tools and therapeutic strategies across the tauopathy disease spectrum.  Development of carbon-11- or fluorine-18-labeled radiotracers with appropriate affinity and specificity for tau would allow noninvasive quantification of tau burden using positron emission tomog. (PET) imaging.  We have synthesized [18F]lansoprazole, [11C]N-Me lansoprazole, and [18F]N-Me lansoprazole and identified them as high affinity radiotracers for tau with low to subnanomolar binding affinities.  Herein, we report radiosyntheses and extensive preclin. evaluation with the aim of selecting a lead radiotracer for translation into human PET imaging trials.  We demonstrate that [18F]N-Me lansoprazole, on account of the favorable half-life of fluorine-18 and its rapid brain entry in nonhuman primates, favorable kinetics, low white matter binding, and selectivity for binding to tau over amyloid, is the lead compd. for progression into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpII8L0rzeJ2LVg90H21EOLACvtfcHk0lixUQeKZ6yrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D&md5=2b2c7c0e014296ec6865430167067066</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fcn500103u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500103u%26sid%3Dliteratum%253Aachs%26aulast%3DFawaz%26aufirst%3DM.%2BV.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DRodnick%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DHockley%26aufirst%3DB.%2BG.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%26atitle%3DHigh%2520affinity%2520radiopharmaceuticals%2520based%2520upon%2520lansoprazole%2520for%2520PET%2520imaging%2520of%2520aggregated%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520progressive%2520supranuclear%2520palsy%253A%2520synthesis%252C%2520preclinical%2520evaluation%252C%2520and%2520lead%2520selection%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D718%26epage%3D730%26doi%3D10.1021%2Fcn500103u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Riss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1039/c3md00017f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+Williamsonauthor=T.+Fryerauthor=Y.+Hongauthor=J.+Baronauthor=F.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology&doi=10.1039%2Fc3md00017f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%26aulast%3DFryer%26aufirst%3DT.%26aulast%3DHong%26aufirst%3DY.%26aulast%3DBaron%26aufirst%3DJ.%26aulast%3DAigbirhio%26aufirst%3DF.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855%26doi%3D10.1039%2Fc3md00017f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span><span class="refDoi"> DOI: 10.1021/cn200002t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains&doi=10.1021%2Fcn200002t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0lixUQeKZ6yrIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275%26doi%3D10.1021%2Fcn200002t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5700</span><span class="NLM_x">–</span> <span class="NLM_lpage">5703</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.bmcl.2012.06.086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5700-5703&author=H.+Watanabeauthor=M.+Onoauthor=H.+Kimuraauthor=K.+Matsumuraauthor=M.+Yoshimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+oxindole+derivatives+for+imaging+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2012.06.086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.086%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520oxindole%2520derivatives%2520for%2520imaging%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5700%26epage%3D5703%26doi%3D10.1016%2Fj.bmcl.2012.06.086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Phenyldiazenyl benzothiazole derivatives as probes for <i>in vivo</i> imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1039/c1md00034a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2Fc1md00034a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=596-600&author=K.+Matsumuraauthor=M.+Onoauthor=H.+Hayashiauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=K.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Phenyldiazenyl+benzothiazole+derivatives+as+probes+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains&doi=10.1039%2Fc1md00034a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1039%2Fc1md00034a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00034a%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPhenyldiazenyl%2520benzothiazole%2520derivatives%2520as%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D596%26epage%3D600%26doi%3D10.1039%2Fc1md00034a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3356</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.02.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.bmc.2013.02.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23601814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVamsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3356-3362&author=K.+Matsumuraauthor=M.+Onoauthor=M.+Yoshimuraauthor=H.+Kimuraauthor=H.+Watanabeauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+styryl+benzimidazole+derivatives+as+probes+for+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2013.02.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease</span></div><div class="casAuthors">Matsumura, Kenji; Ono, Masahiro; Yoshimura, Masashi; Kimura, Hiroyuki; Watanabe, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3356-3362</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This paper describes the synthesis and biol. evaluation of styrylbenzimidazole (SBIM) derivs. as agents for imaging neurofibrillary tangles (NFT) in patients with Alzheimer's disease (AD).  SBIM derivs. were prepd. with 4-iodobenzene-1,2-diamine and substituted cinnamaldehydes.  In binding expts. using recombinant tau and Aβ1-42 aggregates, SBIM-3 showed higher affinity for the tau aggregates than Aβ1-42 aggregates (ratio of Kd values was 2.73).  In in vitro autoradiog. and fluorescent staining, [125I]SBIM-3 (or SBIM-3) bound NFT in sections of AD brain tissue.  In biodistribution expts. using normal mice, all [125I]SBIM derivs. showed high initial uptake into (3.20-4.11%ID/g at 2 min after the injection) and rapid clearance from (0.12-0.33%ID/g at 60 min after the injection) the brain.  In conclusion, appropriate structural modifications of SBIM derivs. could lead to more useful agents for the in vivo imaging of NFT in AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQbIJXXTqoNrVg90H21EOLACvtfcHk0lhCT0i0Zy_r-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVamsr4%253D&md5=abba071beffe5a7bd035ebab09269396</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.02.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.02.054%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520styryl%2520benzimidazole%2520derivatives%2520as%2520probes%2520for%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3356%26epage%3D3362%26doi%3D10.1016%2Fj.bmc.2013.02.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikuni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of <sup>123</sup>I-labeled pyridyl benzoxazole derivatives: novel β-amyloid imaging probes for single-photon emission computed tomography</span> <span class="citation_source-journal">RSC Adv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span><span class="refDoi"> DOI: 10.1039/C4RA10742J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1039%2FC4RA10742J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1009-1015&author=H.+Watanabeauthor=M.+Onoauthor=S.+Iikuniauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+123I-labeled+pyridyl+benzoxazole+derivatives%3A+novel+%CE%B2-amyloid+imaging+probes+for+single-photon+emission+computed+tomography&doi=10.1039%2FC4RA10742J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of 123I-labeled pyridyl benzoxazole derivatives: novel β-amyloid imaging probes for single-photon emission computed tomography</span></div><div class="casAuthors">Watanabe, Hiroyuki; Ono, Masahiro; Iikuni, Shimpei; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1009-1015</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In vivo imaging of β-amyloid (Aβ) plaques by non-invasive techniques such as positron emission tomog. (PET) and single-photon emission computed tomog. (SPECT) may facilitate early diagnosis and drug discovery for the treatment of Alzheimer's disease (AD).  SPECT is known as a more useful modality than PET in terms of routine diagnostic use, but there have been no reports on attractive probes in clin. studies.  In this study, we synthesized and evaluated novel 123I-labeled pyridyl benzoxazole (PBOX) derivs. as SPECT probes for imaging Aβ plaques in vivo.  The PBOX derivs. showed affinity for Aβ(1-42) aggregates in vitro (Ki = 6.9-138 nM).  In biodistibution expts. in normal mice, all these derivs. showed high initial uptake into (4.6-6.6% ID g-1 at 2 min) and rapid clearance (0.3-1.3% ID g-1 at 60 min) from the brain.  Furthermore, [125I]9 clearly labeled Aβ plaques in in vitro autoradiog. of postmortem AD brain sections.  SPECT/CT study with [123I]9 displayed higher radioactivity in Tg2576 mice than wild-type mice.  In addn., ex vivo autoradiograms of brain sections from Tg2576 mice after the injection of [123I]9 showed selective binding of Aβ plaques.  In conclusion, [123I]9 may be a potential SPECT probe for imaging Aβ plaques in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv7CXn1IXocLVg90H21EOLACvtfcHk0lhCT0i0Zy_r-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtbjI&md5=fd2f03d124f85b6c853212ed8f9e013c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2FC4RA10742J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4RA10742J%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DIikuni%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520123I-labeled%2520pyridyl%2520benzoxazole%2520derivatives%253A%2520novel%2520%25CE%25B2-amyloid%2520imaging%2520probes%2520for%2520single-photon%2520emission%2520computed%2520tomography%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D1009%26epage%3D1015%26doi%3D10.1039%2FC4RA10742J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikuni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Development of novel <sup>123</sup>I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer’s disease</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e74104</span><span class="refDoi"> DOI: 10.1371/journal.pone.0074104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1371%2Fjournal.pone.0074104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e74104&author=M.+Onoauthor=Y.+Chengauthor=H.+Kimuraauthor=H.+Watanabeauthor=K.+Matsumuraauthor=M.+Yoshimuraauthor=S.+Iikuniauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Development+of+novel+123I-labeled+pyridyl+benzofuran+derivatives+for+SPECT+imaging+of+%CE%B2-amyloid+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0074104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0074104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0074104%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DIikuni%26aufirst%3DS.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DDevelopment%2520of%2520novel%2520123I-labeled%2520pyridyl%2520benzofuran%2520derivatives%2520for%2520SPECT%2520imaging%2520of%2520%25CE%25B2-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De74104%26doi%3D10.1371%2Fjournal.pone.0074104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mishra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thangamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipem, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamoorthy, G.</span><span> </span><span class="NLM_article-title">Photoisomerization of trans-2-[4′-(dimethylamino)styryl]benzothiazole</span> <span class="citation_source-journal">Photochem. Photobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span><span class="refDoi"> DOI: 10.1111/j.1751-1097.2012.01227.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1111%2Fj.1751-1097.2012.01227.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22924651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1ylsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2013&pages=247-252&author=A.+Mishraauthor=A.+Thangamaniauthor=S.+Chatterjeeauthor=F.+A.+Chipemauthor=G.+Krishnamoorthy&title=Photoisomerization+of+trans-2-%5B4%E2%80%B2-%28dimethylamino%29styryl%5Dbenzothiazole&doi=10.1111%2Fj.1751-1097.2012.01227.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Photoisomerization of trans-2-[4'-(dimethylamino)styryl]benzothiazole</span></div><div class="casAuthors">Mishra, Anasuya; Thangamani, Arumugam; Chatterjee, Soumya; Chipem, Francis A. S.; Krishnamoorthy, Govindarajan</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photoreaction of trans-2-[4'-(dimethylamino)styryl]benzothiazole (t-DMASBT) under direct irradn. has been investigated in dioxane, chloroform, methanol and glycerol to understand the mechanism of photoisomerization.  Contrary to an earlier report, isomerization takes place in all these solvents including glycerol.  The results show that restriction on photoisomerization leads to the increase in fluorescence quantum yield in glycerol.  The results are consistent with the theor. simulated potential energy surface reported earlier using time-dependent d. functional theory (TDDFT) calcns.  DFT calcns. on cis isomers under isolated condition have suggested that cis-B conformer is more stable than cis-A conformer due to hydrogen-bonding interaction.  In the ground state, cis-DMASBT is predominantly present as cis-B.  The fluorescence spectra of the irradiated t-DMASBT suggested that photoisomerization follows not the adiabatic path as proposed by S. K. Saha et al., but the nonadiabatic path.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3iZd_vahSSrVg90H21EOLACvtfcHk0lhvaHLLaRdn6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1ylsLY%253D&md5=6e94b8d6277c6eb12ada116d6c468d54</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2012.01227.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2012.01227.x%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DThangamani%26aufirst%3DA.%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DChipem%26aufirst%3DF.%2BA.%26aulast%3DKrishnamoorthy%26aufirst%3DG.%26atitle%3DPhotoisomerization%2520of%2520trans-2-%255B4%25E2%2580%25B2-%2528dimethylamino%2529styryl%255Dbenzothiazole%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2013%26volume%3D89%26spage%3D247%26epage%3D252%26doi%3D10.1111%2Fj.1751-1097.2012.01227.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Lewis, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokumatsu, K.</span><span> </span><span class="NLM_article-title">Molecular structure and photochemistry of (<i>E</i>)- and (<i>Z</i>)-2-(2-(2-pyridyl)ethenyl)indole. A case of hydrogen bond dependent one-way photoisomerization</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3029</span><span class="NLM_x">–</span> <span class="NLM_lpage">3036</span><span class="refDoi"> DOI: 10.1021/ja00116a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00116a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=3029-3036&author=F.+D.+Lewisauthor=B.+A.+Yoonauthor=T.+Araiauthor=T.+Iwasakiauthor=K.+Tokumatsu&title=Molecular+structure+and+photochemistry+of+%28E%29-+and+%28Z%29-2-%282-%282-pyridyl%29ethenyl%29indole.+A+case+of+hydrogen+bond+dependent+one-way+photoisomerization&doi=10.1021%2Fja00116a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja00116a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00116a008%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DF.%2BD.%26aulast%3DYoon%26aufirst%3DB.%2BA.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DIwasaki%26aufirst%3DT.%26aulast%3DTokumatsu%26aufirst%3DK.%26atitle%3DMolecular%2520structure%2520and%2520photochemistry%2520of%2520%2528E%2529-%2520and%2520%2528Z%2529-2-%25282-%25282-pyridyl%2529ethenyl%2529indole.%2520A%2520case%2520of%2520hydrogen%2520bond%2520dependent%2520one-way%2520photoisomerization%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D3029%26epage%3D3036%26doi%3D10.1021%2Fja00116a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimers Dis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.3233/JAD-2010-1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.3233%2FJAD-2010-1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252FmtlajsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2010-1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Rojo Leonel E; Alzate-Morales Jans; Saavedra Ivan N; Davies Peter; Maccioni Ricardo B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-89</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We describe the interactions of two benzimidazole derivatives, astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compounds, with important medical applications in the treatment of allergies and gastrointestinal disorders respectively, specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-beta polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochemical studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: i) in vitro by parallel artificial membrane permeability assay followed by experimental Log P determinations; and ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concentration ratios for these compounds were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are positively correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3LzL_5H7rpeIHSmpohpd0fW6udTcc2eYkSGLTV4Jj87ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252FmtlajsQ%253D%253D&md5=0cde76ef256596028059014926c12e71</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1262%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedra%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimers%2520Dis%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589%26doi%3D10.3233%2FJAD-2010-1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Differentiating Alzheimer disease-associated aggregates with small molecules</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1016/j.nbd.2007.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.nbd.2007.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=17761424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=251-260&author=N.+S.+Honsonauthor=R.+L.+Johnsonauthor=W.+Huangauthor=J.+Ingleseauthor=C.+P.+Austinauthor=J.+Kuret&title=Differentiating+Alzheimer+disease-associated+aggregates+with+small+molecules&doi=10.1016%2Fj.nbd.2007.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating Alzheimer disease-associated aggregates with small molecules</span></div><div class="casAuthors">Honson, Nicolette S.; Johnson, Ronald L.; Huang, Wenwei; Inglese, James; Austin, Christopher P.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease is diagnosed postmortem by the d. and spatial distribution of β-amyloid plaques and tau-bearing neurofibrillary tangles.  The major protein component of each lesion adopts cross-β-sheet conformation capable of binding small mols. with submicromolar affinity.  In many cases, however, Alzheimer pathol. overlaps with Lewy body disease, characterized by the accumulation of a third cross-β-sheet forming protein, α-synuclein.  To det. the feasibility of distinguishing tau aggregates from β-amyloid and α-synuclein aggregates with small mol. probes, a library contg. 72,455 small mols. was screened for antagonists of tau-aggregate-mediated changes in Thioflavin S fluorescence, followed by secondary screens to distinguish the relative affinity for each substrate protein.  Results showed that > 10-fold binding selectivity among substrates could be achieved, with mols. selective for tau aggregates contg. at least three arom. or rigid moieties connected by two rotatable bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9wia16OfSrVg90H21EOLACvtfcHk0liRjVabg5xfow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO&md5=70434cbb21ca7e4380e06bf5113ee868</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2007.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2007.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DDifferentiating%2520Alzheimer%2520disease-associated%2520aggregates%2520with%2520small%2520molecules%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2007%26volume%3D28%26spage%3D251%26epage%3D260%26doi%3D10.1016%2Fj.nbd.2007.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Quinoline and benzimidazole derivatives: candidate probes for <i>in vivo</i> imaging of tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10857</span><span class="NLM_x">–</span> <span class="NLM_lpage">10862</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1738-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1523%2FJNEUROSCI.1738-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=16306398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10857-10862&author=N.+Okamuraauthor=T.+Suemotoauthor=S.+Furumotoauthor=M.+Suzukiauthor=H.+Shimadzuauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Fujiwaraauthor=M.+Nemotoauthor=M.+Maruyamaauthor=H.+Araiauthor=K.+Yanaiauthor=T.+Sawadaauthor=Y.+Kudo&title=Quinoline+and+benzimidazole+derivatives%3A+candidate+probes+for+in+vivo+imaging+of+tau+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.1738-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Suemoto, Takahiro; Furumoto, Shozo; Suzuki, Masako; Shimadzu, Hiroshi; Akatsu, Hiroyasu; Yamamoto, Takayuki; Fujiwara, Hironori; Nemoto, Miyako; Maruyama, Masahiro; Arai, Hiroyuki; Yanai, Kazuhiko; Sawada, Tohru; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10857-10862</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques predominantly comprise hyperphosphorylated tau protein and represent pathol. characteristics of Alzheimer's disease (AD).  These lesions occur before the presentation of clin. symptoms and correlate with the severity of dementia.  In vivo detection of these lesions would thus prove useful for preclin. diagnosis of AD and for tracking disease progression.  The present study introduces three novel compds., 4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine (BF-126), 2-[(4-methylamino)phenyl]quinoline (BF-158), and 2-(4-aminophenyl)quinoline (BF-170), as candidate probes for in vivo imaging of tau pathol. in the AD brain.  When solns. of these compds. are injected i.v. into normal mice, these agents exhibit excellent brain uptake and rapid clearance from normal brain tissue.  These compds. display relatively lower binding affinity to β-amyloid fibrils and higher binding affinity to tau fibrils, compared with previously reported probe BF-168.  In neuropathol. examn. using AD brain sections, BF-126, BF-158, and BF-170 clearly visualize NFTs, neuropil threads, and paired helical filament-type neuritis.  Autoradiog. using 11C-labeled BF-158 further demonstrated labeling of NFTs in AD brain sections.  These findings suggest the potential usefulness of quinoline and benzimidazole derivs. for in vivo imaging of tau pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1dHoJmFJtNLVg90H21EOLACvtfcHk0liRjVabg5xfow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K&md5=4b0bc18420a2429789d47bcb91eeb11c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1738-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1738-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DSuemoto%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemoto%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DQuinoline%2520and%2520benzimidazole%2520derivatives%253A%2520candidate%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10857%26epage%3D10862%26doi%3D10.1523%2FJNEUROSCI.1738-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer’s disease brain</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1007/s11307-013-0667-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs11307-013-0667-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=23868612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=19-27&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Yoshikawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Use+of+a+benzimidazole+derivative+BF-188+in+fluorescence+multispectral+imaging+for+selective+visualization+of+tau+protein+fibrils+in+the+Alzheimer%E2%80%99s+disease+brain&doi=10.1007%2Fs11307-013-0667-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain</span></div><div class="casAuthors">Harada Ryuichi; Okamura Nobuyuki; Furumoto Shozo; Yoshikawa Takeo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Selective visualization of amyloid-β and tau protein deposits will help to understand the pathophysiology of Alzheimer's disease (AD).  Here, we introduce a novel fluorescent probe that can distinguish between these two deposits by multispectral fluorescence imaging technique.  PROCEDURES:  Fluorescence spectral analysis was performed using AD brain sections stained with novel fluorescence compounds.  Competitive binding assay using [(3)H]-PiB was performed to evaluate the binding affinity of BF-188 for synthetic amyloid-β (Aβ) and tau fibrils.  RESULTS:  In AD brain sections, BF-188 clearly stained Aβ and tau protein deposits with different fluorescence spectra.  In vitro binding assays indicated that BF-188 bound to both amyloid-β and tau fibrils with high affinity (K i  < 10 nM).  In addition, BF-188 showed an excellent blood-brain barrier permeability in mice.  CONCLUSION:  Multispectral imaging with BF-188 could potentially be used for selective in vivo imaging of tau deposits as well as amyloid-β in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkJCOOHC_nB-3MPKNEWB5RfW6udTcc2ebTqmwJfQFYx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D&md5=2b4d4aa9b23c8430946fc594d392a108</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0667-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0667-2%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DUse%2520of%2520a%2520benzimidazole%2520derivative%2520BF-188%2520in%2520fluorescence%2520multispectral%2520imaging%2520for%2520selective%2520visualization%2520of%2520tau%2520protein%2520fibrils%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D19%26epage%3D27%26doi%3D10.1007%2Fs11307-013-0667-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span><span class="refDoi"> DOI: 10.1016/j.tips.2009.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood-brain+barrier+and+surviving+metabolism&doi=10.1016%2Fj.tips.2009.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0lisPlQb-pDKBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood-brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440%26doi%3D10.1016%2Fj.tips.2009.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Snellman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Picon, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskola, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haaparanta-Solin, M.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of [<sup>18</sup>F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1784</span><span class="NLM_x">–</span> <span class="NLM_lpage">1795</span><span class="refDoi"> DOI: 10.1007/s00259-012-2178-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=10.1007%2Fs00259-012-2178-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=22801729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOqsLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1784-1795&author=A.+Snellmanauthor=J.+Rokkaauthor=F.+R.+Lopez-Piconauthor=O.+Eskolaauthor=I.+Wilsonauthor=G.+Farrarauthor=M.+Scheininauthor=O.+Solinauthor=J.+O.+Rinneauthor=M.+Haaparanta-Solin&title=Pharmacokinetics+of+%5B18F%5Dflutemetamol+in+wild-type+rodents+and+its+binding+to+beta+amyloid+deposits+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-012-2178-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Snellman, Anniina; Rokka, Johanna; Lopez-Picon, Francisco R.; Eskola, Olli; Wilson, Ian; Farrar, Gill; Scheinin, Mika; Solin, Olof; Rinne, Juha O.; Haaparanta-Solin, Merja</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1784-1795</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The aim of this study was to investigate the potential of [18F]flutemetamol as a preclin. PET tracer for imaging β-amyloid (Aβ) deposition by comparing its pharmacokinetics to those of [11C]Pittsburgh compd. B ([11C]PIB) in wild-type Sprague Dawley rats and C57Bl/6N mice.  In addn., binding of [18F]flutemetamol to Aβ deposits was studied in the Tg2576 transgenic mouse model of Alzheimer's disease.  Methods: [18F]Flutemetamol biodistribution was evaluated using ex vivo PET methods and in vivo PET imaging in wild-type rats and mice.  Metab. and binding of [11C]PIB and [18F]flutemetamol to plasma proteins were analyzed using thin-layer chromatog. and ultrafiltration methods, resp.  Radiation dose ests. were calcd. from rat ex vivo biodistribution data.  The binding of [18F]flutemetamol to Aβ deposits was also studied using ex vivo and in vitro autoradiog.  The location of Aβ deposits in the brain was detd. with thioflavine S staining and immunohistochem.  Results: The pharmacokinetics of [18F]flutemetamol resembled that of [11C]PIB in rats and mice.  In vivo studies showed that both tracers readily entered the brain, and were excreted via the hepatobiliary pathway in both rats and mice.  The metab. of [18F]flutemetamol into radioactive metabolites was faster than that of [11C]PIB. [18F]Flutemetamol cleared more slowly from the brain than [11C]PIB, particularly from white matter, in line with its higher lipophilicity.  ED ests. for [11C]PIB and [18F]flutemetamol were 2.28 and 6.65 μSv/MBq, resp.  Autoradiographs showed [18F]flutemetamol binding to fibrillar Aβ deposits in the brain of Tg2576 mice.  Conclusion: Based on its pharmacokinetic profile, [18F]flutemetamol showed potential as a PET tracer for preclin. imaging.  It showed good brain uptake and was bound to Aβ deposits in the brain of Tg2576 mice.  However, its high lipophilicity might complicate the anal. of PET data, particularly in small-animal imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9ikaBJMflNbVg90H21EOLACvtfcHk0lisPlQb-pDKBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOqsLjE&md5=4dcf576bc25da98fa04bb177076bef6e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2178-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2178-9%26sid%3Dliteratum%253Aachs%26aulast%3DSnellman%26aufirst%3DA.%26aulast%3DRokka%26aufirst%3DJ.%26aulast%3DLopez-Picon%26aufirst%3DF.%2BR.%26aulast%3DEskola%26aufirst%3DO.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DFarrar%26aufirst%3DG.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DSolin%26aufirst%3DO.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DHaaparanta-Solin%26aufirst%3DM.%26atitle%3DPharmacokinetics%2520of%2520%255B18F%255Dflutemetamol%2520in%2520wild-type%2520rodents%2520and%2520its%2520binding%2520to%2520beta%2520amyloid%2520deposits%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2012%26volume%3D39%26spage%3D1784%26epage%3D1795%26doi%3D10.1007%2Fs00259-012-2178-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i102"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00440">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_65441"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00440">10.1021/acs.jmedchem.5b00440</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Summary of the method and solvent used in radiolabeling, HPLC condition used for the purification of each ligand, the retention time of each ligand in the HPLC analysis, biodistribution of radioactivity after injection of [<sup>125</sup>I]<b>64</b> in normal mice, <i>in vitro</i> fluorescent-staining image of compound <b>3</b> in the AD brain section, <i>in vitro</i> autoradiography of [<sup>125</sup>I]<b>64</b> in the healthy control brain section, quantitative analysis of autoradiography of each ligand, evaluation of <i>in vitro</i> and <i>in vivo</i> stability of [<sup>125</sup>I]<b>64</b>, <sup>1</sup>H NMR spectra files, and detailed methods for radiolabeling and measurements of log D<sub>7.4</sub> values (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00440/suppl_file/jm5b00440_si_001.pdf">jm5b00440_si_001.pdf (15.55 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00440&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00440%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-18%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00440" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b2782c58d942","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
